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 The utility of 193 nm ultraviolet photodissociation (UVPD) is evaluated for high-
throughput proteomics applications including: analysis of small peptides in a traditional 
bottom-up proteomics workflow, analysis of heavily modified larger middle down sized 
peptides, and heavily modified intact proteins in a top-down proteomics workflow. UVPD 
uses higher energy ultraviolet photons (193 nm, 6.4 eV per photon), which are absorbed 
by the backbone to activate and dissociate ions effectively. UVPD dissociation is able to 
generate extensive backbone fragmentation enabling excellent characterization of peptides 
and proteins compared to traditional methods. Moreover, UVPD is also less hindered by 
certain experimental variables such as degree of modification, charge state and even ion 
polarity. These features are easily capitalized on for proteomics applications especially 
analysis of post translational modifications (PTM’s). Characterization of PTM’s is of great 
interest due to their involvement in several important cellular processes including cell 
signaling, tumorigenesis and gene expression.  The studies covered in this work focus on 
utilizing the unique capabilities of UVPD to: 1.) characterize underrepresented peptides 
(acidic peptides and phosphopeptides) in the negative polarity including development of 
software for the analysis of the data generated, 2.) analyze intact proteins which have 
 vii 
undergone extensive chemical modification and charge state augmentation, and 3.)  
precisely characterize histone proteins which are heavily modified due to their central role 
in gene expression and other transcription related functions.  
 
 viii 
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Proteomics is the comprehensive study of proteomes including their constituent 
proteins, protein structure, protein function and protein interactions. Proteomics presents a 
significant analytical challenge due to the extremely heterogeneous nature and the large 
dynamic range of proteins in a proteome. Despite these challenges several techniques have 
been employed such as immunoassay, SDS-PAGE, DNA microarrays, Western blotting, 
and Edman degradation, however the use of mass spectrometry has recently come to the 
forefront due to its ability to analyze entire proteomes in short times and its ever-growing 
capabilities to analyze even the most trace components of the proteome.1–3 
The first analysis of molecules by mass spectrometry is often credited to J.J. 
Thomson and his seminal work in the early 20th century. However, mass analysis of 
biomolecules by mass spectrometry was not fully realized until the era of electrospray 
ionization (ESI) and matrix assisted laser desorption ionization (MALDI) nearly a century 
later. These two landmark modes of ionization were developed simultaneously; one mode 
(ESI) in the lab of John Fenn and the other (MALDI) in the lab of Franz Hillenkamp.4 
Electrospray ionization involves application of a high voltage to a liquid generating an 
aerosol containing charged analytes which are desolvated and analyzed by the mass 
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spectrometer.5  MALDI involves deposition of the analyte in a specific, often acidic, 
crystalline matrix which is then irradiated by a laser. The ion-containing matrix is then 
ablated/desorbed from the surface by laser irradiation and desorbed inside the mass 
spectrometer for mass analysis.6  These two methods were the first used to routinely ionize 
large biomolecules such as peptides and proteins. Presently electrospray is the preferred 
mode for high-throughput protein and peptide analysis due to its natural coupling to high 
performance liquid chromatography separations.7,8 
Meanwhile another development, genome sequencing, has enabled modern mass 
spectrometry based proteomics.9 Complete genomes have made possible the creation of 
databases of protein sequences.10,11 Protein sequences can be generated directly from the 
genome based on the well-known Central Dogma of translation and transcription. After 
filtering out non-coding regions and extraneous information a list of proteins in the form 
of their amino acid sequences is generated, which in turn can be used to interpret mass 
spectral data based on diagnostic ions. Despite the genome having a finite size, the effective 
proteome is actually much greater due to the variability of genome expression, point 
mutations and post-translational modifications of proteins.12 Presently the characterization 
of post-translational modifications by mass spectrometry is an ongoing area of 
development.13–20 The remainder of this first chapter outlines the methods used to 
characterize proteins, peptides and their post-translational modifications using mass 
spectrometry, and a key theme of the doctoral work presented here describes the use of 193 
nm ultraviolet photodissociation (UVPD) as a new approach for proteomics.  
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1.2 HIGH-THROUGHPUT ANALYSIS OF PROTEINS AND PEPTIDES 
High-throughput proteomics, analysis of hundreds to thousands of proteins in a 
single experiment, has become a routine procedure for mass spectrometry due to several 
developments including: coupling of high performance separation techniques to MS 
workflows, MS instrumentation development such as novel fragmentation techniques, and 
development of bioinformatics tools designed for expert analysis of LC-MS data.4,15,21–26 
Coupling of mass spectrometry to liquid chromatography and other forms of 
separation before mass analysis allows temporal resolution of hundreds to thousands of 
compounds.27–30 Without such separation species which ionize most efficiently would 
overwhelm less abundant species or those that ionize poorly.  Additionally, it is common 
to encounter species which give rise to signals with overlapping mass-to-charge ratios 
(m/z), and these can be readily separated based on their differences in sizes or chemical 
properties prior to mass spectrometry analysis, thus alleviating their m/z overlap.31 
In general, reversed phase LC is the method of choice to separate peptides and 
proteins. Reversed phase mode separates molecules based on their hydrophobicity which 
for proteins and peptides this is a proxy for their size and number of hydrophobic 
residues.32–34 Other forms of chromatography are often employed for specific applications 
based on unique molecular characteristics of the sample. For instance, hydrophilic 
interaction chromatography (HILIC) is well suited for separation of hydrophilic molecules 
which may not be retained, separable, or well resolved by reversed phase chromatography.  
HILIC is often the mode of choice for glycosylated and phosphorylated peptides due to the 
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added hydrophilicity imparted by these modifications.35–40 HILIC has the added benefit of 
eluting analytes under a majority organic mobile phase composition, yielding very stable 
electrospray compared to the often more aqueous mobile phases used for reversed phase 
applications.35 
1.2.1 Two dimensional LC-MS  
In an effort to combat the complexity of biological samples, integration of 
additional orthogonal dimensions of separations have gained traction. Traditional peptide 
and protein chromatography separates these molecules primarily based on a single 
characteristic (e.g., hydrophobicity, hydrophilicity, size, etc.). Despite the excellent 
separation power of the reversed phase mode, and other methods such as HILIC, often in 
samples containing thousands of analytes many will co-elute due to similar hydrophobic 
character.  One solution is to separate the analytes a second time based on an orthogonal 
chemical characteristic, such that analytes of similar character X have very different 
character Y. For example, peptides can be separated based on charge using strong cation 
exchange (SCX) and then separated by hydrophobicity using RPLC. Recent advances have 
enabled these orthogonal methods to be performed in an integrated online fashion such that 
the sample is injected onto the LC and both dimensions of separations are performed in an 
automated fashion using a single column with serial packings after which the analytes are 
electrosprayed into the MS for analysis. 
The most well-known example of 2D LC for proteomics called multidimensional 
protein identification technology (MUDPIT) was introduced by the Yates lab.33,41 It uses a 
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single column packed in serial with two different stationary phases, first with C18 RP 
particles and then with SCX particles to form a SCX-RP system for separation of a peptide 
mixture prior to analysis by mass spectrometry.  The choice of these stationary phases is 
ideal in that the mobile phases used for each is compatible with the other stationary phase. 
Peptides are injected onto the SCX column, and a fraction of the absorbed peptides are 
eluted onto a RP column using a salt step gradient. After washing away salts and buffers, 
peptides retained on the RP column are eluted from the RP column into the mass 
spectrometer using a gradient of increasing organic solvent concentration. The RP column 
is re-equilibrated in order to adsorb another fraction of peptides from the SCX column. 
This process is repeated for several fractions of increasing salt concentration form SCX 
column. In its initial implementation by the Yates lab a direct comparison of 1D RP and 
2D SCX-RP analysis were compared based on identified proteins from the 80S ribosome 
from yeast, a model system containing less than 100 total proteins.  The 1D approach 
identified 56 proteins while the 2D approach identified 95 a 70% increase.42 Subsequently 
improved implementations of 2D SCX-RPLC was applied to a more complex yeast cell 
lysate and more than tripled the number of identified proteins compared to 1D 
technology.41  2D-LC methods for large-scale proteomics are now commonplace, as 
evidenced by adoption of this type of strategy in numerous recent reports.43–47  
While advancements and integration of chromatography into the MS workflow 
allowed the introduction of thousands of species, improvements in the capabilities of mass 
spectrometers allows full advantage to be taken of these high-performance separations.  
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1.3 ALTERNATIVE APPROACHES TO PROTEOME CHARACTERIZATION 
Traditional “bottom-up” proteomics involves enzymatically digesting proteins into 
small peptides followed by LC-MS analysis. Bioinformatics software is then used to stitch 
together the original proteins from the identified peptides in a “bottom-up” fashion. 
Bottom-up proteomics has benefited greatly from improvements in LC efficiency (i.e. 
nanobore LC), high resolution accurate mass determination (i.e. Orbitrap mass analyzer), 
and parallelization-capable mass spectrometers (i.e. ion trap-orbitrap hybrid mass 
spectrometer) enabling more peptide identifications and greater characterization of the 
proteome than previously possible.48  Despite the gains in performance, not all peptides are 
easily interrogated using traditional bottom-up approaches, namely PTM-bearing peptides, 
very acidic and very basic peptides. Recently much progress has been made in the use of 
alternative approaches. Three alternative approaches will be introduced and discussed in 
the next sub-sections: top-down proteomics, middle-down proteomics, and negative 
polarity proteomics and are also utilized in the following Chapters:  top-down (Chapters 5 
& 8), middle-down (Chapters 4 & 7), and negative polarity (Chapters 3&6). 
1.3.1 Top-down Proteomics  
Analysis of intact proteins known as “top-down proteomics” (Figure 1.1) presents 
several technical challenges, some of which have been addressed by the increasing 
availability of high resolution/high accuracy MS platforms while others such as efficient 
separations and tandem MS techniques for intact proteins continue to be developed. 
Separations of intact proteins often suffer lower efficiency due to their size and complex 
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chemical makeup (i.e acidic, basic, hydrophobic, and hydrophilic residues) giving rise to 
many poorly controlled analyte-stationary phase interactions and analyte-solvent 
interactions.49,50 Peptides generated by bottom-up methods have significantly simplified 
chemical characteristics, often influenced by the enzyme used to digest them, and 
separation is controlled predominately by hydrophobic interaction with the stationary 
phase.51 For instance, trypsin predominantly generates peptides with a lysine or arginine 
residue at the C-terminus, making peptides generally more amenable to RPLC separations. 
Furthermore, peptides contain fewer ionizable sites and generally exist in two or three 
charge states, whereas intact proteins often exist in more than ten charge states which leads 
to greater signal dilution and fundamental sensitivity concerns. In essence, the signal of a 
particular charge state arising from an equal number of molecules of a peptide or a protein 
may vary several orders of magnitude due to original signal being diluted over many more 
charge states. This problem is further exacerbated during a tandem MS experiment. 
Peptides may dissociate into dozens of fragments whereas intact proteins often dissociate 
into hundreds of possible fragments, again causing signal dilution.52 Additionally, due to 
the narrow spacing of the higher charge state species of proteins, a high resolution 
instrument is required for these analyses; however, this has largely been addressed in recent 
years by the availability of high resolution Orbitrap mass spectrometers.48,53 In spite the 
challenges of analyzing intact proteins, the potential advantages are extremely desirable, 
achievable only through the top-down approach and are now within reach.54 
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 As previously mentioned top-down proteomics offers several distinct advantages. 
One of the most exploitable advantages is the ability to uniquely characterize the entire 
protein and any modifications, further referred to as a proteoform.55 In the case of bottom-
up methods the original nature of the proteoform or proteoform must be inferred based on 
a few representative peptides per protein, thus leaving gaps in sequence coverage and the 
potential for overlooking PTMs.56  In contrast, a top-down methodology can utilize the 
intact mass to identify differing proteins or proteoforms, and use subsequent fragmentation 
to localize any modifications.57 One particular case where this is particularly advantageous 
is in analysis of heavily modified proteins.58  Proteolysis of a mixture of proteoforms yields 
peptides with and without modifications, making it nearly impossible to confidently 
determine whether certain modifications co-exist unless they are located the same 
peptide.59 Analysis of a mixture of intact proteoforms yields a list of protein masses which 
correspond to the protein sequence plus any modifications.  Further interrogation of these 
species by tandem mass spectrometry allows each proteoform to be assigned uniquely (i.e. 
identity and location of each modification) if the fragmentation pattern is sufficiently 
detailed.60  For this and other reasons top-down proteomics has enjoyed a recent surge in 
exploration. The lynchpin in the process of uniquely identifying all detectable proteoforms 
in a mixture is the ability of the MS2 technique to provide full characterization, meaning 
extensive series of fragment ions that allow confirmation of sequence and PTM 
information. Without identifying and localizing the modifications fully, inferences must be 
made similar to bottom-up methodologies, and this nullifies much of the clarity imparted 
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by the top-down method. As described in the previous section, several MS/MS methods 
have made inroads in the area of PTM characterization of intact proteins, including EThcD, 
ETD and UVPD which are discussed in more depth in Chapter 8. 
 
Figure 1.1  Overview of top-down, middle-down, and bottom-up proteomics 
workflows. (from J. Proteome Res., 2013, 12 (3), pp 1067–1077). Briefly, 
top-down proteomics focuses on analysis of intact minimally processed 
proteins, middle-down proteomics focuses on analysis of proteins cleaved 
into fewer large sized peptides, and bottom-up proteomics often utilizes 
trypsin to generate the largest number of small peptides. All methods are can 
be coupled to LC for analysis of complex samples. Spectral complexity is 
the inverse of sample prep (i.e. intact protein generates the richest fragment 
spectra, while bottom up usually generates the sparsest). 
 
1.3.2 Middle-down Proteomics 
Middle-down proteomics (Figure 1.1) uses methods common to both top-down and 
bottom-up analyses. Proteins are cleaved into smaller pieces via enzymatic or chemical 
digestion similar to bottom-up proteomics.61 However, the proteolysis is carefully 
controlled to generate much larger peptides, usually 5-20 kDa in size.  The practical 
methods for generating these peptides has varied greatly and is currently an area of pursuit. 
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A single method to generate middle-down size peptides remains elusive. Currently 
endoproteinase GluC is the most commonly used protease to generate larger middle down 
sized peptides. GluC cleaves C-terminal to glutamic acid.61 In instances when GluC does 
not generate the desired peptides, protease AspN is utilized which cleaves N-terminal to 
aspartic acid.62 Currently novel proteases are being explored in order to deliver a better 
solution for generating middle down peptides. For example, the enzyme known as neprosin 
has shown promise; it is selective for cleavage C-terminal to proline.63 Proline occurs 
relatively infrequently compared to other residues, thus making it an ideal proteolytic 
cleavage point for generating middle down peptides.  Chemical digestion using formic acid 
has also been pursued to generate peptides in this size range.64 Treatment with formic acid 
shows specificity towards acidic residues (aspartic acid and glutamic acid); however, it can 
be relatively non-specific unless the digest conditions are strictly controlled.64  
Since these peptides are very large, MS analysis often follows a top-down approach 
using high resolving power, accurate mass instrumentation.61  Many of the difficulties of 
top-down analysis are mitigated by focusing on this alternative “middle” size regime.  
Given the longer stretch of protein backbone present in middle-down sized peptides, 
combinations of PTMs can often be fully characterized thus overcoming the shortfalls of 
bottom-up PTM analysis.65 The middle-down approach for PTM analysis is further 
discussed in Chapter 7. Middle-down strategies show much promise in the analysis of 




1.3.3 Negative Polarity Proteomics 
 The vast majority of proteomics experiments are conducted under positive polarity 
mode where cations are formed and analyzed. However most mass spectrometers can be 
operated in the negative polarity to generate anions via deprotonation or adduction of halide 
ions. Negative polarity lends itself naturally to analysis of acidic proteomes and PTMs such 
as sulfation and phosphorylation which add negative charge to peptides.66,67 However, 
analysis of peptide and protein anions via electrospray ionization presents several 
challenges, namely poor ionization and inadequate fragmentation. Negative mode 
ionization occurs through deprotonation which is best achieved under basic conditions with 
analytes which are acidic.68 However basic spray solvents cause rapid degradation of 
chromatographic stationary phase and are viewed as incompatible with long-term LC 
operation.69  As a result, negative mode is generally practiced under buffered acidic 
conditions or even using conventional acidic conditions.70 A common way to cope with 
poor sensitivity in the negative mode is to maximize the influx of ions by positioning the 
ESI spray close to the MS inlet. Unfortunately, poor ionization is often exacerbated by 
corona discharge, a phenomenon which occurs when the ESI spray is close to the mass 
spectrometer inlet and electrical arcing occurs or the high voltage applied to the ESI needle 
creates an ionized gas plasma, a factor that occurs more readily in the negative mode owing 
to the low dielectric strengths of nitrogen and oxygen molecules in the atmosphere.71 
Corona discharge can be mitigated by lowering the ESI spray voltage and the spray solvent 
is more organic and less aqueous. 67 Despite the greater hurdles associated with negative 
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ESI, it has been used successfully by utilizing dissociation methods such as UVPD and 
NETD which generate diagnostic fragment anions and mobile phase additives which 
promote deprotonation.69,70  Negative polarity has been used to enhance characterization 
of the acidic proteome, phosphopeptides and glycopeptides.69,73,74 
Traditional CID and HCD when performed in the negative mode generate primarily 
non-diagnostic fragments and neutral losses of water and ammonia, thus proving generally 
useless for database searching and high throughput applications.75–77  Non-diagnostic 
fragmentation can be overcome by using alternative activation methods such as NETD and 
UVPD  and proper experimental conditions discussed further in Chapters 3 and 6, thus 
opening up areas of study for underrepresented portions of the proteome.68,70,78 Figure 7.4 
shows the distribution of pI values of the human proteome depicting the large population 
of acidic proteins and the potential for increasing the depth of proteome coverage with 
negative mode proteomics studies. Chapters 3 and 6 discuss experimental and data analysis 
approaches to improve negative polarity proteomics experiments and data interpretation 




Figure 1.2  Isoelectric point (pI) distribution of proteins in the human proteome showing 
the large portion of proteins which may benefit from negative polarity 
proteomics (red region). Protein pI was calculated using an online isoelectric 
point calculator (http://isoelectric.ovh.org/) and the human proteome from 
UniProt (ID:9606) 
 
1.4 PROTEIN BACKBONE STRUCTURE AND FRAGMENT NOMENCLATURE 
The goal of any tandem MS experiment in proteomics is to effect cleavage of the 
peptide bonds in an extensive, reproducible and predictable way to enable efficient protein 
sequencing. The position of bond breakage and resulting fragment structures is to a large 
extent what sets apart the various activation methods.79 Figure 1.3 shows a generic tetra-
peptide where R represents the amino acid sidechains. Collisional dissociation generates b 
and y type ions by cleavage of the C-N amide bonds. The amide bond is the weakest bond 
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and is readily cleaved under CID conditions.80 Electron-based dissociation generates c and 
z type ions by cleaving the N-Cα bond. UVPD is unique in that it can cleave Cα-C to 
generate a and x type ions, while also generating b, c, y and z type ions.81 The six ion types 
discussed here all include one terminus of the peptide or protein, either the N- or C-
terminus. The N-terminus is present in a, b and c type ions, while the C-terminus is present 
in the x, y and z type ions. In the case that a peptide or fragment is cleaved more than once 
or undergoes secondary fragmentation in which it does not contain either the N- or C-
terminus, it is termed “internal ion” and is not considered diagnostic. Internal ions are not 
commonly used in database searches because they are the result of multiple cleavages and 
do not have a well-defined reference point (i.e. the C- or N-terminus) which allows them 
to be confidently assigned to particular protein sequence.82  Moreover, the search space 
required for assignment of internal ions is orders of magnitude greater than that needed for 
the far more limited N- and C- terminating fragment ions, thus slowing searches and 




Figure 1.3  Peptide fragment nomenclature mapped onto a tetrapeptide. R represents 
possible side chain structure attached to the alpha-carbon (α). a, b and c ions are termed n-
terminal ions as they contain the amino terminus of the peptide and conversely x, y and z 
ions are termed c-terminal as they contain the carboxyl terminus. 
 
1.5 TANDEM MASS SPECTROMETRY 
A tandem mass spectrometer performs mass analysis of analyte ions and then 
submits selected precursor ions to some form of activation such as collision with gas 
molecules (CID), interactions with electrons (ETD, ECD etc.), irradiation by photons 
(UVPD, IRMPD) or other means which produce fragmentation. The resulting fragment 
ions are mass analyzed. Nearly all of the activation techniques proven feasible for high-
throughput analysis of peptides are proteins fall into these three categories: collisional 
activated dissociation, electron-based dissociation or photodissociation.83 Despite the 
variety of techniques, there are several underlying qualities common to all that make them 
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experimentally useful. One of the essential qualities each method possesses is the ability 
to generate predictable and reproducible fragment ions, so called “diagnostic ions.” Figure 
1.3 depicts the six most common diagnostic ion types. The mass of these ions can be 
predicted based on the peptide backbone and modifications of side-chains which can in 
turn be used to generate a list of theoretical masses to identify the peptide or protein being 
analyzed by database searching.  Another key quality of these methods is their ability to be 
applied to a variety of biomolecules.84 All three types of activation methods are widely 
applicable; however, some are much more well suited for certain classes of molecules; the 
strengths and weaknesses of each activation technique will be described in the subsequent 
experimental methods chapter. Lastly a quality that can be desirable although not essential 
is the ability of the technique to be tuned to individual applications.84–86 Dissociation of 
peptides and proteins often require significantly different amounts of energy, thus in order 
to maximize fragment generation of both protein and peptide a tunable dissociation method 
is required. Many of these techniques can be adjusted based on various factors including 
the amount of energy deposited in the analyte, duration of exposure to the analyte, or the 
wavelength of light used, and in some cases multiple parameters can be tuned in concert to 
achieve the ideal result.25 
1.5.1 Collisional Induced Dissociation (CID) 
Traditionally fragmentation of peptides has been achieved by collisional activation 
dissociation (CID). CID is the gold standard dissociation technique for biomolecules due 
to its effective generation of diagnostic b and y type fragment ions, reproducibility and 
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ability to be adjusted to suit various analytes.4 CID has been implemented across the 
majority of commercial MS platforms (TOF, FT-ICR, quadrupole ion trap, linear ion traps, 
etc.) Mechanistically CID of peptides has been studied extensively and is governed by the 
generally accepted proton mobility mechanism stating that cleavage is charge site 
initiated.87–89 In practical terms a peptide with de-localized protons will yield the most 
information rich fragmentation. Protons can become localized around very basic sites such 
as lysine and arginine side chains, thus in general when a peptide’s charge (i.e. extent of 
protonation) exceeds the number of basic sites rich fragmentation will result upon CID.90  
In ion trapping instruments (the platform used in this dissertation), CID is commonly 
implemented in two ways. CID can be achieved via ion trapping and subsequent resonance 
during which the ions are translated radially (CID) within in the trapping region inducing 
collisions with background gas molecules and resulting in dissociation. Alternatively the 
ions can be accelerated axially (HCD) resulting in collisions with background gas.91,92 
During this energetic resonance or axial acceleration, the mass-selected precursor ions are 
accelerated and collide with inert gas molecules like He or N2. The degree of fragmentation 
can be adjusted by attenuation of the amplitude of the resonance waveform, (for CID), or 
attenuation of the acceleration voltage, (for HCD). CID in ion traps has one major 
drawback known as the low mass cutoff which prevents low mass ions from being detected. 
LMCO is governed by the following relationship which is related to the RF amplitude 







Where (m) is the ion mass and (qz)is the stability factor related to the drive RF 
(usually 0.25) and the ejection condition at (qz=0.25) is 0.908. An in-depth discussion of 
ion physics in an ion trap can be found in Reference 93.93  
 Certain classes of PTMs are labile and are often lost before backbone dissociation 
during CID, thus masking their original location on the peptide and making CID a poor 
choice for analysis of phosphopeptides and glycopeptides. More recently HCD has been 
adopted as the preferred mode of collisional dissociation due to its improved performance 
over CID.  Energy deposition can be modified by adjusting the accelerating voltage applied 
to the ions as they travel through the collision cell. HCD has the added benefits of higher 
energy deposition compared to CID, shorter activation time required compared to CID, and 
no low mass cutoff.  Thus far, neither CID or HCD have shown useful implementations in 
the negative polarity for high-throughput proteomics applications due to the lack of 
predictable fragment ion generation and the overwhelming presence of non-diagnostic 
fragments such as neutral losses (i.e. loss of water and ammonia). 76,94 Very basic and very 
acidic peptides undergo preferential cleavage by CID at only a few sites in the peptide 
resulting in poor sequencing of the peptide: proline cleavages dominate basic peptides, 
while aspartic and glutamic acid cleavages dominate acidic peptides.95–97 As the 
importance of PTMs has become well-recognized, several new activation methods have 
been developed to overcome the CID limitations mentioned above. 
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1.5.2. Electron-Based Dissociation 
Electron-based dissociation techniques such as electron transfer dissociation (ETD) 
and electron capture dissociation (ECD) are desirable alternatives to CID due to fact that 
these activation methods do not dislodge labile PTMs yet still allow extensive cleavage of 
peptides and proteins.98 ECD was the original electron-based activation method developed 
for FTICR mass spectrometers, but could not be implemented for quadrupole ion traps 
(QITs) and linear ion traps (LITs) due to the difficulty of introducing low-energy electrons 
into a high radiofrequency field such as used in QITs and linear ion traps .99  ETD had been 
more widely adopted on several commercial mass spectrometry platforms and has been 
proven a useful activation technique for high-throughput protein and peptide analyses, 
therefore the following will focus on ETD.100 ETD utilizes anions, not free electrons, which 
are easily manipulated under conditions found in  ion trap mass spectrometers, unlike ECD 
which utilizes electrons. ETD occurs in an ion trapping region where radical anions are co-
isolated with peptide/protein cations for a predetermined length of time wherein the two 
species may interact and promote a transfer of one electron from the reagent anion to the 
peptide or protein.  The process is exothermic, and the excess energy can be dissipated via 
fragmentation.  Other outcomes are also possible, such as simple charge reduction where 
an electron is transferred but fragmentation does not occur.  This phenomenon is known as 
an “ET-no-D” event.101 ETD fragmentation is hypothesized to occur via hydrogen 
migration following the transfer of electron to a protonated site of the cation.  The process 
is believed to be non-ergodic, allowing the PTMs to be retained on the resulting c type and 
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z type ions which allows the modifications to be localized along the backbone.99,100,102 
Unlike CID, ETD can be achieved under negative polarity conditions by utilizing a radical 
cation of fluoranthene to abstract an electron from the peptide anion promoting electron 
rearrangement resulting in extensive backbone cleavage into diagnostic fragments.78 
The main drawback to ETD is its charge state dependency. ETD is most effective 
for ions in higher charge states which poses a problem for bottom-up proteomic 
experiments (Figure 1) where the majority of peptides carry only two or three positive 
charges.85  For ions in low charge states, this means that the electron transfer reactions are 
less exothermic, and fragmentation is less efficient. In an effort to surmount this problem, 
“activated ion” ETD (AI-ETD) uses supplemental energy in the form of gentle collisional 
activation or photon irradiation to cause supplemental activation of the molecule in order 
to improve the fragmentation efficiency by alleviating the occurrence of ET-no-D.101,103,104 
Riley and coworkers have shown a 60% improvement in peptide identification using AI-
ETD compared to ETD.105 
1.5.3 Ultraviolet Photodissociation (UVPD) 
Ultraviolet photodissociation can be achieved using photons of various 
wavelengths; the following discussion focuses on 193 nm photons (6.4 eV), which are 
absorbed by the amide chromophore of the peptide backbone.106,107 The peptide backbone 
absorbs the photon promoting the ion into an excited electronic state. Dissociation of the 
excited state molecule results in a wide array of ion types including all six common 
diagnostic ions: a,b,c,x,y,and z type ions.81,108 The excited state ion can also return to the 
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ground state after internal conversion, and fragmentation results in b/y ions. UVPD is also 
amenable to negative polarity proteomics experiments because UV photoactivation does 
not depend on charge.73,109  Negative UVPD is further discussed in Chapters 3 and 6. Upon 
UV irradiation peptide anions are dissociated into namely a and x type diagnostic ions. 
Moreover, UVPD does not rely largely on mobile protons as does CID and is thus charge 
state independent, unlike both CID and ETD, allowing small low charged and large highly 
charged peptides to be fragmented in kind.110 
1.6 ADVANCES IN MASS ANALYZERS 
While development of activation techniques enables the creation of more fragment-
rich spectra, concurrent improvements in resolving power and mass accuracy of mass 
analyzers enables better utilization of this information.  High resolution/accurate mass 
(HRAM) spectrometers allow monoisotopic analysis of larger peptides and proteins and 
resolution of nearly isobaric modifications (e.g. phosphorylation: 79.966, sulfation: 
79.957, trimethylation: 42.047, acetylation: 42.011).48,111 Traditionally high resolving 
power mass spectrometry has been restricted to FT-ICR instruments which have now 
achieved resolving powers as high as 2,000,000 using 21 T magnets .112 However, in 2005 
the first commercially available high-resolution mass analyzer not requiring a large high 
field magnetic became available: the OrbitrapTM mass analyzer.113 The Orbitrap platform 
itself has undergone further refinements over the past decade, including reducing the space 
between the electrodes of the analyzer and more recently improvements in ion injection;  
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this compression of the ion packet has enabled resolving power of 1,000,000 to be 
achieved.113–115 
Feeding on the wide scale availability of high resolving power and mass accuracy, 
automated data searching programs (so called bioinformatics platforms) have enabled 
advances in protein discovery and quantification.23,24,116–120  Generally, database searching 
programs generate a list of theoretical peptide or protein masses and match these to the 
masses present in LC-MS data. As the number or proteins or peptides in the sample 
increases, more ions with near-isobaric m/z values are created, causing spectral congestion 
and requiring both higher resolving power for differentiation and greater mass accuracy for 
confident assignment.  Improvements in mass accuracy from 50-200 ppm for a lower 
resolution ion trap mass spectrometer to routinely >5 ppm for an Orbitrap mass 
spectrometer has enabled dramatic reduction in the number of theoretically possible 
matching species by narrowing the mass window as shown in Figure 6. Reducing the 
number of overlapping species in each resolvable mass bin provides faster data searching 
and much higher confidence in the matching of theoretical to observed spectra, known as 
a peptide spectral match (PSM).121 
 
1.7 DATA INDEPENDENT ACQUISITION 
This dissertation has focused on the traditional mode of tandem mass spectrometry 
known as data dependent tandem acquisition (DDA) in which the selection of precursor 
for dissociation is based on a precursor scan and selection criteria specified by the user. 
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Recently the data independent acquisition (DIA) mode of tandem MS has been gaining 
traction and proven successful largely due to advances in resolution and accurate mass 
analysis.122,123 DIA submits the entire range of precursors to MS2 simultaneously and then 
reconstructs the precursors from the fragment ions.  Alternatively, the m/z landscape is 
divided into smaller mass windows still containing many precursors and submitted to 
MS2.124 The latter is a good compromise when the number of precursor signals is too great 
to resolve their overlapping fragment ions.  The most challenging aspect of DIA is data 
analysis for which software has been developed uniquely to interpret this data in the form 
of multiplexed fragment ions. Discussion of the DIA data analysis is beyond the scope of 
this dissertation which exclusively employs data dependent acquisition, however a 
thorough discussion recently made by Hu et al.124 Briefly, the fragment ions are monitored 
over time to generate a chromatogram of the fragments. The fragments are then submitted 
to a database search which is narrowed-down based on predicted peptide retention times 
and other inputs such as proteolytic agent, species of origin of the sample (similar to 
traditional data searching). The fragments are scored as groups in order to determine which 
fragments are from the same precursor, based how well they match a theoretically 
generated fragment ion spectrum as a group. 
The most popular form of DIA presently is known as Sequential Windowed 
Acquisition of All Theoretical Fragment Ion Mass Spectra (SWATH-MS).125 By 
multiplexing precursor fragmentation, compared to one at time in DDA, large gains in 
protein and peptide IDs can be realized. In a direct comparison of DDA and DIA analysis 
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of CDK4 affinity purified samples, 5,089 peptides were identified in all three DIA 
replicates, whereas 2,741 were identified in all three DDA replicates; an 86% increase.126 
 
Figure 1.4  Graphical representation of Target Decoy database searching for LC-MS 
datasets (adapted from Ref. 132). Fragment spectra are compared to true and 
false (decoy) theoretical spectra based on the user selected proteome. All 
matches are ranked and then an FDR is calculated based on the frequencies 
of matches to false and true theoretical spectra  
1.8 TARGET-DECOY DATABASE SEARCHING FOR PROTEOMICS DATA 
Database searching of mass spectral data is also known as target–decoy searching 
and is the most popular way to validate PSMs identified by LC-MS.127 The alternative is 
known as de novo searching and relies on matching the mass differences between series of 
fragments and known amino acids. This thesis focuses on target-decoy methods 
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exclusively; however, a relevant review has been authored by Medzihradszky and 
Chalkeley.128 
The earliest software designed to automate LC-MS data analyses, Sequest, scores 
PSMs based on the correlation between experimental and theoretical fragmentation 
spectra.129 In silico, protein sequence databases are digested to yield peptides, for which 
theoretical product ions are calculated and matched to LC-MS/MS data.127 The main 
Sequest score is called XCorr, where a higher value is better.130  The Xcorr scores is based 
on the number of ions in common between the experimental and theoretical spectrum. 
Several other bioinformatic algorithms have been developed since Sequest, and each uses 
a unique variation of this scoring method.23,24,116,117,120 Both good and bad PSMs are ranked 
by score.  To filter out bad matches and ultimately report confident results with some 
threshold score above which only true matches are made needs to be determined. Originally 
this required manual validation which was time consuming and not standardized across the 
field.131 In order to overcome this problem, the experimental data is searched against a 
database populated by incorrect protein sequences, in addition to the true sequences. The 
incorrect sequences are generated by reversing the correct sequences, thus the terminology 
forward and reverse database was adopted for the forward and reversed sequences. 132,133 
Reversed sequences are also known as decoys. When all the forward and reverse PSMs are 
scored and ranked, the resulting scores can be used to discriminate between truly good 
PSMs (matches to the forward database) and poor PSMs (matches to the decoy database), 
based on the assumption that high scoring PSMs are the result of a real match between 
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experimental and theoretical data and low scoring matches are the result of a match made 
randomly to the decoy theoretical spectra. This enables the calculation of false discovery 
rate (FDR), shown in Figure 5, which is defined as the number of false positives over total 
positives. A 1% FDR has been adopted by the proteomics community as the universal score 
boundary.134–137 PSMs represent individual peptide sequence matches to the mass spectral 
data; these can be stitched together to build up the parent proteins which are then reported 
as the final result of an LC-MS experiment.  
 
Figure 1.5    Target-decoy PSM distributions illustrating a classical 1% FDR cut off. 
High quality spectra match well to forward theoretical spectra and thus 
achieve higher scores, while lower quality or ambiguous spectra may 
match forward decoy spectra poorly and achieve a low score or match a 
decoy theoretical spectrum also likely achieving a low score. However, it 
is accepted that some poor spectra will make high scoring matches to 
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forward spectra by chance, which has been deemed acceptable at a rate of 
1%. Thus, all high score matches are reported and the cutoff for reported 
spectra is the point at which 1% of the total matched spectra are matches 
to decoy theoretical spectra. 
 
 
Figure 1.6     Reduction in theoretical peptide candidates achieved by improved mass 
accuracy as shown by the number of peptide candidates based on increasing 
mass accuracy for an arbitrary peptide of mass 1160.6575 Da in the human 
proteome. 
 
1.9 OVERVIEW OF CHAPTERS  
This dissertation outlines several applications of UVPD which are aimed at 
expanding the depth and breadth of proteome coverage.   Broadly UVPD can achieve this 
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aim by expanding sequence coverage and dissociating underrepresented parts of the 
proteome. 
Dissociation of anions has been elusive for traditional dissociation techniques 
however UVPD provides diagnostic fragmentation of peptide anions. Chapter 3 discusses 
a simple, efficient derivatization method to enhance ionization of anions resulting in 
improved UVPD. 
In chapter 4 HCD and UVPD dissociation of peptides of various characteristics 
(length, charge, chromogenicity).  HCD excels at dissociating peptides with basic sites at 
the C-terminus, whereas UVPD exhibits modestly better performance for longer peptides 
and those with acidic sites near the c-terminus. 
UVPD and HCD dissociation are further investigated in chapter 5. Carbamylation 
is used to probe the role of protonation in mediating the fragmentation of intact proteins. 
Carbamylation is used to block the sidechain of lysine which dramatically reduces the 
charge states displayed allowing the same protein to be studied both fully carbamylated 
and unmodified.  
Despite the utility of UVPD there was no software available to analyze both 
negative and positive mode UVPD LC-MS data. Chapter 6 describes a widely available 
data analysis software package which is trained to accept both positive and negative 
mode UVPD. This software is used to analyze LC-MS data from human liver cell lysates 
using HCD, UVPD and negative UVPD. The complementarity of these three activations, 
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including enhanced sequence coverage and numbers of protein identifications, is 
described. 
 In chapter 7 UVPD is used to analyze heavily modified middle-down size 
peptides from histone proteins in a high-throughput fashion. UVPD is compared to the 
current method of choice ETD. Performance metrics such as sequence coverage, 
modification localization and P-score are evaluated for both methods. UVPD performed 
comparably to ETD in determination of PTM distributions and total identifications, 
UVPD was shown to excel in analysis of the most heavily modified forms.  
Application of UVPD for analysis of histone is continued in Chapter 8. The 
feasibility of shotgun UVPD analysis of intact histones is considered. Performance 
metrics including: number of proteoforms identified, P-score, C-score are compared for 
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2.1 MASS SPECTROMETRY 
The work in this dissertation involved studying large peptides and proteins 
requiring high mass accuracy and resolving power for analysis. High resolution mass 
analyses were performed on a Thermo Fisher Scientific Orbitrap Elite (hybrid linear ion 
trap/Orbitrap mass spectrometer) or a Thermo Fisher Scientific Fusion Lumos (hybrid 
quadrupole /linear ion trap/Orbitrap mass spectrometer). The Orbitrap mass analyzer was 
introduced by Makarov in 2000 and has revolutionized modern proteomic and mass 
spectrometry workflows.1 Orbitrap instruments have many advantages compared to 
traditional ion trap mass spectrometers due to their high mass accuracy, speed, high 
resolution.2  
The Orbitrap analyzer essentially consists of an inner rod-like electrode and an 
outer elliptical shaped hollow cylinder electrode separated by a high vacuum region where 
the ions are trapped. The Orbitrap operates by trapping ions and allowing them to orbit 
around the DC only rod-shaped “spindle electrode.” Prior to analysis in the Orbitrap 
assembly, ions are initially held in a curved linear ion trap which accumulates and bunches 
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the ions. Once a sufficient number of ions are accumulated within the trap, the ion packet 
is transferred to the Orbitrap via several ion optics by reducing the RF voltages and 
applying DC gradients to the curved linear ion trap. Ions are measured based on their 
frequencies as they oscillate along the length of the Orbitrap spindle electrode. The 
oscillations of the ions being sent back and forth across the center electrode is detected by 
the split outer electrode which records an image current. The image current can be 
converted into a mass spectrum because the frequency of the oscillations is proportional to 
the (m/z) of the ion which produced the current. The resolution of the ions is dependent on 
the number of oscillations recorded within the image current.3 This simple but sophisticated 
mass analyzer offers ultra high resolution and high mass accuracy.   
 
2.2 ELECTROSPRAY IONIZATION (ESI) 
Electrospray ionization is a soft ionization technique which induces little to no 
fragmentation during ionization. 4 This process ionizes an analyte dissolved in solvent by 
applying a potential (500-5000V) on a capillary through which the solution is sprayed. 
Upon achieving electrospray, the ionized solvent is aerosolized upon exiting the narrow 
orifice of the capillary. The solvent is evaporated from the plume, leaving charged ions 
which are detected in the mass spectrometer.5 Electrospray ionization (ESI), and nanoESI 
(nESI), were used in the following chapters, depending on the flow rate of sample infusion, 
and required sensitivity of the measurement.  
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2.3 LIQUID CHROMATOGRAPHY 
For complex proteomic samples such as protein extracts from cell lysates, a 
separation step is required prior to mass spectrometric analysis.6 This step reduces signal 
dilution by separating the complex mixture in time, which reduces the number of species 
analyzed simultaneously, and increases the detection of many less abundant analytes. Most 
commonly, peptide/protein mixtures are separated via RP-HPLC, which is then easily 
coupled online to ESI-MS/MS instrumentation. In order to take advantage of chemical 
features unique to a certain class of protein or peptide more specialized approaches are 
used such as hydrophilic interaction liquid chromatography (HILIC).  The LC 
instrumentation and parameters that were utilized in the chapters herein are described in 
the subsequent sections. 
2.3.1 Bottom-Up Proteomics 
For the work presented in this dissertation, chromatographic separations were 
performed using water (A) and acetonitrile (B) mobile phases containing 0.05% acetic acid 
on an Eksigent Nanoultra 2D Plus nano liquid chromatography system (Redwood,CA). 
Both trap  (35 mm × 0.1 mm) and analytical columns with an integrated emitter (15 cm × 
0.075 cm) were packed in house using 3 μm Michrom Magic C18 packing (New Objective, 
Woburn, MA).  Approximately 1 μg of digest was loaded onto the trap column at 2 μl/min 
for 20 min, then separated with a gradient that changed from 0 to 35% B over the course 
of 240 minutes. For nanospray, 1.8 kV was applied at a precolumn liquid voltage junction. 
Alternatively, chromatographic separations were performed using a Dionex RSLC 3000 
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nanobore LC system with water (A) and acetonitrile (B) as mobile phases, with each 
containing 0.1% formic acid. The trap (0.075 cm x 3.5 cm) and analytical column (0.075 
cm × 20 cm, with integrated emitter) were packed in-house using 3.5 μm XBridge BEH 
C18 media (Waters, Milford, MA). Approximately 1 μg of digest was loaded onto the trap 
column at 5 μL/min for 5 min, then separated on the analytical column with a gradient that 
changed from 0 to 35% B over the course of 240 min at a flow rate of 300 nL min–1. For 
nanospray, 1.8 kV was applied at a pre-column liquid voltage junction. 
  
2.3.2 Middle-down Proteomics  
Histone middle -down sized peptides were resuspended in 2% ACN and separated 
using a Dionex RSLC 3000 nano-LC system (Thermo Fisher Scientific, San Jose, CA, 
USA) according to the method of Young et al.7 Approximately 1 μg of peptides was 
injected onto a 3 cm REPROSIL Gold (3 µm particles, 300 Å pore size, Dr. Maisch 
Germany) C18 reverse phase trapping column (100 μm i.d.). Peptides were then transferred 
onto a 20 cm fritted (75 µm i.d.). pulled tip analytical column (New Objective, Woburn, 
MA) packed in-house with PolyCAT A (Poly LC, Columbia, MD), a weak cation exchange 
hydrophilic interaction chromatography (WCX-HILIC) media. Peptides were eluted at a 
flow rate of 300 nL/min using the following gradient: starting at 2% B for 20 minutes, 
going to 55% B at 23 minutes, then to 90% B at 160 min, and finally to 99% B at 170 min. 
Mobile phase A was 75% acetonitrile 20 mM propionic acid (pH 6). Mobile phase B was 




2.3.3 Intact Proteins  
Proteins were separated using a Dionex RSLC 3000 nano-liquid chromatograph 
(Thermo Fisher, San Jose, CA) Approximately 1 µg of proteins were injected onto a 3 cm 
PLRP reverse phase trapping column (75 μm i.d.) packed with 5 µm particles (1000 Å pore 
size). Proteins were then eluted onto a 40 cm fritted 75 μm i.d. pulled tip analytical column 
(New Objective, Woburn MA) packed in-house with PLRP (5 µm particles, 1000 Å pore 
size) at a flow rate of 300 nL/min using a linear gradient of 2%-50% solvent B 
(acetonitrile/0.1% formic acid) over 120 minutes. Solvent A was water/0.1% formic acid. 
 
2.4 PEPTIDE AND PROTEIN PREPARATIONS 
The model peptides DRVYIHPFHL and WAGGDASGE were obtained from 
American Peptide Company (Sunnyvale, CA). Bovine serum albumin was obtained from 
Sigma-Aldrich (St. Louis, MO). Halobacterium salinarum was obtained from American 
Type Culture Collection (ATCC, Manassas, VA). The bacteria were grown in the 
recommended medium (American Type Culture Collection medium 2185). Cells were 
suspended in 10 mM Tris-HCL, 10 mM KCl, 1.5 mM MgCl2 at pH 8 to swell and were 
lysed by dounce homogenization. The whole cell lysate was centrifuged to clarify the 
soluble lysate and to remove the insoluble pellet. 
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Both bovine serum albumin and proteins isolated from H. salinarum were digested 
at 37 °C overnight with trypsin. Prior to digestion, proteins were reduced in 5 mM 
dithiothreitol for 30 min at 55 °C and subsequently alkylated in 10 mM iodoacetamide at 
room temperature in the dark for 30 min. Alkylation was quenched with a second aliquot 
of dithiothreitol, thus bringing the final concentration of dithiothreitol to ∼10 mM. Trypsin 
was added to achieve a 1:20 enzyme-to-substrate ratio, and the solution was buffered at pH 
8 in 150 mM ammonium bicarbonate. After digestion the sample was dried in a vacuum 
centrifuge for subsequent derivatization. 
Ubiquitin (bovine), cytochrome c (equine), myoglobin (bovine), superoxide 
dismutase (bovine), lysozyme (galline), carbonic anhydrase (bovine), and urea were 
obtained from Sigma-Aldrich (St. Louis, MO). E. coli 70S ribosome was obtained from 
New England Biolabs (Ipswich, MA). Solvents were obtained from EMD Millipore 
(Billerica, MA). Tris(2-carboxyethyl) phosphine (TCEP) was obtained from Thermo-
Scientific (Rochford, IL) 
HeLa S3 cells were treated for 24 hrs with 10 mM sodium butyrate and harvested. 
Histones were extracted as previously described. 8   In summary, nuclei were isolated after 
resuspending the cell pellets in nuclei isolation buffer (250 mM sucrose, 0.2%NP-40, 1 
mM CaCL2, 15 mM Tris-HCl pH 7.5, 15 mM NaCl, 60 mM KCL, and 5 mM MgCl2). 
Nuclei were pelleted and resuspended in 0.4 N H2SO4 at a 5:1 ratio (v/v) and incubated for 




Purified histones (~300 µg) were separated by RP-HPLC as previously described.8  
Briefly, histones were fractionated on a Vydac C18 column (10 mm inner diameter, 250 
mm length, 5um particle size). Histones were eluted over a 100 minute gradient from 30% 
to 60% solvent B at a flow rate of 1 mL/min. Solvent A: 2% triflouroacetic acid and 5% 
acetonitrile in water, B: 0.19% triflouroacetic acid and 95% acetonitrile in water. The UV 
detector was adjusted to 214 nm, and fractions for H4, H2A, H2B, H3, H3.3, H3.2 and 
H3.1 were collected base on their characteristic retention times.8  Fractions were dried 
using a SpeedVac concentrator and store at -20 oC . Finally, the isolated histones H3 and 
H4 were submitted to GluC digestion for 8 hrs in 50 mM ammonium acetate buffer (pH 4) 
prior to LC-MS analysis. 
2.4.1 Peptide and Protein Carbamylation 
 Carbamylation was performed as previously reported.9 Briefly, each sample was 
split into two aliquots; one for derivatization and one as a control. Each was suspended in 
200 mM Tris-HCl in the presence or absence of 8 M urea. Both samples were incubated at 
80 °C for 4 h. Samples were desalted using Amicon Ultra 3kDa MWCO spin columns 
(EMD Millipore; Billerica, MA), then evaporated to dryness and resuspended in solvent to 
match the LC starting conditions (2% acetonitrile/98% water/0.1% formic acid) or infusion 
conditions (50% methanol/50% water/1% formic acid. 
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2.5 DATA ANALYSIS 
2.5.1 SEQUEST 
The following parameters were used for searching LC-MS RAW peptide files in 
SEQUEST.10 Proteome Discoverer version 1.4.1.14 was used.  Database searching was 
performed using the SEQUEST HT. Tryptic enzyme specificity was selected allowing up 
to 2 missed cleavages. A maximum delta Cn was set to 0.05. A precursor mass tolerance 
of 7 ppm and fragment mass tolerance of 0.02 Da was used. The following dynamic 
modifications were used: acetylation of N-termini, deamidation (+0.984) of asparagine, 
pyroglutamic acid (-17.027 Da) of glutamine, pyroglutamic acid (-18.011 Da) of aspartic 
acid. Carbamidomethylation (+57.021 Da) of cysteine was treated as a static modification. 
Result filtering was performed using Percolator with the following parameters: Max Delta 
Cn: 0.05, target FDR: 0.01 based on q-value. 
The above search was modified to include the ptmRS node for improved 
phosphopeptide searching. Phosphorylation (+79.966 Da) was added as a variable 
modification on S and T.  
2.5.2 MassMatrix  
The following parameters were used for searching NUVPD spectra in 
MassMatrix.11 Trypsin was selected as the digestion method, and the fragmentation mode 
was set to UVPD. The following dynamic modifications were selected: acetylation of N-
termini, deamidation of asparagine, pyroglutamic acid at glutamic acid, pyroglutamic acid 
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(-17.027 Da) of glutamine. Iodoacetamide derivatization (carbamidomethyl) of cysteine 
was set as a fixed modification. The maximum missed cleavage was set to 2, the precursor 
mass tolerance was set to 7 ppm, and the default fragment mass tolerance of 0.05 Da was 
used. Minimum score of output was set to 2, minimum pp value and pp2 value was set to 
4.3. The minimum pp tag was set to 4.0, and the maximum number of PTMs was set to 4; 
score of output was set to 2, minimum pp value and pp2 value was set to 4.3. The minimum 
pp tag was set to 4.0, and the maximum number of PTMs was set to 4. 
2.5.3 Byonic 
The following parameters were used for searching the LC-MS RAW peptide files 
in Byonic: add decoys was selected.12 Cleavage Sites were set to RK and cleavage side was 
C-terminal. Digestion Specificity was set to Fully Specific and missed cleavages were set 
to 2. A precursor mass tolerance of 7 ppm was used and fragmentation type: 
UVPD/HCD/NUVPD were selected where appropriate. A 15 ppm fragment ion tolerance 
was used. The following modifications were searched for: carbamidomethyl (+57.021464) 
fixed at cysteine, variable deamidation (+0.984016) of asparagine (common), variable 
pyroglutamic acid (-17.026549) of glutamine (rare), variable pyroglutamic acid of aspartic 
acid (-18.010565) (rare), variable acetylation (+42.010565) at protein N-termini (rare). The 
maximum number of precursors per scan was set to 2, and FDR was set to 1% FDR. Unlike 
SEQUEST and MassMatrix, Byonic uses a “protein aware FDR”.  This means that 
candidate peptides from proteins with many peptides already identified receive a 
preferential score compared to ones without any protein level evidence. 
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The above search parameters were modified to include variable phosphorylation 
(+79.966331) of serine and threonine (rare), when searching for phosphopeptides.  
2.5.4 ProSight Lite 
ProSight Lite was used to search middle-down peptide and intact protein data files.  
Prior to analysis in ProSight Lite (Build 1.4.6) several scans were averaged to improve the 
S/N of fragment ions.13 The resulting spectra was deconvoluted using the Xtract algorithm 
available in the Xcalibur Qualbrowser (Thermo Fisher Scientific, San Jose CA) software.  
Monoisotopic output was selected and the S/N level was set to 3, all other parameters were 
left to default. The resulting deconvoluted peak list was input into the ProSight Lite 
software. The canonical H3 or H4 sequences (N-terminal GluC peptide) was imported into 
ProSight Lite. Monoisotopic input and UVPD or ETD were selected as the fragment type 
and a 10-ppm tolerance was applied.  Choice of PTM location was guided by intact mass, 
previously reported sites, and primarily the following metrics: P-score, number of matched 
fragments, and sequence coverage. 
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Chapter 3  
 
Improvement of Shotgun Proteomics in the Negative Mode by 
Carbamylation of Peptides and Ultraviolet Photodissociation Mass 
Spectrometry 
3.1 OVERVIEW 
Although acidic peptides compose a substantial portion of many proteomes, their 
less efficient ionization during positive polarity electrospray ionization (ESI) impedes their 
detection in bottom-up mass spectrometry workflows. We have implemented a 
derivatization strategy based on carbamylation which converts basic amine sites (Lys, N-
termini) to less basic amides for enhanced analysis in the negative mode. Ultraviolet 
photodissociation (UVPD) is used to analyze the resulting peptide anions, as demonstrated 
for tryptic peptides from bovine serum albumin and Halobacterium salinarum in a high 
throughput liquid chromatography/tandem mass spectrometry (LC/MS/MS) mode. 
LC/UVPD-MS of a carbamylated H. salinarum digest resulted in 45% more identified 
peptides and 25% more proteins compared to the unmodified digest analyzed in the 
negative mode. 
3.2 INTRODUCTION 
With the advent of modern mass spectrometric-based proteomics, hundreds or even 
thousands of proteins can be identified in a single experiment.1 Several hurdles still remain 
in the path to efficient sampling of a complete proteome in high-throughput applications. 
Chief among these hurdles is identification of underrepresented proteins (based on analysis 
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of the corresponding peptides created upon proteolysis in the typical bottom-up approach). 
Underrepresented proteins include those that have fewer copies per cell (low abundance) 
as well as those for which the proteolytic peptides are undersampled due to a variety of 
factors. These factors include low protein solubility under the digestion conditions utilized 
(resulting in ineffective proteolysis and inefficient production of representative peptides), 
suboptimal peptide size (mass is too large or too small), and peptides being too hydrophilic 
or hydrophobic resulting in unsatisfactory chromatographic properties and/or poor 
ionization efficiencies. Moreover, peptides are routinely “missed” due to the stochastic 
nature of data dependent tandem mass spectrometry (MS). Several strategies have been 
developed to address undersampling due to low abundance. These approaches include 
reducing sample complexity by fractionation,2 enriching low abundance peptides3 (that 
could contain a targeted post translational modification, for example), preferential 
proteolysis and depletion of the most abundant proteins,4 and immunodepletion of 
abundant proteins.5 Fewer studies have reported means to improve the analysis of peptides 
that ionize poorly upon positive polarity electrospray ionization (ESI) after a conventional 
low pH liquid chromatography (LC) separation.6,7In silico digestion of whole proteomes 
typically result in a bimodal distribution of peptide isoelectric points (pI), even when 
performed with trypsin as the proteolytic agent (which leaves a basic site at both 
termini).8 This natural bimodal pI distribution of proteolytic peptides (as illustrated in 
Figure 3.1) from several model proteomes justifies extra effort in targeting the substantial 
acidic portion of a given peptidome. Although rarely employed in high-throughput 
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proteomics experiments, negative polarity mass spectrometry provides access to the acidic 
peptidome which is not well-suited for positive mode analysis. At neutral and slightly basic 
pH, deprotonation of glutamic and aspartic acid residues promotes the formation of peptide 
anions which can be readily detected and characterized in the negative mode. In order to 
achieve the most efficient deprotonation, high pH mobile phases are typically required for 
LC–MS experiments utilizing negative polarity ESI. Raising the pH of the mobile phase 
several units above the pKa of the amino acid side chains results in deprotonation; however, 
in practice high pH mobile phases are generally incompatible with standard silica based 





Figure 3.1  pI distribution of in silico generated tryptic peptides from H. sapiens, E.coli, 
and S. cerevisiae with up to two missed cleavages. Significant portions (52-
58%) of these tryptic peptidomes are acidic. 
 
Aside from the high pH required for efficient deprotonation of peptides, the ability 
to generate informative fragmentation patterns of peptide anions is also challenging. 
Negative mode analysis suffers from a dearth of options for efficient peptide fragmentation. 
While positive mode peptide analysis is proficiently accomplished using collision induced 
dissociation (CID),9 electron capture or electron transfer dissociation (ECD10 or 
ETD,11 respectively), infrared multiphoton dissociation12 (IRMPD), or some combination 
of the above methods, negative mode tandem mass spectrometry (MS/MS) analysis is more 
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limited. Electron detachment dissociation13 (EDD), negative mode electron transfer 
dissociation14 (NETD), and 193 nm negative mode ultraviolet 
photodissociation15 (NUVPD) have been shown to provide diagnostic fragmentation of 
peptide anions, and the latter two methods have been implemented for the successful 
analysis of elaborate proteomic mixtures. Kjeldsen optimized EDD for the generation of 
diagnostic a and x fragment anions and demonstrated it for LC–MS/MS analysis of a 
simple single protein digest as well as for phosphopeptide identification from 12 model 
proteins.13Using NETD and a mobile phase around pH 10, Coon and co-workers identified 
1412 unique peptides from yeast proteins and showed 45% greater coverage of the acidic 
yeast GRX1 protein when compared to solely positive mode CID and ETD 
activation.6Despite these positive gains on single proteins, NETD required lengthier (>100 
ms) activation times which made it less compatible with high-throughput LC time scales. 
Madsen et al. reported the identification of over 2000 peptides and 659 proteins upon 
ultraviolet photodissociation (UVPD) analysis of HeLa cell lysates analyzed in the 
negative mode.7 UVPD at 193 nm is successfully implemented using a 2–10 ms activation 
period (to allow multiple laser pulses) and commonly produces multiple diagnostic ion 
series; most notably x-, a-, b-, and z-type fragments and occasionally c- and y-type ions. 
UVPD and NETD have been directly compared15 for LC–MS analyses of tryptic digests in 
the negative mode, with the finding that either method, when combined with 
complementary positive mode CID data, increased sequence coverages and peptide 
identifications compared to CID alone.16  UVPD has also proven to be particularly 
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proficient for analysis of peptides with labile acidic post-translational 
modifications17(PTMs), like phosphorylation18 and sulfation,19,20 as these PTMs are not 
lost during UVPD. 
Here we introduce a highly efficient means to lower the pKa of the N-termini and 
lysine side-chains of peptides by converting the reactive amines to amides. This simple 
derivatization procedure is readily implemented on complex proteolytic mixtures and 
results in detection and identification of significantly more peptides in the negative mode 
by UVPD than obtained for noncarbamylated peptide mixtures, as demonstrated for whole 
cell lysates of Halobacterium salinarum. 
3.3 EXPERIMENTAL 
3.3.1 Materials 
HPLC solvents and buffer components were obtained from Sigma-Aldrich (St. 
Louis, MO). Proteomics-grade trypsin was obtained from Promega (Madison, WI). All 
other reagents and solvents were obtained from ThermoFisher Scientific (Fairlawn, NJ). 
The model peptides DRVYIHPFHL and WAGGDASGE were obtained from American 
Peptide Company (Sunnyvale, CA). Bovine serum albumin was obtained from Sigma-
Aldrich (St. Louis, MO). Halobacterium salinarum was obtained from American Type 
Culture Collection (ATCC, Manassas, VA). The bacteria were grown in the recommended 
medium (American Type Culture Collection medium 2185). Cells were suspended in 10 
mM Tris-HCL, 10 mM KCl, 1.5 mM MgCl2 at pH 8 to swell and were lysed by dounce 
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homogenization. The whole cell lysate was centrifuged to clarify the soluble lysate and to 
remove the insoluble pellet. 
3.3.2 Sample Preparation 
Both bovine serum albumin and proteins isolated from H. salinarum were digested 
at 37 °C overnight with trypsin. Prior to digestion, proteins were reduced in 5 mM 
dithiothreitol for 30 min at 55 °C and subsequently alkylated in 10 mM iodoacetamide at 
room temperature in the dark for 30 min. Alkylation was quenched with a second aliquot 
of dithiothreitol, thus bringing the final concentration of dithiothreitol to ∼10 mM. Trypsin 
was added to achieve a 1:20 enzyme-to-substrate ratio, and the solution was buffered at pH 
8 in 150 mM ammonium bicarbonate. After digestion the sample was dried in a vacuum 
centrifuge for subsequent derivatization. 
3.3.3 Derivatization 
Carbamylation was performed as previously reported.21 Briefly, each sample was 
split into two aliquots; one for derivatization and one as a control. Each was resuspended 
in 200 mM Tris-HCl in the presence or absence of 8 M urea. Both samples were incubated 
at 80 °C for 4 h. Derivatized peptides were desalted using C18 spin columns (Pierce, 
Rockford, IL), then evaporated to dryness and resuspended in solvent to match the LC 
starting conditions (2% acetonitrile/98% water/0.05% acetic acid). The peptides 




The H. salinarum samples were analyzed on a Thermo Scientific Orbitrap Elite 
mass spectrometer (Thermo Fisher Scientific, Bremen, Germany) equipped with a 193 nm 
excimer laser (Coherent, Santa Clara, CA) and modified to allow UVPD activation in the 
HCD cell.25 Photodissociation was implemented in a manner described 
previously.7 Chromatographic separations were performed using water (A) and acetonitrile 
(B) mobile phases containing 0.05% acetic acid on an Eksigent Nanoultra 2D Plus liquid 
chromatography system (Redwood, CA). The trap (35 mm × 0.1 mm) and analytical 
column (with integrated emitter) (15 cm × 0.075 cm) were packed in-house using 3 μm 
Michrom Magic C18 packing (New Objective, Woburn, MA). Approximately 3 μg of 
digest was loaded onto the trap column at 2 μL/min for 20 min and separated with a gradient 
that changed from 0 to 35% B over the course of 240 min at a flow rate of 300 nL min–1. 
For nanospray, 2.1 kV was applied at a precolumn liquid voltage junction for negative 
polarity mode, and the tip–inlet distance was carefully adjusted to mitigate the occurrence 
of corona discharge. Survey and MS/MS scans were acquired by averaging one and three 
scans, respectively. Automated gain control targets were 1 000 000 for both survey MS and 
MSn scan modes. The maximum ion time was 200 ms for MS and MSn. 
All data-dependent nano LC–MS methods on the Orbitrap involved an FT survey scan 
(m/z 400–2000) at a resolution of 120 000 followed by a series of MS/MS scans on the top 
10 most abundant ions from the first survey. The minimum signal required for MS2 
selection was 100 000, and the isolation width was fixed at 3 m/z. Dynamic exclusion was 
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enabled for 30 s with a repeat count of one and a list size of 500 m/z values. For UVPD, 
three 2-mJ pulses were delivered during an activation period of 6 ms. Product ions from 
UVPD were detected in the Orbitrap at a resolution of 15 000. 
The RAW data files collected on the mass spectrometer were converted to mzXML files 
by use of MassMatrix data conversion tools (v3.9, http://www.massmatrix.net/download). 
All data were searched using an in-house MassMatrix Web server 
(v2.4.2, http://www.massmatrix.net). The search parameters in MassMatrix employed 
were (i) enzyme, trypsin; (ii) missed cleavage, maximum 2; (iii) modifications, fixed 
iodoacetamide derivative of cysteine and variable oxidation of methionine (fixed 
carbamylation of n-term and lysine, when appropriate for modified samples); (iv) precursor 
ion mass tolerances, 15 ppm for Orbitrap data; (v) product ion mass tolerances, 0.02 Da for 
UVPD-MS data on Orbitrap; (vi) maximum number of modifications allowed for each 
peptide, 3; (vii) peptide length, 6–40 amino acid residues; (viii) score thresholds of 5.3 and 
1.3 for the pp/pp2 and pptag scores, respectively. The Halobacterium_sp_nrc1 database was 
used for Halo data sets. Peptide and protein identifications were both filtered at a 1% false 
discovery rate. The peptide spectral matches were ranked by confidence and listed in 
descending order. As the percentage of matches to the decoy database approached one, all 
spectral matches below that point on the list were discarded. 
60 
 
3.3.5 pKa Calculation 
The change in pKa between carbamylated and unmodified lysine residues and N-
termini were calculated using Marvin 
(http://www.chemaxon.com/marvin/sketch/index.php), a widely available chemical 
visualization and property calculation tool (Marvin 14.7.7, 2014). The inverse log 
of Ka values were calculated using the default parameters. 
3.3.6 In Silico Digestion 
In silico digests were performed using freely available software 
(http://omics.pnl.gov/software/protein-digestion-simulator). FASTA files containing the 
proteomes for H. sapiens, S. cerevisiae, E. coli, and H. salinarum were downloaded from 
the Swiss-prot database (http://beta.uniprot.org/uniprot/? query=*&fil=reviewed%3Ayes) 
in their reviewed forms. Tryptic digests were performed allowing up to two missed 
cleavages. 
3.4 RESULTS AND DISCUSSION 
In order to expand the depth and breadth of coverage in proteomics applications, in 
particular the ability to analyze intrinsically more acidic peptides which may be less 
effectively ionized in positive mode, negative mode offers an appealing option. Having 
previously demonstrated the capabilities of UVPD for analysis of peptides in both the 
positive and negative modes,7 we wished to further extend the proteome coverage by 
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enhancing the range of peptides suitable for analysis in the negative mode. Owing to the 
often lower efficiency of electrospray ionization in the negative mode (which remains an 
area of active interest),22−24 the development of methods to make peptides more amenable 
to deprotonation is a key objective. In practice, this includes strategies to reduce the 
basicities of the most basic sites (such as lysines and the N-termini in peptides), thus 
suppressing protonation and/or increasing the acidities of acidic groups to enhance 
deprotonation. The high pKa of the primary amine functional groups is a particularly 
significant factor, which may strongly influence negative mode ESI efficiencies of 
peptides. The strategy reported here uses a simple and highly efficient carbamylation 
reaction which converts primary amines to amide groups, thus decreasing the pKa values 
of those functional groups (in particular the lysine side-chains and N-termini). The 
carbamylation reaction is shown schematically in Figure 3.2, resulting in a mass shift of 
+43.0058 Da per carbamylation. 
 




Feasibility experiments were undertaken using model peptides in order to optimize the 
carbamylation reaction (i.e., minimize the presence of partially reacted species) and 
cleanup procedure (i.e., minimize sample loss). The carbamylation and C18 spin column 
cleanup procedure was extremely simple and efficient for individual peptides and, in fact, 
translated remarkably well to complex mixtures of tryptic peptides, as described later. 
Reaction efficiencies were estimated based on examination of the abundances of 
carbamylated and unmodified peptides obtained from extracted ion chromatograms for 
individual peptides subjected to carbamylation. The ESI mass spectra obtained in the 
negative mode for one representative unmodified peptide (DRVYIHPFHL) and the same 
peptide after carbamylation are shown in Figure 3.3. The unmodified peptide is observed 
primarily as a singly deprotonated species; the carbamylated peptide is observed 
predominantly as a doubly deprotonated species and its abundance is nearly a factor of 10 
greater than that of the unmodified peptide. Examples of the LC traces used to estimate 
reaction efficiency are shown in Figure 3.4, in which the reaction efficiency of 
carbamylation was estimated to be 97% for peptide LVNELTEFAK (based on integration 
of the peak areas for the unmodified and carbamylated peptides). Carbamylation resulted 
in a modest shift in retention times of peptides because the ionizable amine groups are 
converted to more hydrophobic amide functionalities. It is estimated that the conversion of 
the primary amines (N-terminus and lysine side-chains) to amides changes the pKa of those 
groups from 9.5 and 10.5, respectively, to an estimated pKa of −1.7 (Marvin 14.7.7 
2014 http://www.chemaxon.com). This is also consistent with the shift in charge state 
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Figure 3.3 Negative ESI mass spectra of peptide DRVYIHPFHL: (A) the unmodified 





Figure 3.4  Positive mode extracted ion chromatograms of carbamylated and unmodified 
LVNELTEFAK2+, thus showing the extent of carbamylation of H. 
salinarum tryptic peptides. 
 
In the negative ESI mode, the unmodified peptides typically are detected in low charge 
states, often as singly deprotonated species of modest abundance, whereas the 
corresponding carbamylated peptides are observed in higher charge states and with much 
greater abundances. It is well-known that CID of deprotonated peptides predominantly 
yields fragment ions resulting from uninformative neutral losses of water and CO2. In 
contrast, UVPD of deprotonated peptides results primarily in diagnostic a/x sequence ions 
in addition to lower abundances of b/y and c/z ions and charge-reduced precursors (i.e., via 
photoinduced electron detachment).14 Examples of the rich UVPD mass spectra of an 
unmodified peptide, GEEVTAEVADGPQSVIFDQAENR, and its carbamylated 
counterpart are shown in Figure 3.5. The relative abundances and types of fragment ions 
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are similar for both the unmodified and carbamylated peptide, indicating that 
carbamylation does not suppress or significantly alter the UVPD process. 
 
Figure 3.5 UVPD mass spectra of GEEVTAEVADGPQSVIFDQAENR from H. 
salinarum: (A) unmodified (2−) and (B) carbamylated (2−). # indicates the 
loss of water. 
 
While these initial experiments were important for proving the feasibility of the method, 
to evaluate the scalability of the carbamylation reaction for more complex mixtures of 
tryptic peptides, BSA was digested and the resulting peptides were carbamylated. 
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Extracted ion chromatograms (EIC) were generated to monitor the elution of both 
unmodified and the corresponding carbamylated peptides. The areas of the extracted ion 
peaks were used to measure the efficiency of carbamylation according to the following 
equation where A is chromatographic peak area: 
 
In agreement with the reactions of individual model peptides, the reaction efficiencies of 
the measured BSA tryptic peptides averaged more than 97%. Other derivatization reagents 
(such as the popular 4-sulfophenyl isothiocyanate) have been used in the past successfully 
to enhance negative mode ionization, but their success for high-throughput proteomics 
applications have proven to be subpar due to the low reaction efficiencies for complex 
multicomponent mixtures.25 As also noted above, the dominant charge states of the 
resulting carbamylated tryptic peptides of BSA were typically shifted by one charge (e.g., 
from 1– to 2−), and the abundances increased by a factor of 7.6 on average relative to the 
unmodified peptides. 
Trypsin was used as the protease of choice in this study because it is the enzyme most 
commonly used for mass spectrometric-based bottom-up proteomics applications. One 
advantage of using trypsin for conventional positive mode LC–MS studies is that it 
generally results in at least two very basic sites (N-terminus and C-terminal K or R 
residues) which enhances the formation of multiply charged peptide cations that are ideal 
for CID and database searches. Carbamylation reduces the pKa values of the lysine side-
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chain and N-terminus, thus reducing the basicity of those sites and making them less 
ionizable in the positive mode and overall making the peptides more amenable to negative 
mode ESI. By retaining the use of trypsin in the present study, the protein mixtures can be 
subjected to tryptic digestion, then split into two samples: one for traditional bottom-
up/positive mode approach and the other processed in parallel using the 
carbamylation/negative mode UVPD strategy. This dual positive/negative MS/MS 
approach should extend the range of peptides (and therefore proteins) identified with 
confidence. Moreover, the nearly stoichiometric carbamylation reaction efficiencies 
observed for the model peptides and BSA digest allowed carbamylation of the Lys side-
chains and N-termini to be treated as fixed modifications. 
A summary of the observed carbamylated peptides and their corresponding peak areas is 
shown in Table 3.1 for carbamylated BSA tryptic peptides. In cases where peptides contain 
multiple primary amines (i.e., one or more lysine side-chains plus the N-terminus), the 
predominant products were the fully carbamylated species (Figure 3.6). Despite the 
reaction undertaken in somewhat basic conditions (pH 8), the pKa of the arginine side-
chain is substantially greater (pKa 12.5) and thus the majority (>99%) of arginine side-




Table 3.1  List of carbamylated BSA peptides and the chromatographic peak areas of the 
carbamylated peptide and its corresponding unmodified peptide. For the case 
of multiple (double and triple) modifications, each sequential modification is 
shown. CARB indicates the peptide modification at the N-terminus, and 
CARB(K) indicates the modification at the lysine side-chain. %Mod 
represents the estimated percentage of each peptide that is carbamylated 
(versus remains unreactive), calculated by dividing the peak area of the 
carbamylated peptide (from the extracted ion chromatogram) by the summed 





Figure 3.6  Positive mode ESI spectrum of RPKPQQFFGLM (Mr 1347.72 Da) after 
carbamylation. The major species observed is doubly modified (N-terminus 
and K), corresponding to a doubly carbamylated species (Mr 1433.72 Da). 
 
To evaluate the carbamylation/UVPD strategy for a larger array of peptides, the method 
was applied to the analysis of the H. salinarum proteome. Many of the proteins in the H. 
salinarumproteome are naturally acidic, thus resulting in a large distribution of tryptic 
peptides possessing lower than average pI values (average 5.8) (Figure 3.7). In fact, over 
65% of the predicted tryptic peptides are expected to have pI values below 7. 
Carbamylation was used to further reduce the average peptide pI values by decreasing the 
pKa values of the N-termini and lysine residues. After tryptic digestion of the proteins 
extracted from the H. salinarum lysate, the peptides were incubated and carbamylated in 8 
M urea and desalted. Upon comparison of the chromatograms obtained from the 
carbamylated and noncarbamylated tryptic peptides, the carbamylated peptides were 
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retained on the column for between 5 and 15 min longer than their underivatized 
counterparts, and the degree of the retention time shift scaled with the number of 
carbamylated sites. This increase in hydrophobicity agrees with the findings mentioned 
earlier for the model peptides and BSA peptides and is consistent with replacement of the 
ionizable primary amines by the more hydrophobic amide moieties. Despite the increased 
retention times, most carbamylated peptides eluted when the mobile phase composition 
contained less than 35% (v/v) acetonitrile. 
 
Figure 3.7   pI distribution of in silico generated tryptic peptides from H. salinarum with 
up to two missed cleavages. 
 
An example of an LC trace for a carbamylated tryptic digest of H. salinarum and a 
representative UVPD mass spectrum for one peptide (ΔDNVAAIIIGSR carbamylated at its 
N-terminus) is shown in Figure 3.8. The UVPD mass spectrum is dominated by a/x ions 
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with lower abundances of z ions, and the sequence coverage for this peptide is very high 
(as is also the case for many of the other carbamylated tryptic peptides). Inspection of the 
charge state distributions of those peptides identified by UVPD for H. 
salinarum demonstrates a shift in average charge state for the carbamylated peptides, as 
summarized in Figure 3.9. Among the 789 carbamylated peptides identified by UVPD, a 
larger portion was detected as 3– and 2– charge states, whereas more were detected as 2– 
and 1– charge states among the 549 peptides identified for the noncarbamylated digest. 
More importantly, the average peptide abundances were higher for the carbamylated digest 
than the unmodified digest by a factor of 2.4, thus confirming the signal enhancement 





Figure 3.8  (A) Negative mode LC–MS trace (total ion chromatogram) of H. 
salinarum tryptic peptides. Inset: ESI mass spectrum acquired at 195.3 min. 
(B) UVPD mass spectrum of carbamylated peptide DNVAAIIIGSR (2−) 






Figure 3.9  Distributions of charge states for carbamylated (light bars) and unmodified 
(dark bars) tryptic peptide spectral matches (PSMs) found for the digest of H. 
salinarum. 
 
The UVPD fragmentation patterns of the more highly charged peptides give better peptide 
sequence coverage. For carbamylated peptides, 1.7 diagnostic ions per residue on average 
were generated for peptides in the 3– charge state, 1.3 diagnostic ions per residue for 
peptides in the 2– charge state, and 0.6 diagnostic ions per residue in the 1– charge state. 
The similarities in the average number and types of fragment ions for carbamylated versus 
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noncarbamylated peptides offers assurance that the carbamylation reaction does not 
suppress or significantly alter the rich UVPD patterns generated for peptide anions. With 
respect to the types of fragment ions, the distributions are nearly identical for both the 
carbamylated and unmodified peptides: averaging 50% a/x ions, 30% b/y ions, and 20% 
c/z ions (Figure 3.10) 
 
Figure 3.10  Distribution of ion types resulting from UVPD of unmodified and 
carbamylated tryptic peptide anions from H. salinarum 
 
The average number and standard deviation of peptides and proteins identified from the H. 
salinarum proteome were calculated from triplicate negative mode LC–MS UVPD 
analyses of the carbamylated and the unmodified tryptic digests, as summarized in Figures 
Figures 3.11 (histograms) and and Figure 3.12 (Venn diagrams). Combining three runs led 
to the identification of 1086 peptides for the carbamylated digest compared to 747 for the 
unmodified digest. Similarly, at the protein level, 430 proteins were identified based on the 
peptides found in the carbamylated digests compared to 348 proteins for the unmodified 
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digests. Upon combining the results of three runs, 682 peptides were found uniquely for 
the carbamylated digest, 343 peptides were found exclusively for the unmodified digest, 
and surprisingly only 404 were found for both digests. At the protein level, 156 proteins 
were uniquely identified from the results of the carbamylated tryptic digest, whereas 74 
were exclusively found for the unmodified digest, and 274 proteins were identified in both 
cases. The results show 45% more peptide identifications and 25% more protein 
identifications after carbamylation when compared to the unmodified digest. With respect 
to the charge states of the peptides that were identified, on average 267 carbamylated 
peptide spectral matches (PSMs) were found in the 3– charge state compared to 174 PSMs 
for unmodified peptides, 1325 carbamylated PSMs were found in the 2– charge state 
compared to 1086 PSMs for unmodified peptides, and 19 carbamylated PSMs were found 




Figure 3.11  Average number of peptide and protein identifications from negative 
LC/UVPD-MS analyses of carbamylated and unmodified H. 





Figure 3.12  Combined number of (A) unique peptide and (B) protein identifications from 
LC/UVPD-MS analyses of carbamylated and unmodified tryptic peptides 
from H. salinarum in the negative mode in triplicate. 
 
Average number of peptide and protein identifications from negative LC/UVPD-MS 
analyses of carbamylated and unmodified H. salinarum tryptic peptides (in triplicate). 
Interestingly a reasonably large number of peptides (343) were identified only from 
analysis of the unmodified digest. Given the stochastic nature of data dependent acquisition 
and bias toward the most abundant peptide precursor ions,26 many peptides are not selected 
for fragmentation in a routine mass spectrometry proteomics experiment.27 Closer 
inspection of those peptides identified only for the unmodified tryptic digests show larger 
peptides on average than ones commonly identified for the carbamylated digests (Figure 
3.13). On the basis of the retention times of these peptides (Figure 3.14), they are also more 
hydrophobic (with longer elution times), and thus carbamylation of these large peptides 
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would be expected to further increase their hydrophobicities and further delay elution. This 
may account in part for why this set of peptides was not identified for the corresponding 
carbamylated digest. 
 
Figure 3.13  Mass distribution of peptides identified uniquely in the carbamylated peptide 
data set (light bars) and peptides identified uniquely in the unmodified 





Figure 3.14  Number of peptides identified uniquely in the unmodified peptide data set 
sorted by elution time for a tryptic digest of H. salinarum. 
 
3.5 CONCLUSION 
Carbamylation of lysine residues and N-termini was utilized to enhance the ionization of 
peptides by negative polarity ESI and improve the sensitivity of negative mode LC/UVPD-
MS analyses. Results show a significant enhancement in negative mode ionization of 
carbamylated peptides compared to unmodified peptides, consistent with the significant 
decrease in pKa upon carbamylation of primary amines. Carbamylation of tryptic digests 
resulted in 45% more peptide identifications and 25% more protein identifications 
compared to that obtained for the unmodified digests, confirming the enhancement in 
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sensitivity in the negative mode. The improvement in peptide identification metrics also 
arises from a shift to higher charge states, thus yielding more efficient UVPD. The 
carbamylation method could be combined with other proteases, like LysC, to ensure 
multiple modifications of each peptide. 
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Impact of Protease on Ultraviolet Photodissociation Mass Spectrometry 
for Bottom-up Proteomics 
 
4.1  OVERVIEW 
Recent mass spectrometric studies have reported enhanced proteome coverage by 
employing multiple proteases or by using multiple or alternative activation methods such 
as electron transfer dissociation in combination with collisional activated dissociation 
(CAD). In this study the use of 193 nm ultraviolet photodissociation for analysis of 
thousands of Halobacterium salinarum peptides generated by four proteases (trypsin, 
LysC, GluC and chymotrypsin) was evaluated in comparison to higher energy CAD 
(HCD). Proteins digested by trypsin resulted in greater sequence coverage for HCD over 
UVPD.  LysC digestion resulted in similar sequence coverages for UVPD and HCD; 
however, for proteins digested by GluC and chymotrypsin 5-10% more sequence coverage 
on average was achieved by UVPD. HCD resulted in more peptide identifications (at 1% 
false discovery rate) for trypsin (4356 peptides by HCD versus 3907 peptides by UVPD), 
whereas UVPD identified greater numbers of peptides for LysC digests (1033 peptides by 
UVPD versus 844 HCD), chymotrypsin digests (3219 peptides for UVPD versus 2921 for 
HCD) and GluC digests (2834 peptides for UVPD and 2393 for HCD) and correspondingly 




4.2  INTRODUCTION   
Bottom-up mass spectrometric methods have become the mainstream approach for 
high throughput proteomics, including both qualitative and quantitative applications.1–5  
The tremendous success is due in part to the ability to generate extensive arrays of 
characteristic peptides upon proteolytic digestion of proteins, thus facilitating highly 
effective database searches based on MS/MS spectra of peptides.  Trypsin has 
conventionally been the protease of choice for bottom-up proteomics due to the desirable 
characteristics of the resulting peptides.1,3,6 Tryptic peptides are terminated by residues 
possessing basic side-chains (Lys or Arg), thus affording sites that protonate readily and 
yielding efficient ionization in the positive mode. Moreover, given the frequency of tryptic 
cleavage sites many of the resulting peptides are predicted to be small (< 7 residues) and 
thus less amenable to effective sequencing by MS/MS.7,8 Recently groups have shown the 
merits of utilizing multiple proteases in conjunction with collisional activated dissociation 
(CAD) in a bottom up proteomics workflow.8–10  The use of multiple proteases in series or 
parallel on a common sample has been adopted to increase the breadth of proteome 
coverage by taking advantage of the differential specificities of the various proteases 
employed and the different characteristics of the resulting peptides (i.e. size, 
hydrophobicity, charged sites etc).8–12 
Introducing variation in peptide character (i.e. size, amino acid composition, and 
location, type and frequency of ionizable sites) via multiple proteases may result in non-
ideal peptides for CAD. For example, peptides bearing internal basic sites may result in 
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production of unassignable fragment ions upon MS/MS. This shortcoming can be 
addressed by use of other activation methods. For instance, ETD has been shown to provide 
more extensive sequence coverage of large peptides with the added advantage of labile 
modification retention.13 However, at the same time electron-based activation methods are 
biased towards peptides in higher charge states and with greater sequence lengths. Recently 
an approach combining both ETD and CAD in conjunction with multiple protease 
digestion of a HeLa cell lysate was reported, resulting in substantial improvement in 
peptide backbone fragmentation and more robust peptide identification.14   
In recent years ultraviolet photodissociation (UVPD) has proven to be suitable for 
a broad range of proteomics applications and conveniently offers many of the desirable 
characteristics of both CAD and ETD.15–27 In particular, activation of protonated peptides 
by 193 nm UVPD yields a, b, c, x, y, and z fragment ions, a “blend” of both CAD- and 
ETD-type fragments. The present study integrates the use of multiple proteases to create 
orthogonal sets of peptides and UVPD for peptide characterization with the goal of 
uncovering fundamental insight into the effects of peptide size, charge state and amino acid 
composition on photoactivated fragmentation. For instance, the peptide backbone (i.e. 
amide functionality) serves as a chromophore for UV absorption,28  thus peptides of various 
lengths, such as those generated by LysC versus trypsin, may exhibit varying degrees of 
fragmentation. Moreover, it is known that the presence of aromatic residues enhances UV 
cross-sections, and thus peptides bearing aromatic residues, such as those generated by 
chymotrypsin, may display enhanced UVPD.29 In general, coupling the versatility of 
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UVPD with the potential benefits of using multiple proteases afford a compelling 
opportunity to further extend the depth of proteome sequence coverage. To date UVPD 
remains uncharacterized across multiple proteases for bottom-up analyses. In this study we 
evaluate the 193 nm UVPD fragmentation of thousands of peptides arising from multiple 
proteases, including trypsin, chymotrypsin, GluC and LysC. 
4.3  EXPERIMENTAL METHODS 
4.3.1  Materials 
HPLC solvents were obtained from EMD Millipore (Temecula, CA), and buffer 
components were obtained from Sigma-Aldrich (St. Louis, MO).  Proteomics-grade 
trypsin, r-LysC, GluC, and chymotrypsin were obtained from Promega (Madison, WI). All 
other reagents and solvents were obtained from Thermo Fisher Scientific (Fairlawn, NJ). 
Halobacterium salinarum was obtained from American Type Culture Collection (ATCC, 
Manassas, VA). 
4.3.2  Sample Preparation  
H. salinarum was grown in the recommended media (American Type Culture 
Collection media 2185). Cells were suspended in 10 mM Tris-HCl, 10 mM KCl, 1.5 mM 
MgCl2 at pH 8 to swell and were lysed by dounce homogenization. The whole cell lysate 
was centrifuged to clarify the soluble lysate and to remove the insoluble pellet. Proteins 
isolated from H. salinarum were digested with various enzymes according to the following 
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procedures. Prior to digestion, proteins were sequentially reduced in 5 mM dithiothreitol 
(DTT) for 30 minutes at 55 °C and alkylated in 10 mM iodoacetamide at room temperature 
in the dark for 30 minutes. Alkylation was quenched with a second aliquot of DTT, 
bringing the final concentration of DTT to ~10 mM. After alkylation each sample was split 
into three separate aliquots for triplicate analysis. The same process was followed for each 
protease (chymotrypsin, GluC, LysC, and trypsin) prior to digestion. 
Proteases were added in a 1:50 enzyme-to-substrate ratio, and the solution was 
buffered at pH 8 in 150 mM ammonium bicarbonate for trypsin and GluC digests (using 
25 mM Tris-HCl and 1 mM EDTA pH 8.5 for LysC digests, and 100 mM Tris-HCl and 10 
mM CaCl2 pH 8.0 for chymotrypsin digests). Digestion proceeded for 18 hr at 37 
oC for 
trypsin, LysC and GluC or 12 hr at 25oC for chymotrypsin. After digestion all samples 
were quenched with 1% formic acid and cleaned over a spin cartridge loaded with C18 
resin (Pierce Biotechnology) prior to LC-MS analysis.  
4.3.3 Liquid Chromatography and Mass Spectrometry 
The H. salinarum digests were analyzed on a Thermo Scientific Orbitrap Elite mass 
spectrometer (Thermo Fisher Scientific, Bremen, Germany) equipped with a 193 nm 
excimer laser (Coherent, Santa Clara, CA) and modified to allow UVPD in the HCD cell.30 
Chromatographic separations were performed using water (A) and acetonitrile (B) mobile 
phases containing 0.05% acetic acid on an Eksigent Nanoultra 2D Plus nano liquid 
chromatography system (Redwood,CA). Trap  (35 mm × 0.1 mm) and analytical column 
with an integrated emitter (15 cm × 0.075 cm) were packed in house using 3 μm Michrom 
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Magic C18 packing (New Objective, Woburn, MA).  Approximately 1 μg of digest was 
loaded onto the trap column at 2 μl/min for 20 min, then separated with a gradient that 
changed from 0 to 35% B over the course of 240 minutes. For nanospray, 1.8 kV was 
applied at a precolumn liquid voltage junction. MS1 and MS2 scan were single scans 
without averaging.  Automated gain control targets were 1,000,000 for both survey MS 
and MSn scan modes. The maximum ion time was 100 ms for MS and MSn. 
While low energy collision induced dissociation (CID) is the most popular 
benchmark fragmentation method for high-throughput bottom-up proteomics experiments, 
for the purposes of the present comparison higher energy collision dissociation (HCD) was 
chosen as the comparative fragmentation method to 193 nm UVPD.  Both HCD and UVPD 
are implemented in the HCD cell of the modified Thermo Orbitrap Elite mass spectrometer. 
Moreover neither HCD nor UVPD suffer from the low mass cut-off which plagues 
conventional CID in ion trap instruments.  Additionally both methods generate, to different 
extents, ion types not traditionally seen in low energy CID such as a, c, x and z type ions.  
All data-dependent nano LC-MS methods on the Orbitrap involved an FT MS1 scan 
(m/z 400–2000) at a resolution of 120,000 followed by a series of MS2 scans on the top ten 
most abundant ions from the MS1 scan. All MS1 and MS2 scans were comprised of a single 
scan; no averaging was performed. The minimum signal required for MS2 selection was 
10,000, and the isolation width was fixed at 3 m/z. Dynamic exclusion was enabled for 30 
s with a repeat count of one and a list size of 500 m/z values. For UVPD, normalized 
collision energy of 1.0 was used to transfer ions into the HCD cell, following which two 2 
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mJ pulses were delivered during an activation period of 4 msec. Product ions from UVPD 
were detected in the Orbitrap at a resolution of 15,000. For HCD, normalized collision 
energy of 35 was used to activate precursors during a 0.1 ms period. Product ions were 
detected in the Orbitrap at R = 15,000.  A single MS2 scan was collected for UVPD and 
HCD fragmentation. For MS/MS spectra collected at R = 15,000, the signal is sampled for 
100 msec in the Orbitrap analyzer, and thus the Orbitrap analysis time is the rate limiting 
step (not the UVPD or HCD steps).  Data was analyzed using Proteome Discoverer v 1.3 
(Thermo Fisher Scientific) running the SEQUEST search algorithm.  Peptides were 
identified at a 1% false discovery rate. Raw MS/MS data was searched against the 
Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC)  proteome containing 
2426 protein sequences which can be found online at www.uniprot.org under Proteome ID 
UP000000554. The protein list was downloaded as a FASTA file and compiled into a 
SEQUEST protein database.  
 
4.4 RESULTS AND DISCUSSION 
For this systematic evaluation of the impact of the protease and activation method 
on bottom-up mass spectrometric strategies, Halobacterium salinarum was used as a model 
proteome. H. salinarum is a more acidic proteome than the more commonly explored 
Saccharomyces cerevisiae (yeast) or E. coli, thus allowing assessment of bottom-up 
methods for proteomes with lower pKa values. The proteins extracted from the H. 
salinarum lysate were subjected to proteolysis via chymotrypsin, GluC, trypsin, or LysC, 
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prior to chromatographic separation and electrospray ionization of the eluting peptides and 
tandem mass spectrometric characterization by HCD or UVPD. The numbers, charge 
states, and average masses of the peptides identified were determined as a function of 
protease and activation method, as well as sequence coverages and numbers of proteins 
identified.  Examples of the MS/MS spectra obtained for two peptides, DIHPTAIIK (2+) 
from the trypsin digest and HDGAPAIDGIDDTIISDDTARY (3+) from the chymotrypsin 
digest, are shown in Figure 4.1.  As well established, the HCD spectra are dominated by 
diagnostic b/y ions, and the UVPD spectra show a more diverse array of product ions, 





Figure 4.1  Comparative UVPD and HCD fragment ion spectra for a Chymotryptic 
peptide (HDGAPAIDGIDDTIISDDTARY, 3+) (top) and tryptic peptide 




The average numbers of peptides identified upon HCD and UVPD analysis of the 
digests generated from the four proteases are shown in Figure 4.2, along with the 
corresponding number of proteins identified from the matched peptides. As expected, the 
greatest number of peptides were identified from the tryptic digest (4356 by HCD and 3905 
by UVPD), followed by the chymotryptic digest, then the GluC digest, then the LysC 
digest.  Interestingly, although HCD outperformed UVPD for the tryptic digest, with 
identification of more than 10% additional peptides, UVPD yielded more peptide 
identifications than HCD for both the GluC and chymotrypsin digests: 2834 peptides 
(UVPD) versus  2393 peptides (HCD) for GluC, a 20% increase, and 3219 peptides 
(UVPD) versus 2921 peptides (HCD) for chymotrypsin, a 10% enhancement. The results 






Figure 4.2  Average number of identified peptides and proteins by UVPD and HCD 
 
Choice of protease for a bottom-up workflow has a direct impact on the sizes of 
peptides generated, and this size effect is further reflected by the activation method used to 
interrogate the peptides.  The average sizes, calculated in terms of mass, of the H. 
salinarum peptides identified by HCD and UVPD are summarized in Figure 4.3 for each 
of the four proteases. The LysC peptides are considerably larger (>30% on average) than 
those generated by the other three proteases. The greater peptide size is likely due to the 
low frequency of cleavage sites (only lysine) for LysC relative to the other proteases which 
hydrolyze at more than one type of amino acid. The peptides successfully identified by 
HCD were found to be typically 5-15% larger than those identified by UVPD, with the 
average peptide size upon UVPD found to be 1436 Da for the chymotryptic digest (1547 
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Da for HCD) , 1418 Da for the GluC digest (1597 Da for HCD), 1647 Da for the tryptic 
digest (1636 Da for HCD), and 2061 Da for the LysC digest (2194 Da for HCD).   
 
 
Figure 4.3  Average mass of peptides identified by UVPD and HCD for four proteases. 
 
The distributions of peptide sizes identified upon UVPD of each digest are shown 
in more detail in Figure 4.4.  The average masses and mass distributions of the peptides 
identified for the chymotrypsin and GluC digests are similar, peaking around 1400-1450 
Da.  The average peptide mass is higher for the tryptic digest (closer to 1600 Da) with a 
broader distribution, and this trend is further exaggerated for the LysC digest, with the 
average mass shifted closer to 2100 Da. The total number of peptides identified by UVPD 




Figure 4.4  Histograms showing distributions of peptide sizes (based on mass) identified 
by UVPD from chymotrypsin (top left), GluC (top right), trypsin (bottom 
left), and LysC (bottom right). 
 
The difference in peptide sizes noted in Figure 4.3 may arise in part from the charge 
states of the peptides that lead to the most informative and confident MS/MS spectra by 
UVPD versus HCD.  The distributions of the charge states (1+ to 5+) of the peptides 
identified for each of the four digests are illustrated in Figure 4.5.  A greater proportion of 
lower charged peptides were identified by UVPD for all proteases. This observation is most 
notable for the chymotrypsin digest for which over 16% of UVPD spectral matches are in 
the 1+ charge state, whereas only 4% of HCD spectral matches are in the 1+ charge state.  
Poor HCD fragmentation is anticipated for singly charged precursors due to the lack of 
mobile protons needed to facilitate the charge-mediated fragmentation pathways 
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commonly promoted by collisional activation.31 This shortcoming is further exacerbated 
by the particularly acidic nature of the peptides produced upon GluC digestion.  UVPD 
does not appear to be as heavily dependent on charge state as HCD given the larger 
proportion of less highly charged peptides (singly and doubly charged peptides) identified 
by UVPD relative to those identified by HCD. In addition, chymotrypsin, which cleaves at 
the carboxyl side of Y, F, W and L residues, as well as causing some other non-specific 
cleavages, results in smaller peptides (Figure 4.4) which consequently tend to be less 
highly charged than their larger LysC counterparts. UVPD proved well suited for 
identifying the smaller peptides in low charge states or larger peptides with few basic sites 
compared to HCD.  
 
 
Figure 4.5  Charge state distribution of peptide identified by UVPD and HCD for four 
proteases 
 
On average peptides from the LysC digest were identified in the highest charge 
states compared to peptides produced from the other proteases (Figure 4.5). Due to the 
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creation of larger peptides upon LysC digestion as evidenced by the larger average sizes 
of LysC peptides identified by UVPD and HCD (2194 Da and 2093 Da average mass for 
peptides detected by UVPD and HCD, respectively), the likelihood of having more charge 
bearing residues and populating higher charge states is greater.  
The distributions of charge states of peptides identified by HCD and UVPD were 
nearly identical when generated by proteolysis with trypsin. The majority of peptides 
identified were doubly charged as expected for trypsin which cleaves after basic lysine or 
arginine residues (e.g. leaving at least two sites for protonation: one basic residue and the 
N-terminus). In contrast, the GluC peptides identified by UVPD were somewhat more 
likely to be found in the 2+ charge state than those identified by HCD (75% and 62%, 
respectively, Figure 4.5). Despite the formation of similar sized peptides for GluC and 
trypsin, the fact that GluC yields peptides terminated by acidic residues accounts for the 
difference in charges states when compared to the peptide pool produced by trypsin, 
(Figures 4.4 and 4.5). 
The total number of proteins identified (Figure 4.1) and the distribution of 
sequence coverages for those proteins (Figure 4.6) provide two other metrics that allow 
comparison of the performance of UVPD and HCD for the analysis of the four proteolytic 
digests.  As expected based on the numbers of identified peptides discussed above, the 
numbers of identified proteins follow a parallel trend, with UVPD identifying the greatest 
number of proteins for the GluC and chymotrypsin digests. HCD outperformed UVPD for 
the trypsin digest (1127 proteins identified for HCD versus 1061 proteins for UVPD, or 
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6% more for HCD), but UVPD outperformed HCD for the LysC, GluC, and chymotryptic 
digests in terms of the number of identified proteins (LysC: 513 UVPD vs 430 HCD, GluC: 
773 UVPD vs 727 HCD, chymotrypsin: 829 UVPD vs 763 HCD) (Figure 4.2).   
 





Furthermore, proteolysis with trypsin yielded the best sequence coverages for both 
UVPD and HCD (Figure 4.6). The histograms of protein sequence coverage showed an 
average coverage of 35-40% per protein identified for the tryptic digest and significantly 
more proteins identified with greater than 50% sequence coverage compared to the 
analogous findings for the LysC, GluC, and chymotrypsin digests. The distributions of 
GluC, LysC and chymotrypsin sequence coverages all had average values in the range of 
15-20% and displayed significantly fewer proteins with coverages greater than 50% 
(compared to the trypsin results).  These trends are not surprising given the widespread 
adoption and refinement of trypsin protocols which have made trypsin the gold standard 
for mass spectrometry-based bottom-up proteomic workflows.  Trypsin exhibits excellent 
fidelity (i.e. very little nonspecific cleavage) whereas the other proteases, especially 
chymotrypsin, routinely promote nonspecific cleavages. Non-specific cleavage may result 
in peptides which are too small for optimal detection (i.e. < 400 Da) or which may not be 
properly processed in database searches.  In this study several low specificity cleavages (M 
and L residues) were discovered when processing the chymotrypsin data.  
With respect to the sequence coverages obtained upon UVPD versus HCD, 
although the shapes of the distributions were similar (Figure 4.6), there was a consistent 
increase in the portion of proteins identified with higher sequences coverages for UVPD 
compared to HCD for the chymotrypsin and GluC digests, whereas HCD outperformed 
UVPD for the trypsin digest.   The sequence coverages for the LysC digest were nearly 
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indistinguishable by UVPD and HCD.  These results suggest that UVPD may be the 
preferred activation method when GluC or chymotrypsin is used. 
Figure 4.7 shows in a Venn diagram format the total number of proteins which 
were identified in common and uniquely by UVPD and HCD. For all four digests, the 
majority of the same proteins were identified by both UVPD and HCD; however, there was 
a notable subset of proteins which were uniquely identified by UVPD or HCD.  For the 
GluC, chymotrypsin, and LysC digests, 20-25% of unique proteins were contributed by 
UVPD, compared to 7-12% of proteins uniquely identified by HCD. This trend reflects in 
part the greater total number of proteins identified by UVPD for the GluC, chymotrypsin 
and LysC digests (Figure 4.2).  HCD identified more unique proteins than UVPD only for 
the trypsin digest. In general, HCD and UVPD exhibited good complementarity, generally 






Figure 4.7 Venn diagram showing number of unique proteins identified by UVPD 
and HCD 
 
Coon et al. showed a considerable increase (average of 31%) in S. cerevisiae protein 
identification upon inclusion of unique protein identifications from combined CAD and 
ETD results of multiple proteases including LysN, GluC, trypsin, ArgC, and LysC over 
any single protease.8  Following on this prior observation, combining the unique protein 
identifications of all proteases identified by HCD and UVPD for all four proteolytic digests 
in the present study yielded a total of 1986 uniquely identified proteins (Figure 4.8) from 
H. salinarum, a 45% average increase in identifications over the number obtained by 
analyzing the peptides generated from any single protease, using a single activation 
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Figure 4.8  Venn diagram of total unique proteins identified by UVPD and HCD across 
all proteases 
 
One of the most notable characteristics of 193 nm UVPD is the great diversity of 
fragment ion types.  The distributions of fragment ion types (a, b, c, x, y, z produced via 
back-bone cleavages and d,v and w ions from side-chain losses in conjunction with 
backbone cleavages) produced by UVPD and HCD of peptides from the four digests are 
shown in Figure 4.9. With respect to the comparison of the ion types produced by UVPD 
versus HCD, the relative portion of the N-terminal a, b and c ions was remarkably 
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consistent, whereas the portions of C-terminal x,y, and z ions showed much greater 
discrepancies between UVPD and HCD.  The contributions from x and z ions were more 
significant for UVPD, and y ions were far more dominant for HCD.  In addition, various 
side-chain loss ions (d,v,w) were produced upon UVPD but not by HCD.  The variation in 
the distributions of ion types is attributed to the different mechanisms of UVPD and HCD, 
HCD pathways are typically charge-mediated processes that result in cleavage of the most 
labile amide backbone bonds along with a few preferential cleavages (such as occurring 
adjacent to proline).  In contrast, dissociation directly from excited electronic states may 
occur after UV photoabsorption, thus allowing access to pathways not active for HCD.  
Interestingly, the distribution of fragment ion types varied even more dramatically based 
on the protease used to create the peptides.  As expected, for the peptides identified in the 
LysC and trypsin digests by UVPD and HCD, there was a much greater portion of C-
terminal fragment ions than N-terminal fragment ions, an outcome consistent with the 
placement of a basic Arg or Lys residue at the C-terminus of those peptides.  In contrast, 
N-terminal fragment ions were favored for the peptides identified from the GluC and 
chymotrypsin digests. The peptides from the GluC and chymotrypsin digests have the 
standard N-terminus primary amine as a consistent basic site, and may have Arg or Lys 
residues throughout the sequence but not restricted to the C-terminus.  These characteristics 
favor formation of N-terminal fragment ions. Several d, v, and w ions were observed upon 
UVPD of selected peptides from the LysC, chymotrypsin and GluC digests. These ions 




Figure 4.9  Distribution of UVPD and HCD fragment ions for different proteases used 
for Halobacterium cell lysate. The abundances of the various fragment ion 
types were compiled for the 25 most confidently identified peptides (based 
on XCorr scores) from each digest.  
 
4.5 CONCLUSION 
Following LC/MS-MS analysis of thousands of H. salinarum peptides generated 
by multiple proteases, UVPD and HCD showed several distinctions. UVPD was able to 
identify peptides in significantly lower charge states across all samples, supporting the 
lower charge state dependence of UVPD and lower reliance on mobile protons for 
generating diagnostic fragment ions.  At the same time a greater portion of smaller peptides 
were identified by UVPD (10% smaller by mass on average than those identified by HCD). 
HCD out-performed UVPD for identification of tryptic peptides (11% more identifications 
than by UVPD), whereas similar numbers of proteins and peptides were identified by HCD 
and UVPD for the LysC digests. For those peptides which were not terminated by basic 
residues (e.g. those from GluC and chymotrypsin digests), significantly more were 
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identified by UVPD over HCD (20% more identifications by UVPD on average). More 
modest gains in total protein sequence coverage were found based on UVPD of the GluC 
or chymotryptic digests (increases of 10% and 5%, respectively) compared to the sequence 
coverages obtained by HCD.  
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We evaluate the impact of carbamylation of the primary amines of the side-chains 
of lysines and the N-termini on the fragmentation of intact protein ions and the 
chromatographic properties of a mixture of E. coli ribosomal proteins. The fragmentation 
patterns of the six unmodified and carbamylated proteins obtained by higher energy 
collision dissociation (HCD) and ultraviolet photodissociation (UVPD) were compared.  
Carbamylation significantly reduced the total number of protons retained by the protein 
owing to the conversion of basic primary amines to non-basic carbamates. Carbamylation 
caused a significant negative impact on fragmentation of the protein by HCD (i.e. reduced 
sequence coverage and fewer diagnostic fragment ions) consistent with the mobile proton 
model which correlates peptide fragmentation with charge distribution and the opportunity 
for charge-directed pathways.  In addition, fragmentation was enhanced near the N- and C-
termini upon HCD of carbamylated proteins. For LCMS/MS analysis of E. coli ribosomal 
proteins, the retention times increased by 16 minutes on average upon carbamylation, an 
outcome attributed to the increased hydrophobicity of the proteins after carbamylation.  As 
noted for both the six model proteins and the ribosomal proteins, carbamylation had 
relatively little impact on the distribution or types of fragment ions product by UVPD, 
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supporting the proposition that the mechanism of UVPD for intact proteins does not reflect 
the mobile proton model. 
5.2 INTRODUCTION    
Improved chromatographic methods coupled with high performance mass 
analyzers and increasingly sophisticated informatics have facilitated the efficient 
separation, analysis, and identification of intact proteins in the gas phase, thus inspiring 
great interest in top-down strategies for proteomics.1–3  While measurement of the accurate 
mass of a protein is a crucial first step, complete characterization of a proteoform  (i.e. a 
unique molecular form of a protein including its mutations and specific post-translational 
modifications) requires much more information about the sequence, as well as the identity, 
number and position of modifications.4 There are several established methods to activate 
and dissociate intact proteins; collisionally activated dissociation (CAD5) and beam-type 
higher energy collision dissociation (HCD6,7) and electron-based methods (most 
commonly electron transfer dissociation (ETD 8,9), have been used for the most significant 
high throughput top-down studies.  Ultraviolet photodissociation (UVPD) is the newest 
activation method that has been developed for the analysis of intact proteins.10–16  The 
absorption of high energy photons (typically 6.4 eV per 193 nm photon) results in extensive 
backbone cleavages that result in formation of a,b,c,x,y, and z ions. UVPD affords high 
sequence coverage, the ability to map sites of post-translational modifications, and has 
shown promise for top-down LC-MS applications.16 
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Top-down methods have not reached the widespread adoption of bottom-up 
methods for high throughput proteomics, in part owing to less effective activation methods 
for intact proteins.1 In the context of activation of proteins, performance metrics tend to 
decrease with increasing mass, and charge state plays a major role.17,18 Upon electrospray 
ionization, protein ions are generated in a wide array of charge states, thus making it 
especially important to more extensively evaluate and understand the impact of charge state 
on the fragmentation of proteins.5,19 There have been several systematic studies of protein 
dissociation using collisional activation, including ones that have examined the influence 
of charge state and other factors on fragmentation pathways.19–23 CAD of intact proteins 
depends on proton mobility for fragmentation, as also well-recognized for peptide 
fragmentation induced by collisional activation.24 Protons are typically sequestered at the 
more basic sites (Arg, Lys, His, N-terminus), but these protons can be mobilized via 
addition of energy to the ion.25 For proteins in higher charge states, the additional protons 
associated with less basic sites along the backbone facilitate b/y fragmentation 
pathways.24,26,27 As similarly noted for peptides, cleavages are preferentially enhanced at 
acidic residues for lower charge states (i.e. absence of mobile protons). McLuckey and co-
workers have shown that CAD of intact proteins in low charge states (i.e. ones typified by 
low proton mobility) results in enhanced cleavage at glutamic acid and aspartic acid 
residues and a reduction in other diagnostic backbone b/y fragments compared to 
fragmentation of higher charge states having a greater number of mobile protons.20 In 
another CAD study of intact proteins, Agar et al. reported enhanced cleavages adjacent to 
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glycine, lysine, glutamine and N-terminal to serine, tyrosine, isoleucine, leucine and 
proline, none of which are prominent in typical CAD spectra of tryptic peptides.23The 
irregular distribution of basic residues in proteins may give rise to these uncommon 
cleavage pathways.  Not surprisingly, CAD spectra of tryptic peptides with missed 
cleavages (i.e. peptides having a basic Arg residue other than at the C-terminus)  often 
display these same dissociation pathways.23 
The production of diagnostic c/z sequence ions upon ETD of intact proteins is also 
highly dependent on the charge density and charge state. ETD of proteins in low charge 
states result in far fewer fragments and reduced sequence coverage compared to ones in 
higher charge states owing to the propensity for non-dissociative charge reduction 
associated with electron attachment.28,29 The ability of ETD to map post-translational 
modifications remains a particularly compelling advantage which balances the sub-par 
performance for proteins in lower charge states.30,31  In contrast to collisional and electron-
based activation, UVPD has shown less dependence on charge state, and many of the 
fragmentation processes do not require mobile protons.32 
The number and locations of charge sites can be further modulated by addition of 
supercharging agents to the solutions or by derivatization to convert specific functional 
groups to more or less basic ones.33 Williams and Iavarone studied the impact of 
supercharging on fragmentation of intact proteins.  Supercharging was achieved via 
addition of m-nitrobenzyl alcohol to the solution prior to ESI.34 Collisionally activated 
fragmentation of the supercharged states yielded a small number of highly abundant 
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fragment ions clustered around narrow stretches of the protein backbone compared to the 
more widespread fragmentation observed upon CAD of intermediate charge states.35 The 
Smith group manipulated the charge states of intact proteins via chemical derivatization of 
acidic sites and addition of basic moieties or ones with fixed charges.36 Capping acidic sites 
with neutral moieties shifted the charge states very little during ESI, suggesting that 
carboxylic acid side-chains played a relatively minor role in determining the charge states 
of proteins upon ESI. Addition of basic and fixed charge moieties had a significant impact 
on the charge state of intact denatured proteins, suggesting that the number of basic sites 
modulated the range of charge states adopted by the proteins.36 Guanidination increases 
the basicity of lysine residues and promotes proton sequestration (reducing proton 
mobility), and was used as a means to probe the influence of proton mobility on CAD of 
ubiquitin.37  For the 10+ charge state of ubiquitin, the resulting fragmentation of the 
guanidinated protein occurred largely C-terminal to aspartic acid in a charge remote 
fashion as predicted by the mobile proton theory.  For the 10+ charge state of non-
guanidinated ubiquitin, non-specific amide bond cleavages to produce traditional b/y ions 
and enhanced cleavage N-terminal to proline were observed. This contrast in fragmentation 
behavior that arose from guanidination demonstrated that reduction in proton mobility 
restricted the non-specific fragmentation pathways.37 
 In the present study we directly evaluate the dependence of UVPD and HCD on 
proton mobility and charge state for several proteins. In order to affect both protein charge 
state and proton mobility, we employ a highly efficient carbamylation reaction which 
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converts the basic primary amines of lysine sidechains and the N-terminus to less basic 
carbamates. Not only does this reduce the average charge state adopted by a given protein 
upon electrospray ionization, it removes sites of proton sequestration which alters proton 
mobility.   The impact of charge state and proton mobility on HCD and UVPD of six 
proteins and a mixture of ribosomal proteins were investigated. Comparisons of sequence 
coverage, distributions of sequence ions, and fragment ion type are reported for multiple 
charge states of unmodified and carbamylated proteins. 
5.3 EXPERIMENTAL  
5.3.1 Materials   
Ubiquitin (bovine), cytochrome c (equine), myoglobin (bovine), superoxide 
dismutase (bovine), lysozyme (galline), carbonic anhydrase (bovine), and urea were 
obtained from Sigma-Aldrich (St. Louis, MO). E. coli 70S ribosome was obtained from 
New England Biolabs (Ipswich, MA). Solvents were obtained from EMD Millipore 
(Billerica, MA). Tris(2-carboxyethyl) phosphine (TCEP) was obtained from Thermo-
Scientific (Rochford, IL) 
5.3.2 Carbamylation 
  Carbamylation was performed as previously reported.33 Briefly, each sample was 
split into two aliquots; one for derivatization and one as a control. Each was suspended in 
200 mM Tris-HCl in the presence or absence of 8 M urea. Both samples were incubated at 
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80 °C for 4 h. Samples were desalted using Amicon Ultra 3kDa MWCO spin columns 
(EMD Millipore; Billerica, MA), then evaporated to dryness and resuspended in solvent to 
match the LC starting conditions (2% acetonitrile/98% water/0.1% formic acid) or infusion 
conditions (50% methanol/50% water/1% formic acid). 
5.3.3 Separation 
Proteins were separated using a Dionex RSLC 3000 nano-liquid chromatograph 
(Thermo Fisher, San Jose, CA) Approximately 1 µg of proteins were injected onto a 3 cm 
PLRP reverse phase trapping column (75 μm i.d.) packed with 5 µm particles (1000 Å pore 
size). Proteins were then eluted onto a 40 cm fritted 75 μm i.d. pulled tip analytical column 
(New Objective, Woburn MA) packed in-house with PLRP (5 µm particles, 1000 Å pore 
size) at a flow rate of 300 nL/min using a linear gradient of 2%-50% solvent B 
(acetonitrile/0.1% formic acid) over 120 minutes. Solvent A was water/0.1% formic acid. 
5.3.4 Mass Spectrometry  
Proteins for infusion were suspended in a solution of water, acetonitrile and formic 
acid (49.5/49.5/1) at a final concentration of 10 μM. For proteins having known disulfide 
bonds, a 20X molar excess of TCEP was added to the solution prior to infusion.  The 
proteins were either infused directly  at 3 µL/min using a HESI II Source (Thermo Fisher 
Scientific, San Jose CA) or introduced by nano LC ESI into an Orbitrap Fusion Lumos 
mass spectrometer (Thermo Fisher Scientific, San Jose  CA) customized for 
implementation of UVPD as described previously.38 
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Spectra were analyzed in the Orbitrap mass analyzer at a resolving power of 
120,000 at m/z 200, using Intact Protein Mode. 250 scans were collected and averaged for 
infusion experiments. LC-MS data was collected in a top speed (7 s cycle) data-dependent 
manner where each MS1 consisted of 4 μscans (AGC target of 1.0E+05, max injection time 
of 100 ms) and MS2 consisted of 6 μscans (AGC target of 5.5E05, max injection time of 
250 ms).  Precursor ions were filtered according to intact protein monoisotopic precursor 
selection, thus focusing on proteins with charge states greater than 5+.   Spray voltage was 
set to 1.8 kV.  MS2 isolation width was set to 5 m/z using the quadrupole for mass filtering. 
Precursors selected more than five times in 120 s were excluded from MS2 selection for 
120 s. HCD normalized collision energy (NCE) was optimized (10-30NCE) per charge 
state for infusion experiments and set to 20NCE for LC-MS experiments. UVPD performed 
in the high pressure cell of the dual linear ion trap was achieved via a single 5 ns laser pulse 
from a Coherent ExciStar XS 500 (Santa Clara, CA) 193 nm excimer laser. Laser power 
was set to 1.0 mJ for both infusion and LC-MS experiments.  
5.3.5 Data Analysis 
High resolution intact protein fragmentation spectra were deconvoluted using the 
Xtract algorithm enabled in Thermo XCalibur Qual Browser (Thermo Fisher Scientific, 
San Jose, CA.). The deconvoluted data was further processed via Prosight Lite build 
1.3.5744.1622 (http://prosightlite.northwestern.edu/ ) to generate sequence coverage maps 
and confirm the degree of carbamylation based on the presence of fragment ions within a 
10 ppm tolerance 39.  Only fragment ions that contain the N-terminal or C-terminal residue 
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of the sequence are searched and identified;  internal ions are not identified. Protein 
backbone cleavage maps were generated using msProduct 
(http://prospector.ucsf.edu/prospector/cgi-bin/msform.cgi?form=msproduct) outputs to 
assign cleavage position, fragment intensity and ion type. These results were further 
processed and represented graphically using Microsoft Excel (Microsoft, Redmond WA.)  
LC-MS data was processed using ProSight PC 4.0. The protein sequence database 
was populated using the Uniprot reviewed E. coli K12 database (accessed October 2016).  
To enable analysis of the MS/MS spectra of carbamylated proteins, a custom sequence 
database was created which treated all lysine residues as carbamylated and N-termini as 
carbamylated or acetylated. The results were filtered at the proteoform level using a P-
Score cutoff of 1.0E-05. 
5.4 RESULTS & DISCUSSION 
This study focuses on evaluating the impact of modifying charge sites (lysines, N-
termini) of intact proteins on the outcome and metrics of HCD and UVPD. Six model 
proteins and a ribosomal protein mixture were introduced using infusion or via nanoLC, 
respectively, then subjected to HCD and UVPD. In particular, this work aims to compare 
the fragmentation of carbamylated and unmodified proteins to evaluate the influence of 
mobile protons and charge state upon HCD and UVPD.  Carbamylation of the primary 
amines of lysines and the N-terminal amine converts them to non-basic groups (Figure 
5.1), leaving arginine residues as the most basic sites, followed by histidines. 
Carbamylation of proteins changes not only the number of protons retained by each protein 
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during ESI but also the localization and mobility of protons, as evidenced by the sometimes 
significant variations in fragmentation observed in the MS/MS spectra generated upon 
HCD, as described in more detail below.  Six model proteins were selected to span an array 
of molecular sizes and have a range of number, locations and distributions of basic Lys/Arg 
sites.  For example, lysozyme, cytochrome c and myoglobin have similar total numbers of 
highly basic sites (20, 18, and 22, respectively), but the number of arginine residues varies 
considerably (only two for cytochrome c and myoglobin, but 11 for lysozyme).  Since 
fragmentation near the termini is dominant upon collisional activation of intact proteins, 
proteins were selected with lysines near the N-terminus (ubiquitin, cytochrome c, 
lysozyme, superoxide dismutase) or near the C-terminus (cytochrome c, superoxide 
dismutase, carbonic anhydrase) or with arginines in those segments.   A list of the six 
protein sequences is provided in Figure 5.2. 
5.4.1 Effect of carbamylation on charge state distribution of intact proteins 
Prior to evaluating the variations in fragmentation patterns upon carbamylation, 
first the distributions of charge states of unmodified versus carbamylated proteins were 
examined.  The charge states adopted by a protein upon ESI are influenced by several 
factors, including protein size, number of basic and acidic residues, solvent composition 
and solvent additives, among others. In this study proteins were sprayed using conventional 
denaturing conditions prior to or after carbamylation of all lysines and N-termini. For 
example, ubiquitin (8.5 kDa) contains seven lysine residues and was modified a total of 
eight times upon carbamylation with nearly 100% efficiency, indicating highly efficient 
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carbamylation of all seven primary amines of the lysine side-chains plus the N-terminus 
(Figure 5.3). Figure 5.3 shows the ESI mass spectra of unmodified and carbamylated 
ubiquitin, myoglobin, and carbonic anhydrase (and the same pairs of ESI mass spectra are 
shown in Figure 5.4 for cytochrome c, lysozyme, and superoxide dismutase).  For each of 
the six proteins, the shift in the charge state distributions after carbamylation is dramatic.  
The range of charge states for unmodified ubiquitin is +6 to +13, whereas it is +4 to +9 
after carbamylation.   Myoglobin (16.9 kDa) has 19 lysines and displays charge states from 
+10 to +24 prior to carbamylation and +7 to +16 after carbamylation.  Carbonic anhydrase 
(29 kDa, 18 Lys) also shows a significant shift in charge state distribution upon 
carbamylation, ranging from +14 to +35 prior to carbamylation and from +10 to +28 after 
carbamylation.  The same shift in charge states also occurs for cytochrome C, lysozyme, 
and superoxide dismutase (Figure 5.4).  The significantly lower basicity of carbamylated 
groups in comparison to primary amines accounts for the notable reduction in charge states 
of the proteins.    
 For the subsequent MS/MS experiments described in the next sections, several 
charge states were selected for HCD and UVPD.  Typically one charge state higher than 
the median charge state and one charge state lower than the median were selected for 
MS/MS analysis, as well as one charge state that “overlapped” between each unmodified 
and carbamylated protein.  Owing to the incredibly rich MS/MS spectra of intact often 
containing more than 100 fragment ions, displaying numerous annotated spectra is 
cumbersome and thus an alternative graphical representation was used for this study. In 
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order to show the distribution of cleavages of the backbone, the relative fragment ion 
abundances originating from cleavages at each backbone position were plotted as 
histograms spanning the protein sequence. The abundances of all N-terminal (a,b,c ions) 
and C-terminal (x,y,z ions) corresponding to each inter-residue position were summed, and 
the two sums were stacked and placed at their appropriate inter-residue cleavage site along 
the protein backbone.   
5.4.2 Ubiquitin 
Collisional activation of the 10+ and 12+ charge states of ubiquitin (Figure 5.6) 
resulted in remarkably similar fragmentation patterns, exhibiting significant cleavage C-
terminal to three glutamic acid residues (Glu16, Glu18, Glu18), as well as N-terminal to 
proline (P19). This pattern shows that fragmentation of ubiquitin is dominated by 
preferential pathways (e.g. adjacent to acidic residues and proline); similar behavior has 
been reported previously [15,20,23. There were also many non-specific cleavages across 
much of the backbone, yielding numerous low abundance b and y ions and resulting in 
similar total sequence coverages for both charge states (84% for 10+ and 89% for 12+). 
Collisional activation of the 10+ charge state of carbamylated ubiquitin (Figure 5.7) 
resulted in a similar preference towards proline-mediated cleavage; however, the dominant 
cleavage occurred N-terminal to a different proline residue:  Pro37 (IleI36/Pro37) instead 
of Pro19 and HCD resulted in somewhat lower sequence coverage (72%) compared to the 
10+ charge state of the unmodified protein.   
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HCD of one representative low charge state (6+) of unmodified ubiquitin displayed 
extensive cleavage across the entire backbone (Figure 5.6), along with enhanced cleavage 
N-terminal to P19 and N-terminal to P37 and a number of enhanced cleavages C-terminal 
to acidic residues (Asp32, Glu34, Asp39, Asp52, and Asp57). HCD of the corresponding 
6+ charge state of carbamylated ubiquitin showed prominent fragmentation channels N-
terminal to Pro19 and Pro37 as well as an array of nonspecific backbone cleavages 
spanning residues Ile3 to Glu18 (Figure 5.7). The fragmentation pattern of carbamylated 
ubiquitin (6+) upon HCD most closely resembled the fragmentation of the 10+ charge state 
of unmodified ubiquitin. With respect to this similarity in fragmentation behavior, it 
appears that the lower charge state of carbamylated ubiquitin (6+) was in part compensated 
by the greater mobility of protons upon carbamylation of the lysine side-chains.  
Interestingly, the HCD fragmentation pattern of the 4+ charge state of carbamylated 
ubiquitin did not exhibit the preferential Pro cleavage observed for all of the other charge 
states, and instead cleavages C-terminal to acidic residues were exceptionally prominent 
(Asp21, Asp32, Asp39, Asp52, Asp58, Glu64).  The exaggerated enhancement of 
cleavages C-terminal to acidic residues has been noted previously for low charge states of 
unmodified proteins,15,40–42 and it is echoed for the very low charge state (4+) of 
carbamylated ubiquitin in the present study.  In general, the fragmentation patterns of each 
of the three representative charge states of carbamylated ubiquitin (4+, 6+, 10+) displayed 
significant differences in the locations and sites of preferential cleavages, and the total 
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sequence coverages (56%-72%) were notably lower than the coverages obtained for the 
unmodified protein (83%-89%) upon HCD (see Table 5.1). 
Unlike the variations in fragmentation patterns observed upon HCD of unmodified 
ubiquitin, the fragmentation patterns generated upon UVPD are nearly independent of 
charge state and only modest differences are noted among the backbone cleavage 
histograms of the 6+, 10+, and 12+ charge states (Figure 5.8). Closer inspection of the 
histograms reveals subtle variations in the relative portions of C- and N-terminal product 
ions, but overall the fragmentation is considerably more uniform across the backbone upon 
UVPD compared to HCD. This trend is also reflected in the consistently high sequence 
coverage obtained from UVPD of ubiquitin irrespective of charge state (99% - 100%, 
Table 1), an outcome which also holds true for carbamylated ubiquitin (87% - 99%). For 
all charge states, UVPD of carbamylated ubiquitin showed suppressed backbone 
fragmentation in the stretch from Pro19 to Ile36 compared to the unmodified protein, along 
with significantly lower abundances of N-terminal fragment ions across the entire sequence 
(Figure 5.9).  However, in contrast to HCD of carbamylated ubiquitin, which favored 
preferential cleavages at proline and acidic residues, UVPD of carbamylated ubiquitin 
largely exhibited non-specific backbone fragmentation akin to the pattern observed upon 
UVPD of unmodified ubiquitin.  
5.4.3 Cytochrome c 
Upon ESI, cytochrome c retains the heme group (+616.191 Da) bound at C14 and 
C17, and this heme group is incorporated in assignment of all fragment ions that encompass 
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those cysteine residues.  HCD of the 12+, 14+ and 16+ charge states of cytochrome c 
(Figure 5.10) resulted in a dominant cleavage N-terminal to proline (P77). Backbone 
cleavages adjacent to two lysine residues (K26 and K28) were also prominent, and HCD 
promoted a wide variety of non-specific backbone cleavages to produce ample series of 
b/y ions.  For each of these charge states, HCD resulted in high sequence coverage (72% - 
88%, Table 1) as evidenced by relatively broad fragmentation along the backbone, aside 
from a few stretches of little or no fragmentation (Cys14 to Thr19, Phe36 to Gln42). HCD 
of carbamylated cytochrome c (Figure 5.11) also resulted in enhanced backbone cleavage 
N-terminal to Pro77; however, aside from consistent fragment ions near the C- and N-
termini, the MS/MS spectra obtained for the 6+, 8+ and 10+ charge states exhibited large 
stretches lacking any fragmentation and the overall sequence coverages were significantly 
lower for carbamylated cytochrome c (50% - 70%).    
In contrast to the fragmentation patterns observed upon HCD of cytochrome c, 
UVPD (Figure 5.12 does not result in a dominant cleavage N-terminal to Pro77, and rather 
backbone cleavage N-terminal to Pro30 and Pro45 were more prominent pathways. 
Moreover, UVPD resulted in non-specific fragmentation across nearly the entire backbone 
that yielded high sequence coverages for all charge states (87% to 90%).  The heme-
binding domain covering the stretch from Cys14 though Cys17 remain resistant to 
fragmentation by both HCD and UVPD, confirming the stabilization of this region owing 
to the thioether bonds between the heme and two cysteine residues.    
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UVPD of carbamylated cytochrome c resulted in extensive non-specific 
fragmentation across the backbone (Figure 5.13). At the lowest charges state (6+) 
carbamylated cytochrome c exhibited preferential cleavage N-terminal to Pro77; however, 
as charge state increased (8+ and 10+) this cleavage became less prominent and the 
cleavages N-terminal to Pro30 and Pro45 were enhanced at higher charge states.  As noted 
earlier for the ubiquitin analysis, carbamylation had a much lower impact on the 
fragmentation of cytochrome c, regardless of charge state, compared to the far more 
striking impact on HCD in which backbone fragmentation throughout the protein was 
significantly curbed. The sequence coverage afforded by UVPD was 84% to 91% for the 
various charge states of carbamylated cytochrome c (Table 1), nearly identical to the range 
obtained for the unmodified protein and well above that obtained upon HCD.  
5.4.4 Lysozyme 
Lysozyme, which naturally has four disulfide bonds, was reduced prior to MS/MS 
analysis to mitigate the well-known suppression of fragmentation caused by disulfide 
bonds in proteins.  Upon ESI, lysozyme produced ions in charge states that spanned 9+ to 
20+ (Figure 5.4). HCD of lysozyme in the 12+, 15+, and 18+ charge states resulted in 
approximately 50% sequence coverage (Table 1), with significant gaps at the N- and C- 
termini as well as the mid-section of the protein.  For the two lower charge states (12+ and 
15+), some C-terminal and N-terminal ions were observed across the entire backbone, 
whereas only N-terminal b ions were observed exclusively for the first half of the sequence 
and only C-terminal y ions were observed for the last half of the sequence (Figures 5.4 and 
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5.14). This trend for selective formation of N-terminal and C-terminal product ions was 
further enhanced for the 18+ charge state and fragmentation was preferentially clustered 
around a few residues (e.g. Asn27/Trp28, Ile88/Thr89). 
Lysozyme has six lysine residues and therefore was carbamylated at seven 
positions (N-terminus, Lys1, Lys13, Lys33, Lys96, Lys97, Lys116). After carbamylation 
the charge states ranged from 7+ to 14+.  HCD of carbamylated lysozyme (Figure 5.5 and 
5.15) resulted in markedly sparser fragmentation dominated by cleavages consolidated in 
the stretch from Asn26 to Phe33 (NWVCAAKF) and Lys96 to Asn103 (KKIVSDGN).  
These two regions are the longest stretches of the protein sequence which contain no basic 
Arg or His residues and only contain carbamylated Lys residues. The limited fragmentation 
observed for the carbamylated protein resulted in low sequence coverages (<30% Table 1) 
for all three charge states.  Similar to the behavior observed upon HCD of the higher charge 
states of the unmodified protein, predominantly N-terminal b type ions were produced for 
N-terminal half of the protein and C-terminal y ions for the C-terminal half of the protein.  
Four of the most dominant products generated upon HCD of unmodified lysozyme arose 
from cleavage C-terminal to aspartic acid. Only one of these cleavages remained prominent 
after carbamylation.   
As illustrated in Figure 5.5 and 5.16, UVPD of lysozyme (12+, 15+, and 18+ 
charge states) yielded nonspecific cleavages across nearly the protein backbone 
independent of charge state and resulted in far greater sequence coverages (averaging 85%, 
Table 1) than observed for HCD (averaging 54%). Interestingly the number of 
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complementary pairs of N-terminal and C-terminal fragment ions decreased as charge state 
increased, and in the 18+ charge state the majority of C-terminal fragment ions were 
restricted to the C-terminal half of the protein just as the majority of N-terminal fragment 
ions were restricted to the N-terminal half of the protein.  This result was similar to the 
segregation of C-terminal and N-terminal fragment ions noted above for HCD of lysozyme, 
albeit with a far greater total number of backbone cleavage sites observed upon UVPD.  
The sequence coverage obtained upon UVPD of carbamylated lysozyme (Figure 
5.5 and 5.17 for 8+, 10+, 12+) decreased (averaging 62%) compared to the coverage 
obtained upon UVPD of unmodified lysozyme (averaging 85%), just like was noted upon 
HCD. However, there was still significantly greater fragmentation throughout the protein 
upon UVPD than observed upon HCD. The prominent fragmentation across the Asn27-
Phe34 stretch was also observed upon UVPD, like HCD.  The UVPD fragmentation trends 
showed less dependence on charge state for both the unmodified and carbamylated protein 
compared to HCD, again attesting to the reduced impact of mobile protons on modulation 
of fragmentation.   
5.4.5 Superoxide dismutase  
Upon ESI, superoxide dismutase (SOD) produced ions in charge states ranging 
from 10+ to 23+ after reduction of disulfide bonds.  HCD of SOD in the 12+, 16+, and 20+ 
charge states resulted in nonspecific cleavage (Figure 5.18) of the backbone to yield 
approximately 50% sequence coverage (Table 1). The most extensive fragmentation was 
concentrated in the regions spanning Val27 to Gly35 and Gly91 to Tyr108.  SOD exhibited 
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C-terminal and N-terminal product ion segregation that increased with charge state such 
that only N-terminal b ions are dominant for the first half of the protein and C-terminal y 
ions are dominant for the second half of the protein. 
SOD underwent efficient carbamylation at all ten lysine residues (the acetylated N-
terminus was not modified) and the dominant charge state shifted from 20+ for the 
unmodified protein to 14+ after carbamylation.  Similar to the trend noted for the other 
proteins, the sequence coverage obtained upon HCD of carbamylated SOD decreased 
significantly relative to that of unmodified SOD, even for the same charge state (e.g. 35% 
coverage for carbamylated SOD (12+) and 55% coverage for unmodified SOD (12+)) 
(Table 1).   HCD of carbamylated SOD decreased as the charge state decreased (Figure 
5.19), and overall was sparse compared to HCD of the unmodified protein. For the 12+ 
charge state, fragmentation was prominent only near N-terminus and the region spanning 
Gly92 to Asp99 with minor contributions near the C-terminus. For the 14+ and 16+ charge 
states, HCD resulted in some selective fragmentation in the middle region of the sequence, 
including stretches from Val27 to Thr37 and Asn84 to Pro100. 
UVPD of both unmodified SOD (12+, 16+ and 20+) and carbamylated SOD (12+, 
14+, 16+) resulted in numerous nonspecific cleavages (Figures 5.20, 5.21) across the 
protein backbone and was virtually independent of charge state, yielding sequence 
coverages that averaged 73% (Table 1). Both N-terminal and C-terminal products were 
generated throughout the protein.  Enhancement of cleavages adjacent to proline residues 
(Pro13, Pro64, Pro72, Pro100, Pro121) was observed for both unmodified and 
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carbamylated SOD.  What is perhaps most remarkable about the fragmentation of SOD is 
the lack of overlap among the regions of enhanced fragmentation for HCD versus UVPD 
and for the carbamylated versus unmodified protein. For example, the region of greatest 
backbone fragmentation spanned residues Val92 to Gly106 for HCD of unmodified SOD 
(16+), residues Val92 to Pro100 for HCD of carbamylated SOD (16+), residues His19 to 
Thr86 for UVPD of unmodified SOD (16+), and residues Phe43 to Pro100 for UVPD of 
carbamylated SOD (12+). This comparison highlights the complementary nature of HCD 
and UVPD, as well as the impact of carbamylation on fragmentation.  
5.4.6 Myoglobin 
Myoglobin produced ions in charge states ranging from 9+ to 24+; after 
carbamylation the charge states ranged from 7+ to 16+ and the clean spectra confirmed 
that carbamylation occurred with near 100% efficiency at 20 sites (19 lysines plus the N-
terminus).  HCD of myoglobin in the 12+, 16+, and 20+ charge states resulted in 
nonspecific cleavage across much of the backbone (Figures 5.6 and 5.22) and yielded an 
average of 50% sequence coverage (Table 1).   Several prominent preferential cleavages 
were observed, such as N-terminal to Pro120, and C-terminal to both Leu2 and Glu6.  The 
trend of significant b and y ion segregation (i.e. b ions preferentially observed for the N-
terminal half of the protein and y ions dominating for the C-terminal half) was again noted, 
especially for the higher charge states. After carbamylation, there was a significant 
decrease in fragmentation of myoglobin upon HCD as evidenced by sequence coverages 
that averaged only 20% (Table 1).  The few sequence ions that were observed were 
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clustered near the first 20 residues of the N-terminus (b ions) or C-terminus (mostly y ions), 
leaving the mid-section of the protein unsequenced (Figure 5.23).  Myoglobin contains a 
large number of K residues in the region of the protein devoid of fragments (15 Lys out of 
19 total Lys), suggesting that heavy modification of the internal portion of the protein 
disrupts the formation of fragment ions by HCD. Myoglobin contains only two highly basic 
arginine residues (Arg31, Arg139) in its entire sequence, meaning that the 11 His residues 
serve as the other basic sites mostly likely to be protonated during ESI. Interestingly, the 
regions which do yield fragment ions do not contain His residues, suggesting that histidine 
may sequester protons or otherwise hinder fragmentation of carbamylated proteins. 
 UVPD of myoglobin resulted in mainly nonspecific cleavages which resulted in 
high sequence coverage (up to 94% for the 16+ charge state and averaging 92% for all of 
the charge states examined, Table 1). Cleavage N-terminal to Pro120 was observed upon 
UVPD, just as it was prominent upon HCD, but cleavage C-terminal to Phe33, Phe46, and 
Phe48 were of similar relative abundance to that of the P120 cleavage (Figure 5.24), 
suggesting that fragmentation may be enhanced adjacent to aromatic residues which are 
known to have high UV photoabsorption cross-sections. UVPD of carbamylated 
myoglobin results in numerous nonspecific cleavage along the backbone Figure 5.25), 
yielding sequence coverages from 74% to 83% for the 8+, 10+, and 12+ charge states 
(Table 1).  Although this level of sequence coverage is lower than the average 92% 
coverage observed for unmodified myoglobin upon UVPD, it is three to four times greater 
than observed upon HCD.  Several prominent backbone cleavages were noted C-terminal 
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to Phe33 and N-terminal to several Pro residues which were identical to those observed 
upon UVPD of unmodified myoglobin. In general, myoglobin showed the greatest 
difference in overall fragmentation between HCD of the carbamylated and unmodified 
protein and most similarity for UVPD of the unmodified and modified protein. This finding 
suggests that for proteins which are arginine poor, modification of lysine residues severely 
hinders production of b and y type ions upon collisional activation but has little impact on 
the performance or outcome of UVPD.  
5.4.7 Carbonic anhydrase 
Upon ESI, carbonic anhydrase produced ions in charge states ranging from 14+ to 
35+ (Figure 5.3).  HCD resulted in rather sparse fragmentation of all charge states (Figure 
5.26), yielding sequence coverages averaging only 35%.  Several dominant cleavages 
occurred at Pro residues, and the majority of fragments entailed backbone cleavages within 
75 residues of either the C- or N-termini.  The highest charge state examined by HCD (34+) 
displayed a shift towards fragmentation at only the C-terminus region. Carbamylation of 
carbonic anhydrase was efficient, resulting in modification of all 18 Lys residues plus the 
C-terminus and shifting the charge states to 10+ to 28+ upon ESI (Figure 5.3).  HCD of 
carbamylated carbonic anhydrase resulted in preferential cleavages similar to that observed 
for unmodified carbonic anhydrase, albeit with even lower sequence coverage (averaging 
20%) and with virtually no fragmentation along the N-terminal half of the protein (Figure 
5.27).   
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 UVPD of carbonic anhydrase resulted in a larger degree of non-specific cleavages 
(Figure 5.28), yielding sequence coverages that averaged 63% (Table 1).  Similar to HCD, 
several cleavages adjacent to Pro residues were moderately enhanced. UVPD of 
carbamylated carbonic resulted in an average sequence coverage of 32% (Table 1).  
Similar to what was observed for HCD, a large stretch of the protein remained unsequenced 
upon UVPD of the carbamylated protein (Figure 5.29), although the suppression of 
fragmentation was less dramatic than noted for HCD. The UVPD fragmentation patterns 
of carbamylated carbonic anhydrase (16+, 22+, 29+) most closely resembled the UVPD 
fragmentation pattern of unmodified carbonic anhydrase in the 34+ charge state, supporting 
the observation that fragmentation patterns of carbamylated proteins are most similar to 
the ones obtained for the highest charge states of the unmodified counterparts. 
5.4.8 Effect of carbamylation on sequence coverage 
Sequence coverage for all six proteins studied was lowest for carbamylated proteins 
activated by HCD and highest for unmodified proteins activated by UVPD (Table 1 with 
sequence maps shown in Figures 5.30-5.35 for each of the six proteins). In general, 
carbamylation caused reduced sequence coverage regardless of activation method, and the 
reduction in sequence coverage for the carbamylated proteins was notably more precipitous 
for HCD than UVPD.  UVPD routinely achieved higher coverage and consistently 
outperformed HCD for both carbamylated and unmodified proteins.  Myoglobin, the most 
lysine-rich protein, displayed the largest disparity between HCD and UVPD of the 
carbamylated species (77% coverage for UVPD and only 22% for HCD over three charge 
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states), an outcome also mirrored for the unmodified proteins (92% coverage for UVPD 
and only 54% for HCD on average).  The relatively modest reduction in sequence coverage 
for UVPD of carbamylated proteins relative to unmodified proteins recapitulates the lack 
of significant dependence on proton mobility for the UVPD process relative to HCD.  
Based on analysis of the series of fragment ion maps, HCD of carbamylated proteins 
enhances terminal-mediated fragmentation (i.e. enhancement of smaller a,b,c ions near the 
N-terminal portion of the protein, x,y,z ions near the C-terminal portion, and sparse 
fragmentation in the mid-section) which could explain the reduced sequence coverage as 
protein size increases. 
5.4.9 Effect of carbamylation on cleavage preferences    
Under certain circumstances, collisional activation of proteins generates dominant 
fragment ions resulting from preferential cleavages, typically ones directly related to 
specific amino acids.15,23 In general, this phenomena is most prominent upon activation of 
the highest and lowest charge states and is most frequently manifested in preferential 
cleavages N-terminal to Pro and C-terminal to Asp and Glu residues.43–45 To assess the 
overall impact of carbamylation on these preferential cleavages, the distributions of key 
categories of fragment ions of ubiquitin (Figure 5.36), cytochrome c (Figure 5.37), and 
were compiled owing to the relatively extensive sequence coverage of these three proteins 
regardless of carbamylation or activation method.  
HCD of unmodified ubiquitin showed an increasing degree of preferential N-
terminal proline cleavage with increasing charge state and a significant portion of 
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preferential cleavages C-terminal to acidic residues (Glu and Asp) (Figure 5.36), similar 
to previous observations by Reid and McLuckey.20 Upon carbamylation of ubiquitin, N-
terminal proline cleavage was significantly suppressed for the +4 charge state, whereas 
cleavage C-terminal to Asp and Glu were greatly enhanced, suggesting that charge remote 
fragmentation dominates at this low charge state generated upon carbamylation (Figure 
5.36). The 10+ charge state of carbamylated ubiquitin displayed a degree of N-terminal 
Pro cleavage upon HCD similar to that observed for the 12+ of unmodified ubiquitin and 
a reduced percentage of C-terminal Asp and Glu cleavages. UVPD of both unmodified and 
carbamylated ubiquitin resulted in lower portions of preferential cleavages and 
significantly more contributions from non-specific cleavages of the entire backbone. 
HCD resulted in similar portions of preferential N-terminal Pro and C-terminal Glu 
and Asp cleavages of cytochrome c regardless of charge state, and these distributions 
changed only modestly upon carbamylation (Figure 5.37).  In particular, Pro-specific 
fragmentation was enhanced after carbamylation for the 8+ charge state of cytochrome c.  
The contribution of preferential cleavages diminished for HCD of the 10+ charge state of 
carbamylated cytochrome c, but this distribution was likely skewed owing to the notable 
enhancement of non-specific cleavages at the C-terminus end of the protein. UVPD of 
cytochrome c displayed more dominant fragmentation C-terminal to Phe than HCD, 
reiterating that the aromatic chromophore played a role in directing site-specific 
fragmentation by UVPD.  Interestingly, UVPD of both unmodified and carbamylated 
cytochrome c resulting in enhanced N-terminal Pro cleavage and somewhat suppressed C-
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terminal Asp and Glu cleavages compared to HCD. In addition, the sites of the preferential 
cleavages varied for HCD relative to UVPD.  Cleavage adjacent to Pro44 and Pro76 were 
favored for HCD, whereas UVPD displayed enhanced N-terminal cleavage at two 
additional proline residues:  Pro30 and Pro71.  Thus, UVPD did not show any particular 
discrimination of Pro residues, whereas the preferential Pro cleavage was selective upon 
HCD, suggesting that specific sequence motifs or charge site locations influenced the 
proline cleavages of cytochrome c upon HCD. 
Lysozyme contains only two proline residues with both located in the middle 
section of the protein, a region where fragmentation is typically suppressed for top-down 
MS/MS methods.  Upon HCD, both unmodified and carbamylated lysozyme displayed 
little Pro-selective cleavage, and instead preferential cleavages adjacent to Glu and Asp 
were more prominent (Figure 5.14).  Upon carbamylation a slight increase in C-terminal 
Asp and Glu cleavages was observed for the 8+ charge state upon HCD.   The more 
extensive and non-selective fragmentation across the backbone by UVPD generated higher 
sequence coverage and resulted in ample N-terminal Pro and C-terminal Glu and Asp 
cleavages.  Upon carbamylation, the degree of Pro cleavage decreased significantly upon 
UVPD, as well as a decrease in cleavage C-terminal to Phe.  
5.4.10  LC-MS of carbamylated E.coli ribosomal proteins 
Carbamylation not only causes a significant change in the charge states of proteins 
and their fragmentation patterns but also alters the chromatographic properties of proteins. 
To examine the potential impact of carbamylation on a top-down LCMS/MS workflow, 
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the E.coli ribosome containing 56 proteins was used as a benchmark mixture.  Figure 5.38 
shows the base peak LCMS traces for a mixture of ribosomal proteins prior to and after 
carbamylation.  For the mixture subjected to carbamylation, the composition of eluting 
proteins was checked throughout the LC run, and there was no evidence for non-
carbamylated forms.  In essence, carbamylation proceeded with near 100% efficiency. As 
specific examples of eluting proteins, Figures 5.39 and 5.40 show extracted ion 
chromatograms and corresponding MS1 spectra of ribosomal protein L24 from the 50S 
subunit prior to and after carbamylation.  The significant reduction in charge state upon 
carbamylation is evident in Figures 5.39 and 5.40 for which the most abundant charge state 
shifts from 16+ (unmodified) to 11+ (carbamylated) for 50S L24. The retention time 
changes by over 36 minutes upon carbamylation, thus reflecting the increase in 
hydrophobicity after modification of the 16 lysines and N-terminus of this 11.2 kDa (103 
residues) protein. In general, carbamylation increases the retention times of the ribosomal 
proteins by an average of 16 ± 7 minutes, an increase that is modulated by the number of 
lysine residues per protein (e.g. the hydrophobicity and concomitant change in retention 
time scales with the number of carbamylated groups).  The sequence maps are shown in 
the lower half of Figures 5.39 and 5.40, and the following sequence coverages were 
obtained:  62% for HCD and 80% for UVPD of the L24 protein (16+) and 27% for HCD 
and 71% for UVPD of the carbamylated L24 protein (10+), again exhibiting a significant 
decrease in coverage upon HCD of the carbamylated protein and a much smaller decrease 
in coverage upon UVPD.   
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Table 5.2 summarizes LC-MS results comparing HCD and UVPD for the 
collective set of ribosomal proteins, with specific performance results (including molecular 
weight, retention time, and sequence coverage) for a subset of six individual proteins 
shown in Table 5.3. Carbamylation significantly reduced the number of ribosomal proteins 
and matched fragment ions identified by HCD but had a far more modest impact on the 
UVPD results.  In fact, carbamylation resulted in a greater than 50% reduction in total 
protein identifications for HCD (from 53 to 24 proteins), with a similar trend for the 
number of proteoforms characterized (180 to 75 proteoforms), number of ribosomal 
proteins identified (42 to 22 proteins), and average number of fragments matched (23 to 13 
matching fragments per protein).  For the subset of proteins analyzed in detail in Table 5.3, 
the sequence coverage averaged 46% for the six unmodified proteins but plunged to 22% 
for the same carbamylated proteins. UVPD generated nearly 50% more matched fragments 
on average compared to HCD, regardless of carbamylation, indicating better protein 
characterization and sequence coverage (Table 5.2).  Carbamylation caused little change 
in the number of proteins (46 versus 48) and proteoforms (134 versus 134) identified by 
UVPD.  For the same subset of proteins reported in Table 5.3, the sequence coverage 
averaged 70% for the six unmodified proteins by UVPD and decreased to 60% for the 
carbamylated proteins. 
5.5 CONCLUSION   
Carbamylation offers a highly efficient means to modify the lysine sidechains and 
N-terminus of proteins, occurring with nearly 100% efficiency.  Carbamylation of intact 
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protein molecules causes (i) reduction of the observed charge states upon ESI, (ii) 
modulation of HCD and UVPD fragmentation, and (iii) increases in LC retention times 
owing to the greater hydrophobicity after conversion of primary amines to carbamylated 
groups. Overall carbamylation significantly decreased the sequence coverage produced by 
HCD and resulted in a much more modest impact on UVPD. Fragmentation was 
preferentially enhanced near the N- and C-termini for HCD of carbamylated proteins 
(typically resulting in smaller fragment ions) with a concomitant reduction in 
fragmentation in the mid-sections (larger fragment ions).  Although this apparent decrease 
in fragmentation in the mid-section of the protein could suggest that the larger fragments 
were converted to smaller N- and C-terminal fragment ions by secondary fragmentation 
pathways, there was no evidence for this premised based on examination of the 
fragmentation patterns as the HCD collision energy was varied.  Carbamylation had 
relatively little influence on the distribution or types of fragment ions generated upon 
UVPD, recapitulating the premise that the mechanism of UVPD is not highly dependent 
on mobile protons. MS/MS analysis of intact proteins remains a formidable challenge, and 
carbamylation offers a convenient way to modulate charge states  and resolve overlapping 










Figure 5.2 The sequence of each protein is shown along with the molecular weight, the 
number of residues, and the composition of basic residues (Arg, Lys, His). 
Lysine residues are highlighted in bold red font; arginines are shaded in blue; 





















Figure 5.5.  Backbone cleavage histograms of lysozyme (12+): a) HCD of unmodified 
lysozyme, b) UVPD of unmodified lysozyme, c) HCD of carbamylated 
lysozyme, and d) UVPD of carbamylated lysozyme. Some of the most 
enhanced backbone cleavage sites are labelled.  The sequence of lysozyme 
is shown along the x-axis, with every other residue omitted.  All N-terminal 
sequence ions are shown as blue bars; all C-terminal sequence ions are 






Figure 5.6 Backbone cleavage histograms of ubiquitin by HCD. The sequence of the 
protein is shown along the x-axis.  All N-terminal sequence ions are shown 
as blue bars;  all C-terminal sequence ions are shown as orange bars. HCD 








Figure 5.7   Top:  ESI mass spectra of unmodified and carbamylated ribosomal protein 
50S L24 from E.coli.  Bottom:  Sequence maps annotated for HCD 
fragmentation (upper sequence maps) and UVPD (lower sequence maps).  
The types of fragment ions generated from backbone cleavages are color 
coded as follows:  a/x green;  b/y blue; c/z red.  Gold-highlighted boxes 






Figure 5.8  Backbone cleavage histograms of ubiquitin by UVPD. The sequence of the 
protein is shown along the x-axis.  All N-terminal sequence ions are shown 
as blue bars;  all C-terminal sequence ions are shown as orange bars. UVPD 





Figure 5.9  Backbone cleavage histograms of carbamylated ubiquitin by UVPD. The 
sequence of the protein is shown along the x-axis.  All N-terminal sequence 
ions are shown as blue bars;  all C-terminal sequence ions are shown as 






Figure 5.10 Backbone cleavage histograms of cytochrome C by HCD. Some of the most 
enhanced backbone cleavage sites are labelled.  The sequence of the protein 
is shown along the x-axis.  All N-terminal sequence ions are shown as blue 
bars;  all C-terminal sequence ions are shown as orange bars. HCD NCE 









Figure 5.11  Backbone cleavage histograms of carbamylated cytochrome C by HCD. 
Some of the most enhanced backbone cleavage sites are labelled.  The 
sequence of the protein is shown along the x-axis.  All N-terminal sequence 
ions are shown as blue bars;  all C-terminal sequence ions are shown as 
orange bars. HCD NCE was optimized as follows 6+: 23NCE, 8+: 18 NCE, 




Figure 5.12  Backbone cleavage histograms of cytochrome C by UVPD. The sequence 
of the protein is shown along the x-axis.  All N-terminal sequence ions are 
shown as blue bars;  all C-terminal sequence ions are shown as orange bars. 





Figure 5.13  Backbone cleavage histograms of carbamylated cytochrome C by UVPD. 
The sequence of the protein is shown along the x-axis.  All N-terminal 
sequence ions are shown as blue bars; all C-terminal sequence ions are 




Figure 5.14  Backbone cleavage histograms of lysozyme by HCD. Some of the most 
enhanced backbone cleavage sites are labelled.  The sequence of the protein 
is shown along the x-axis.  All N-terminal sequence ions are shown as blue 
bars; all C-terminal sequence ions are shown as orange bars. HCD NCE was 




Figure 5.15  Backbone cleavage histograms of carbamylated lysozyme by HCD. Some 
of the most enhanced backbone cleavage sites are labelled.  The sequence 
of the protein is shown along the x-axis.  All N-terminal sequence ions are 
shown as blue bars; all C-terminal sequence ions are shown as orange bars. 





Figure 5.16  Backbone cleavage histograms of lysozyme by UVPD. The sequence of 
the protein is shown along the x-axis.  All N-terminal sequence ions are 
shown as blue bars; all C-terminal sequence ions are shown as orange bars. 




Figure 5.17  Backbone cleavage histograms of carbamylated lysozyme by UVPD. The 
sequence of the protein is shown along the x-axis.  All N-terminal sequence 
ions are shown as blue bars; all C-terminal sequence ions are shown as 




Figure 5.18  Backbone cleavage histograms of superoxide dismutase by HCD. Some of 
the most enhanced backbone cleavage sites are labelled.  The sequence of 
the protein is shown along the x-axis.  All N-terminal sequence ions are 
shown as blue bars; all C-terminal sequence ions are shown as orange bars. 





Figure 5.19  Backbone cleavage histograms of carbamylated superoxide dismutase by 
HCD. Some of the most enhanced backbone cleavage sites are labelled.  The 
sequence of the protein is shown along the x-axis.  All N-terminal sequence 
ions are shown as blue bars; all C-terminal sequence ions are shown as 
orange bars. HCD NCE was optimized as follows 12+: 20 NCE, 14+: 15 




Figure 5.20  Backbone cleavage histograms of superoxide dismutase by UVPD. The 
sequence of the protein is shown along the x-axis.  All N-terminal sequence 
ions are shown as blue bars; all C-terminal sequence ions are shown as 




Figure 5.21  Backbone cleavage histograms of carbamylated superoxide dismutase by 
UVPD.  The sequence of the protein is shown along the x-axis.  All N-
terminal sequence ions are shown as blue bars; all C-terminal sequence ions 




Figure 5.22  Backbone cleavage histograms of myoglobin by HCD. Some of the most 
enhanced backbone cleavage sites are labelled.  The sequence of the protein 
is shown along the x-axis.  All N-terminal sequence ions are shown as blue 
bars; all C-terminal sequence ions are shown as orange bars. HCD NCE was 




Figure 5.23  Backbone cleavage histograms of carbamylated myoglobin by HCD. The 
sequence of the protein is shown along the x-axis.  All N-terminal sequence 
ions are shown as blue bars; all C-terminal sequence ions are shown as 
orange bars. HCD NCE was optimized as follows 8+: 25NCE, 10+: 20 




Figure 5.24  Backbone cleavage histograms of myoglobin by UVPD. The sequence of 
the protein is shown along the x-axis.  All N-terminal sequence ions are 
shown as blue bars; all C-terminal sequence ions are shown as orange bars. 







Figure 5.25  Backbone cleavage histograms of carbamylated myoglobin by UVPD. 
Some of the most enhanced backbone cleavage sites are labelled.  The 
sequence of the protein is shown along the x-axis.  All N-terminal 
sequence ions are shown as blue bars; all C-terminal sequence ions are 




Figure 5.26   Backbone cleavage histograms of carbonic anhydrase by HCD. Some of the 
most enhanced backbone cleavage sites are labelled.  The sequence of the 
protein is shown along the x-axis with every other residue omitted.  All N-
terminal sequence ions are shown as blue bars;  all C-terminal sequence ions 
are shown as orange bars. HCD NCE was optimized as follows 22+: 




Figure 5.27  Backbone cleavage histograms of carbamylated carbonic anhydrase by 
HCD. Some of the most enhanced backbone cleavage sites are labelled.  The 
sequence of the protein is shown along the x-axis with every other residue 
omitted.  All N-terminal sequence ions are shown as blue bars; all C-
terminal sequence ions are shown as orange bars. HCD NCE was optimized 




Figure 5.28  Backbone cleavage histograms of carbonic anhydrase by UVPD. The 
sequence of the protein is shown along the x-axis with every other residue 
omitted.  All N-terminal sequence ions are shown as blue bars; all C-





Figure 5.29  Backbone cleavage histograms of carbamylated carbonic anhydrase by 
UVPD. The sequence of the protein is shown along the x-axis with every 
other residue omitted.  All N-terminal sequence ions are shown as blue bars; 
all C-terminal sequence ions are shown as orange bars. UVPD was set to 1 





Figure 5.30 Representative sequence maps for unmodified and carbamylated ubiquitin. 
The types of fragment ions generated from backbone cleavages are color 
coded as follows:  a/x green; b/y blue; c/z red.  Gold-shaded residues denote 









Figure 5.31 Representative sequence maps for unmodified and carbamylated 
cytochrome c. The types of fragment ions generated from backbone 
cleavages are color coded as follows:  a/x green; b/y blue; c/z red.  Gold-
shaded boxes denote sites of carbamylation. Red-shaded residues denote 
acetylated N-termini. Gold-shaded and gray-shaded residues indicated the 





Figure 5.32  Representative sequence maps for unmodified and carbamylated lysozyme. 
The types of fragment ions generated from backbone cleavages are color 
coded as follows:  a/x green;  b/y blue; c/z red.  Gold-shaded residues denote 








Figure 5.33  Representative sequence maps for unmodified and carbamylated 
superoxide dismutase. The types of fragment ions generated from backbone 
cleavages are color coded as follows:  a/x green;  b/y blue; c/z red.  Gold-










Figure 5.34   Representative sequence maps for unmodified and carbamylated 
myoglobin. The types of fragment ions generated from backbone cleavages 
are color coded as follows:  a/x green;  b/y blue; c/z red.  Gold-shaded 










Figure 5.35   Representative sequence maps for unmodified and carbamylated carbonic 
anhydrase. The types of fragment ions generated from backbone cleavages 
are color coded as follows:  a/x green;  b/y blue; c/z red.  Gold-shaded 





Figure 5.36  Distribution of fragment ions generated by HCD and UVPD categorized as 
preferential cleavages (N-terminal to proline, C-terminal to glutamic and 
aspartic acids, C-terminal to phenylalanine) and all non-specific pathways 
(other N-terminal and C-terminal cleavages) for unmodified and 






Figure 5.37  Distribution of fragment ions generated by HCD and UVPD categorized as 
preferential cleavages (N-terminal to proline, C-terminal to glutamic and 
aspartic acids, C-terminal to phenylalanine) and all non-specific pathways 
(other N-terminal and C-terminal cleavages) for unmodified and 














Figure 5.39 Top: Extracted ion chromatogram (EIC) of 50S L24 ribosomal protein 
showing elution at ~51 minutes. Bottom:  MS1 spectrum shows charge 
states ranging from 7+ to 21+ and the corresponding UVPD sequence 






Figure 5.40  Top:  Extracted ion chromatogram (EIC) of carbamylated 50S L24 
ribosomal protein showing elution at ~88 minutes. Bottom: MS1 mass 
spectrum showing charge states ranging from 6+ to 13+ and the 










Table 5.1  Sequence coverages obtained for various charge states of unmodified and 













Unmodified Carbamylated Unmodified Carbamylated 
Proteins* 53 ± 1 24 ± 1 46 ± 2** 48 ± 1** 
Proteoforms 180 ± 2 75 ± 3 134 ± 1 134 ± 11 
Ribosomal 
proteins 




23 ± 12 13 ± 5 45 ± 25 38 ± 18 
*includes proteins identified in sample not associated with E. coli  ribosomal 
subunits 
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Extending Proteome Coverage by Combining MS/MS Methods and a 
Modified Bioinformatics Platform adapted for Database Searching of 
Positive and Negative Polarity 193 nm Ultraviolet Photodissociation 
Mass Spectra 
6.1 OVERVIEW 
To extend proteome coverage obtained from bottom-up mass spectrometry 
approaches, three complementary ion activation methods, higher energy collision 
dissociation (HCD), ultraviolet photodissociation (UVPD), and negative mode UVPD 
(NUVPD), are used to interrogate the tryptic peptides in a human hepatocyte lysate using 
a high performance OrbitrapTM mass spectrometer. The utility of combining results from 
multiple activation techniques (HCD+UVPD+NUVPD) is analyzed for total depth and 
breadth of proteome coverage.  This study also benchmarks a new version of the Byonic 
algorithm which has been customized for database searches of UVPD and NUVPD data.  
Searches utilizing the customized algorithm resulted in over 50% more peptide 
identifications for UVPD and NUVPD tryptic peptide datasets compared to other search 
algorithms. Inclusion of UVPD and NUVPD spectra resulted in over 600 additional protein 





Ongoing advances in mass spectrometry (MS)-based proteomics have resulted in 
the identification of an ever-increasing number of proteins and proteoforms in cell lysates 
and other complex biological samples.1–4 This increase arises from several technological 
improvements.  New sample preparation methods target scarce post-translational 
modifications (PTMs) or enrich specific classes of molecules, thus improving the depth or 
breadth of sample analysis.5–9 High performance instrumentation has been designed 
specifically for proteomics applications with greater throughput at the forefront, such as 
implementation of parallelization methods.10 In addition, software that exploits the 
increasing resolving power and mass accuracy metrics of new mass spectrometers and that 
accommodates a growing array of novel ion activation methods has been developed.11–17 
Until recently these advancements have primarily been adapted for positive mode 
ionization (e.g. formation and analysis of protonated peptides), owing to three reasons.  
First, electrospray ionization typically generates greater signal intensities in the positive 
mode because signal suppression arising from corona discharge under negative polarity 
conditions is a common occurrence.18,19 Second, liquid chromatography methods usually 
use an acidic mobile phase modifier to improve LC peak shape which naturally enhances 
protonation of eluting peptides.20,21 Third, protonated peptides generally exhibit more 
informative fragmentation patterns upon collisional activation than do deprotonated 
peptides, thus facilitating effective database searches.22–24 These three factors have 
contributed to the pervasiveness of positive mode proteomics and account for the 
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prevailing success of bottom-up strategies. In contrast, far less effort has been devoted to 
the negative ionization mode, which means there are avenues of opportunity for extending 
proteomic analysis. For example, the negative mode is well suited for acidic peptides, ones 
that might be overlooked in the positive mode owing to their naturally low abundances 
(such as for phosphopeptides), spectral congestion from co-eluting peptides, or poor 
ionization due to high pKa values. Compounding the experimental difficulties of LC-MS 
methods in the negative mode is the dearth of bioinformatics software adapted to analyze 
the MS/MS spectra of deprotonated peptides.  The often uninformative nature of MS/MS 
spectra generated by collision induced dissociation (CID) of deprotonated peptides, spectra 
which are often dominated by small neutral losses, has played a prominent role in this 
context.25 
Despite these hurdles, some recent effort has been directed at exploring the negative 
ionization mode for bottom-up proteomics, and significant inroads have been reported.13,26–
32  Primarily two alternative ion activation methods for peptide anions are under 
development for high throughput workflows: negative electron transfer dissociation 
(NETD)28–30,32 and negative ultraviolet photodissociation (NUVPD).13,26,33,34 The 
performance of NETD has been significantly improved by incorporation of a supplemental 
activation step to increase the fragmentation efficiency.31,32 This enhanced NETD method 
is termed activated ion NETD (AI-NETD) and has shown promising results.31,32,35 In the 
most impressive AI-NETD proteomics study to date, Riley et al.  identified over 8600 
unique peptides and over 1300 proteins in a 90-min analysis of human embryonic stem cell 
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lysate using AI-NETD.32 UVPD uses photon absorption, rather than electron transfer, to 
activate and dissociate peptides. Madsen et al. identified over 3600 peptides and over 800 
proteins from a cell lysate of Halobacterium salinarum by NUVPD.13 The hallmark of both 
these novel activation methods is their ability to generate diagnostic fragment ions for 
negatively charged peptides in a high throughput LC-MS/MS mode. Both AI-NETD and 
NUVPD tend to generate a and x ions; either as radical or non-radical forms. The 
development of these methods has spurred adaptation and customization of bioinformatics 
platforms to support data analysis. Originally OMSSA was modified by the Coon group 
for database searches of NETD and AI-NETD spectra,30 whereas MassMatrix was  
modified by the Brodbelt group for analysis of NUVPD data.13 More recently the 
bioinformatics platform Byonic was modified and optimized for negative polarity spectral 
matching and was shown to outperform previous software for analysis of NETD data 
acquired in a high throughput LC-MS manner, culminating in greater than 50% more 
peptide identifications in a tryptic digest of yeast to their in-house customized OMSSA 
software.12  
In this study, we implemented UVPD and NUVPD on a high performance Orbitrap 
mass spectrometer and demonstrated the complementarity of using negative and positive 
polarity analyses to broaden proteome coverage. The Byonic database search algorithm 
was adapted for interrogating UVPD spectra in both positive and negative ion modes to 
facilitate database searches, yielding the greatest number of peptide spectral matches 
(PSMs) and identified peptides and proteins in a negative polarity LC-UVPD-MS 
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experiment reported to date.  Peptide and protein metrics from NUVPD datasets analyzed 
by both Byonic and MassMatrix were compared, and the performance of Byonic was 
compared to Proteome Discoverer/SEQUEST for assessment of UVPD and HCD data in 
the positive mode.  
6.3 MATERIALS & METHODS 
6.3.1 Preparation of human hepatocyte lysate  
HC-04 cells (MRA-975, ATCC Manassas, VA), human hepatocytes, were 
maintained in Dulbecco’s modified Eagle’s medium/Ham’s F12 50/50 mix (Gibco Life 
Technologies, Grand Island, NY) supplemented with 10% heat-inactivated fetal bovine 
serum (Gibco Life Technologies) and 2 mM l-glutamine (Gibco Life Technologies). Cells 
were washed twice with PBS and then scraped from the culture surface with 10 ml of ice-
cold PBS and centrifuged at 2,000 g at 4°C for 5 minutes. The supernatant was then 
removed and replaced with 1 ml of ice-cold urea lysis buffer (50 mM Tris, pH 8, 8 M urea, 
150 mM NaCl, 1mM EDTA) supplemented with 2 μg/ml of aprotinin (MD Biomedicals, 
Solon, OH), 10 μg/ml of leupeptin (Roche Diagnostics, Indianapolis, IN), 1mM 
iodoacetamide (Sigma-Aldrich, St. Louis, MO), 50 μM PR-619 (Lifesensors, Malvern, PA) 
and 1 mM phenylmethanesulfonyl fluoride (PMSF; Sigma-Aldrich). Cells were lysed by 
extrusion through a 20-gauge needle (Becton Dickinson, Franklin Lakes, NJ) attached to a 
1-ml syringe (Becton Dickinson) 25 times and placed on ice for 40 minutes. The lysate was 
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then cleared by centrifugation at 14,000 g for 20 minutes and final protein concentration 
was determined using the DC protein assay (Bio-Rad, Hercules, CA). 
6.3.2 Materials 
HPLC solvents were obtained from EMD Millipore (Temecula, CA), and buffer 
components were obtained from Sigma-Aldrich (St. Louis, MO). Proteomics-grade trypsin 
was obtained from Promega (Madison, WI). All other reagents and solvents were obtained 
from Thermo Fisher Scientific (Fairlawn, NJ).  
6.3.3 Protein digestion  
Proteins isolated from the liver cell lysate were sequentially reduced in 5 mM 
dithiothreitol (DTT) for 30 min at 55 °C then alkylated in 10 mM iodoacetamide at room 
temperature in the dark for 30 min. Alkylation was quenched with a second aliquot of DTT, 
bringing the final concentration of DTT to ∼10 mM. After alkylation, the sample was split 
into three separate aliquots for triplicate analysis.  
Trypsin was added in a 1:50 protease-to-protein ratio, and the solution was buffered 
at pH 8 in 100 mM ammonium bicarbonate. Digestion proceeded for 18 h at 37 °C. After 
digestion, all samples were quenched with 1% formic acid and cleaned over a spin cartridge 




Chromatographic separations were performed using a Dionex RSLC 3000 
nanobore LC system with water (A) and acetonitrile (B) as mobile phases, with each 
containing 0.1% formic acid. The trap (0.075 cm x 3.5 cm) and analytical column (0.075 
cm × 20 cm, with integrated emitter) were packed in-house using 3.5 μm XBridge BEH 
C18 media (Waters, Milford, MA). Approximately 1 μg of digest was loaded onto the trap 
column at 5 μL/min for 5 min, then separated on the analytical column with a gradient that 
changed from 0 to 35% B over the course of 240 min at a flow rate of 300 nL min–1. For 
nanospray, 1.8 kV was applied at a precolumn liquid voltage junction.  
The hepatocyte digests were analyzed on a Orbitrap Fusion Lumos mass 
spectrometer (Thermo Scientific Instruments) equipped with a 193 nm excimer laser 
(Coherent, Santa Clara, CA) and modified to allow UVPD in the linear ion traps as 
previously described.36 UVPD was performed in the low-pressure trap using two pulses 
(2.5 mJ, 5 ns per pulse). HCD was performed in the ion routing multipole at 35% NCE 
during a 0.1 ms period.  
The Orbitrap mass spectrometer was operated using the following parameters 
regardless of fragmentation type:  top speed (3 sec cycle), MS1 at 60 000 resolving power, 
1 μscan per spectrum, 1 × 105 AGC target, 15 V source fragmentation, peptide 
monoisotopic precursor selection; and MS2 at 15 000 resolving power, 1 μscan per 
spectrum, and 1 × 105 AGC target. The minimum signal required for MS2 selection was 
400,000, and the isolation width was fixed at 3 m/z. Dynamic exclusion was enabled for 
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30 s with a repeat count of 3 and exclusion duration of 60 sec. In essence, this means that 
any m/z value may be selected and subjected to MS/MS three times within a 30 s interval, 
then excluded from selection for the next 60 s.   
6.3.5 Data analysis 
Detailed descriptions of the data analysis workflow and parameters are provided in 
the supplemental material. Briefly the RAW data files were imported directly into 
Proteome Discoverer (SEQUEST+ Percolator) or Byonic for processing; data files were 
converted to mzXML files by use of the MassMatrix data conversion tools for analysis by 
MassMatrix. Results from all three informatics platforms were filtered to 1% FDR. Data 
was searched against the human proteome (UP000005640) downloaded from Uniprot 
(02/14/2017). Positive polarity HCD and UVPD LC-MS data files were analyzed using 
Byonic and SEQUEST+Percolator. Negative polarity UVPD data were analyzed using 
Byonic and MassMatrix. 
6.4 RESULTS AND DISCUSSION 
The goal of this study is to evaluate the utility of combining the results of three 
MS/MS activation techniques for the analysis of a tryptic cell lysate. The three activation 
techniques considered were HCD for positively charged peptides and UVPD for both 
positively and negatively charged peptides. For this effort a widely available proteomics 
search engine, Byonic, was customized to further improve the informatics tools available 
for UVPD spectra. Herein we describe how the use of UVPD for both positively and 
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negatively charged peptides can uniquely complement conventional HCD of positively 
charged peptides.  At the same time, we report the performance enhancements offered by 
a search algorithm customized for UVPD data, thus significantly extending the breadth of 
proteome coverage obtained from UVPD data based on greater numbers of identified 
peptides and proteins and greater sequence coverage of proteins identified. We report 
results based on analyses of tryptic digests of human liver cell lysate. Baseline performance 
was established using MassMatrix (previously the only tool available for large scale 
analysis of proteomics datasets acquired in the negative mode by UVPD) and 
SEQUEST+Percolator for conventional MS/MS data acquired in the positive mode.   
Byonic has been shown to be more sensitive than Sequest, Mascot, PEAKS, 
MaxQuant, and MS Amanda.37 Enhanced sensitivity has been achieved through a series of 
refinements.38 These refinements include:  (1) use of peak ranks (that is, most intense, 
second most intense, and so forth) rather than presence/absence, (2) sequence-based peak 
intensity prediction, implemented as multiplicative weights (for example, a large weight 
for collisional fragmentation on the N-terminal side of proline), (3) reduced score for larger 
m/z errors, (4) “2D” FDR estimation (that is, simultaneous control of both protein and 
peptide FDRs), and, most relevant here, (5) peak prediction based upon fragmentation 
method.  For positive-mode UVPD, Byonic scores a- and a-dot (radical) ions, x-ions, b-
ions, and y-ions. Sequence-based adjustments of weights, for example, up-weighting on 
the N-terminal side of proline, are as in HCD. For negative mode UVPD, Byonic scores 
negative a-dot (radical) and x-ions, along with neutral losses of carbon dioxide, with 
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roughly equal weights for all predicted ions.  In comparison to Byonic, Sequest does not 
use the peptide sequence to predict theoretical fragment ion abundances, and the statistical 
basis for considering fragment ion abundances is less sophisticated. In addition, the 
quantization of m/z errors (categorization based on full value, half value, zero) is less 
refined in Sequest.  A closer examination of the nuances of MassMatrix based on manual 
inspection of high-scoring decoy matches indicates that unfragmented precursor ions may 
be mistaken for product ions, and there appears to be less consistency of scoring based on 
specific ion types. These factors, which are considered or addressed in the Byonic 
algorithm, may contribute to the different outcomes of Byonic relative to Sequest and 
MassMatrix.  
6.4.1 Complementarity of UVPD and HCD 
Figure 6.1 shows representative HCD, UVPD and NUVPD mass spectra for one 
peptide analyzed in both positive and negative modes (HCD (3+), UVPD (3+) and NUVPD 
(2-) spectra of LNDGHFMPVLGFGTYAPPEVPR, a tryptic peptide originating from 
protein P42330). HCD generates the expected b/y fragment ions for the protonated peptide, 
whereas UVPD generates predominantly b/y ions, some a ions, and to a lesser extent some 
c, x and z ions.  Neither UVPD nor NUVPD generates more than 50% of the total possible 
y or x ions that contain the C-terminus; however, when combined nearly 70% of the 
possible x/y-type ions are confirmed.  HCD of this peptide resulted in 62% coverage, 
UVPD resulted in 70% sequence coverage; and NUVPD afforded 70% sequence coverage; 
the combination yielded a total of 77% sequence coverage.  Other examples of HCD, 
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UVPD, and NUVPD spectra are shown in Figures 6.2 and . Both HCD and UVPD provide 
high sequence coverage for many peptides in the positive mode, and the sizes and charge 
states of peptides identified by each method are similar, as discussed later. The contrast in 
diagnostic quality of the MS/MS spectra is much more notable for peptides analyzed in the 
negative mode.  In this case, HCD mainly results in neutral losses and internal fragment 
ions which are less useful for peptide sequencing, whereas UVPD produces characteristic 
a/x ions that afford high sequence coverage (Figure 6.1)  Examination of the other MS/MS 
spectra in Figures 6.2 and 6.3 provides more evidence of the complementary nature of 
HCD and UVPD, especially when both positive and negative modes are utilized.  In 
general, the series of backbone cleavages for individual peptides varies for each activation 






Figure 6.1  A) HCD (3+), B) UVPD (3+), and C) NUVPD (2-) spectra of tryptic peptide 
LNDGHFMPVLGFGTYAPPEVPR showing complementary information 
from each technique. Combining all methods yields 70% coverage by a and 





Figure 6.2  MS/MS spectra generated by A) HCD (35 NCE) and B) UVPD (2 pulses,                            
2.5   mJ per pulse) for peptide HNGAPAIDGIDDTIISDDTAR (3+) from a 





Figure 6.3     Negative polarity MS/MS spectra generated by A) HCD (35 NCE) and B) 
UVPD (2 pulses, 2.5 mJ per pulse) for peptide 
ELEQVCNPIISGLYQGAGGPGPGGFGAQGPK (2-) from a tryptic 
digest of proteins extracted from human hepatocytes. 
 
The average number of peptides and proteins identified using Byonic versus 
SEQUEST for positive-mode UVPD runs and versus MassMatrix for NUVPD runs, based 
on triplicate runs is shown in Figure 6.4.  Customization of Byonic’s algorithm contributed 
only a small amount to its greater sensitivity for analysis of positive-mode UVPD spectra, 
as the differences between Byonic’s UVPD and HCD fragment ion predictions for 
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unmodified peptides are not large: no immonium ions in UVPD mass spectra, more 
abundant a- and a-dot (radical) ions in UVPD mass spectra, and some modest differences 
in favored neutral losses (for example, carbon dioxide rather than water and ammonia loss). 
Customization of Byonic for negative-mode mass spectrometry was required to obtain any 
results at all for activation methods such as NETD or NUVPD. The difference in scoring 
an NETD spectrum and a NUVPD spectrum is not large:  an NUVPD spectrum is scored 
much like an NETD spectrum of a precursor with one more negative charge, that is, Byonic 
scores an NUVPD spectrum of a precursor with charge 2- much as it scores an NETD 
spectrum of a precursor with charge 3-.11 Construction of Venn diagrams allows evaluation 
of the overlap in the peptide and protein identifications at 1% FDR for each MS/MS mode, 
as illustrated in Figure 6.5.   
 
 
Figure 6.4   Number of tryptic peptide and protein identifications based on Byonic, 





Figure 6.5      Venn diagrams illustrating the number of peptides (left) and proteins (right) 
identified based on HCD in the positive mode and UVPD in both the 
positive and negative modes.   
 
By combining the results of three runs (and eliminating peptides identified more than 
once), HCD identified over 33,000 peptides, and UVPD identified over 28,000 peptides in 
the positive mode and over 14,000 peptides in the negative mode.  Most significantly, over 
6,500 peptides were uniquely identified by UVPD in the positive mode and over 2,500 
peptides were uniquely identified by UVPD in the negative mode.  These additional peptide 
identifications meant that UVPD (combining positive and negative modes) identified over 
600 additional proteins not found by HCD alone. Overlap of unique peptides from the 
triplicate runs of each method accounted for around one third of all identified peptides, 
identification by two or more runs accounted for approximately two thirds of all identified 
peptides across methods (Figure 6.6).  Overall the greatest number of peptides was 
identified based on the HCD method, likely owing to the greater signal to noise of HCD 
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mass spectra compared to UVPD mass spectra, thus resulting in informative, interpretable 
spectra from lower abundance precursor ions. 
 
Figure 6.6     Overlap of peptides from HCD, UVPD and NUVPD replicates from 
tryptic digests of proteins extracted from human hepatocytes. 
 
The high degree of overlapping protein and peptide identifications shows the 
complementary nature of UVPD, NUVPD and HCD, and at the same time the unique 
identifications for each activation mode extend the breadth of total proteins identified. 
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Furthermore, the overlap of peptides identified by SEQUEST+Percolator and Byonic from 
the UVPD dataset is shown in Figure 6.7.  
 
 
Byonic identified over 98% of the all peptides identified by UVPD. SEQUEST+Percolator 
uniquely identified ~1.5% (457 peptides.)  
 
 
Figure 6.7    Overlap of UVPD peptides identified by Byonic and SEQUEST+Percolator  
from tryptic digests of proteins extracted from human hepatocytes. 
 
Figure 6.8 shows a sequence map for protein P42330 (an aldo-keto reductase) 
which was identified based on peptide spectral matches from HCD, UVPD and NUVPD 
from the human liver lysate.  Individually, no single activation method achieved over 52% 
sequence coverage.  In fact, the regions identify by each method were largely orthogonal. 
For example, only 5% of the sequence overlapped for the peptides identified by HCD and 
NUVPD, thus illustrating the potential of NUVPD to characterize peptides that might not 
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be well covered by HCD alone. Combining the MS/MS spectra from all three activation 
methods resulted in total sequence coverage of 70% of the protein.   
 
Figure 6.8     Sequence coverage of P42330 (36853 Da) resulting from HCD (yellow), 
UVPD (pink) and NUVPD (blue). Peptides sequenced by all three methods 
are highlighted in orange, those sequenced by UVPD and NUVPD in 
purple, and those sequenced by NUVPD and HCD are shown in green. 
 
The distribution of peptide sizes and charge states for all peptide spectral matches 
is displayed in histogram format in Figure 6.9. The y-axis is normalized to the total 
population of unique peptides from each search. The population of unique peptide masses 
identified by Byonic for HCD and UVPD appear as skewed-right distributions with 
average peptide masses of 2008 Da and 2128 Da respectively. However, the distribution 
of NUVPD identified peptide masses was more symmetric with a larger spread and an 
average mass of 2095 Da. With respect to the charge states, the portions of 2+, 3+, and 4+ 
peptides identified by UVPD and HCD in the positive mode are similar, with nearly equal 
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percentages of doubly and triply protonated peptides. In the negative mode, there is a 
significant preference for identification of doubly deprotonated peptides by NUVPD. The 
shift to lower charge states for the peptides identified by NUVPD is reasonable given that 
the acidic mobile phase most commonly used for reversed phase liquid chromatography 
suppresses extensive deprotonation of peptides. The size distribution of NUVPD identified 
peptides is skewed towards larger peptides compared to UVPD and HCD.  We speculate 
that the apparent shift to larger peptides for NUVPD may be due to two factors. One factor 
is the potential low efficiency of deprotonation of small tryptic peptides which is dominated 
by their terminal basic sites. Second, longer peptides often have greater hydrophobicities 
and elute later in the LC gradient.  Ionization in the negative mode is less efficient in the 
early, highly aqueous portion of the gradient, and ionization efficiency increases as the 
organic content of the mobile phase increases.  Thus, the apparent increase in size of 
peptides for NUVPD may be related to the improved electrospray conditions in the latter 





Figure 6.9     Histogram showing size of peptides identified by HCD, UVPD and NUVPD 
using Byonic. The inset histograms display the charge states of the 
identified peptides in the positive and negative modes.   
 
The isoelectric point (pI) distribution of peptides identified by UVPD and NUVPD 






Figure 6.10   A) Portions of peptides identified by NUVPD versus UVPD from tryptic 
digests of proteins extracted from human hepatocytes. The peptides are 
ordered based on isoelectric point.  B) Distribution of isoelectric point of 
peptides identified by UVPD and NUVPD. 
 
A larger proportion of the identified peptides from NUVPD analysis populated the 
pI 3-5 range while the range of 5-11 was generally dominated by a larger proportion 
identified by UVPD suggested NUVPD is well suited to study particularly acidic peptides 
and proteins. 
6.4.2 Comparison of Forward and Reverse PSMs Ranking Between Platforms 
  To further investigate the sensitivity/specificity tradeoff, receiver operator 
characteristic (ROC) curves were plotted for forward and decoy PSMs derived from 
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searches using Byonic, SEQUEST+Percolator and MassMatrix (the latter only for 
NUVPD). A ROC curve displays the number of forward PSMs (correct hits) as a function 
of the reverse PSMs (false hits). These plots display the ability of a method to discriminate 
between true and false PSMs at a given threshold (or number of false PSMs).  An ideal 
method would generate an ROC curve which lies along the top left of the graph (immediate 
plateau) suggesting complete discrimination between decoy and forward PSMs; conversely 
a poor method would show an ROC curve lying along the line y=x, suggesting that for each 
forward PSM a reverse PSM occurs. For these comparisons, no cutoff was used for the 
false discovery rate (FDR). All PSMs were filtered to a single best PSM per spectrum (i.e. 
the best PSM from any given spectrum was considered unique to that spectrum, and any 
other PSMs to the same spectrum were not plotted). The PSMs were ranked by q-value for 
SEQUEST-Percolator data, Log Prob for Byonic and pp-tag for MassMatrix.  The metrics 
q-value, Log Prob, and pp-tag are used to establish the quality of a match and also to 
establish FDR for a set of PSMs. The resulting ROC curves represent the number of PSMs 
matching to the decoy database that must be tolerated to achieve a given number of forward 
PSMs. 
ROC curves for PSMs determined using the Byonic and SEQUEST+Percolator 
search algorithms based on the UVPD mass spectra of the tryptic human liver peptides 
acquired in the positive mode are shown in Figure 6.11. The ROC curves show the full 
sensitivity/ specificity tradeoff for both Byonic and SEQUEST + Percolator. For example, 
with Byonic, approximately 41,000 PSMs with only a few decoy PSMs (too few to be 
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observed in the plot), about 49,000 PSMs with 50 decoy PSMs, or over 52,000 PSMs with 
1000 decoy PSMs, are obtained. For construction of this plot, all top-ranking PSMs from 
the search engines were retrieved, rather than allowing the software to threshold at 1% 
FDR.  In this particular case, it is apparent that 1% FDR may be a worse choice than 0.1% 
FDR for Byonic, because 1% FDR increases sensitivity only slightly while degrading 
specificity significantly. The ROC curve from the Byonic data processing is shifted higher 
and to the left, suggesting greater specificity and sensitivity in assignment of PSMs, mainly 
due to generic scoring improvements such as rank-based intensities and m/z-error scoring, 
rather than SEQUEST’s m/z binning. The SEQUEST+Percolator ROC curve plateaus at 
46,533 forward PSMs, whereas the Byonic ROC curve plateaus at 52,658 forward PSMs, 
yielding a 13% improvement in sensitivity. At an estimated PSM level FDR of 1%, 44,179 
forward PSMs clear the threshold based on the use of the SEQUEST+Percolator search 
method, whereas 51,859 PSMs clear the threshold based on the Byonic search.  It is not 
exactly clear why MassMatrix gives much lower performance than Byonic, but manual 
inspection of high-scoring decoy matches shows that MassMatrix sometimes mistakes 
unfragmented precursor ion for a product ion, and can achieve a high score from a mix of 





Figure 6.11     ROC plot for UVPD data searched by Byonic (Orange) and SEQUEST 
(blue). 
 
Figure 6.12 shows the ROC curves for PSMs identified from the NUVPD data set 
assigned by MassMatrix and Byonic. The ROC curve based on the Byonic output plateaus 
significantly higher at 31,972 compared to MassMatrix at 12,395, a 157% improvement in 
sensitivity.  Interestingly, the slope for both curves is similar, suggesting that they have 
similar specificity towards forward PSMs. Re-analysis of a HeLa/NUVPD dataset reported 
in Madsen et al.13 using the optimized Byonic algorithm resulted in a nearly 70% increase 
in protein and over 85% increase in peptide identifications, confirming the practical gains 
realized by this upgraded NUVPD spectral search algorithm (additional details are 





Figure 6.12.  ROC plot for NUVPD data analyzed by MassMatrix (blue) and Byonic 
(orange) from tryptic digests of proteins extracted from human 
hepatocytes. 
 
6.4.3 Protein Oblivious and Protein Aware   
One of the unique features of the Byonic algorithm is its default use of a two-dimensional, 
protein aware false discovery rate (2D FDR) which bolsters peptide identifications by 
enhancing the scores of peptides from proteins which are confidently identified. We have 
compared the UVPD and NUVPD results with and without utilization of the 2D FDR 
feature. The use of 2D FDR did not impact protein identification for the UVPD dataset. 
Using a traditional protein oblivious 1% FDR (1D FDR or just FDR), on average 2660 
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proteins were identified, whereas 2663 proteins were identified when the 2D FDR (protein 
aware FDR) at 1% FDR was employed. Greater gains were observed for the number of 
unique peptide identification when using the 2D FDR method. A 1D search identified 
17534 peptides on average, whereas a 2D search identified 20315 unique peptides for a 
gain of 14%. Compared to the corresponding SEQUEST+Percolator search which yielded 
12363 peptide identifications, the 2D FDR method in Byonic yielded a 64% gain, 35% of 
which are attributed to unique peptides assigned based on the use of a 2D FDR. A 
comparable gain in peptide identifications was noted for NUVPD data. The number of 
protein IDs was unchanged between 1D and 2D results for the NUVPD searches. However, 
incorporation of the 2D FDR resulted in 13% more peptide identifications at 1% FDR. 
These results are reflected by ROC analysis of the 1D and 2D searches (Figures 6.13 and 
6.14). The selectivity is nearly the same for both 1D and 2D ROC curves, but the onset of 




Figure 6.13   ROC plot comparing 1D and 2D FDR results for UVPD data from tryptic 
digests of proteins extracted from human hepatocytes. The graphs indicate 
that the majority of improvement is based on the search algorithm used, 






Figure 6.14    ROC plot comparing 1D and 2D FDR results for NUVPD data from 
tryptic  digests of proteins extracted from human hepatocytes.The graphs 
indicate that the majority of the improvement is based on the search 
algorithm used, not inclusion of 2D FDR. 
 
6.4.4 Increased protein sequence coverage 
Given the increase in the number of peptides identified by Byonic compared to 
SEQUEST and MassMatrix, protein sequence coverage would be expected to change as 
well. Figures 6.15, 6.16 and 6.17 show the distribution of protein sequence coverages for 
HCD, UVPD, and NUVPD, respectively, reported by Byonic (blue), SEQUEST (red) and 
MassMatrix (green). The distribution of protein sequence coverages are shifted to higher 
values when using Byonic, likely owing to the use of the protein aware scoring to include 
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peptides that would have otherwise been filtered out conventionally.30 
 
Fig 6.15 Distribution of sequence coverages obtained for proteins by HCD reported 
by Byonic (blue) and SEQUEST (red) from tryptic digests of proteins 





Fig 6.16         Distribution of sequence coverages obtained for proteins by UVPD 
reported by Byonic (blue) and SEQUEST (red) from tryptic digests of 





Fig 6.17         Distribution of sequence coverages obtained for proteins by NUVPD 
reported by Byonic (blue) and MassMatrix (green) from tryptic digests of 
proteins extracted from human hepatocytes. 
 
 The average protein sequence coverage reported for HCD was 25.1% for Byonic 
compared to 16.3% for SEQUEST in Figure 6.15. The average protein sequence coverage 
reported for UVPD was 27.3% for Byonic compared to 18.9% using SEQUEST in Figure 
6.16. The average protein sequence coverage reported for NUVPD was 20.5% for Byonic 
compared to 13.6% for MassMatrix in Figure 6.17.  Overall Byonic improved protein 
sequence by more than 6% across all activation methods. A comparison of protein 
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sequence coverage distributions for HCD, UVPD, and NUVPD data sets using the same 
search algorithm (Byonic) is shown in Figure 6.18. 
 
 
Fig 6.18         Distribution of sequence coverages obtained for HCD, UVPD, and 
NUVPD from tryptic digests of proteins extracted from human 
hepatocytes. 
 
6.4.5 Identification of post-translational modifications: phosphopeptides  
It has been previously shown that UVPD affords a special ability to characterize 
post-translational modifications (PTMs) owing to the fact that these modifications are not 
labile upon photoactivation, and the high sequence coverage afforded by UVPD allows 
confident pinpointing of the sites of PTMs.33,34,39–42 An example of one phosphopeptide 
identified in the liver cell lysate using all three MS/MS strategies is shown in Figure 
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6.19. All three methods yielded good sequence coverage of the peptide: 92% coverage for 
HCD (3+), 83% coverage for UVPD (3+), and 100% coverage for NUVPD (2-). Despite 
similar sequence coverages, the retention of the phosphate group varied significantly 
among the three activation modes. As shown in Figure 6.19, the dominant products 
generated by HCD did not retain the phosphate group, an outcome particularly notable for 
the y ion series. UVPD of the same 2+ peptide showed only moderate phosphate loss. In 
general, UVPD generated a nearly 50/50 distribution of products that retained or lost the 
phosphate group. Further optimization of the laser energy and pulse number could improve 
phosphate retention. UVPD of the doubly deprotonated peptide generated a clean series of 
fragments retaining the phosphate moiety, displaying less than 5% phosphate loss. No 
enrichment was performed on these samples nor were they treated during growth or lysis 
for retention of PTMs, and a more targeted approach would be essential in order to 
maximize the identification of phosphopeptides and other modified peptides in complex 
cell lysates akin to the ones analyzed in the present study. However, this initial result 
recapitulates the promising combined strategy of HCD, UVPD, and NUVPD to enhance 




Figure 6.19   A) HCD, B) UVPD, and C) NUVPD of phosphorylated 
LKDLFDYSPPLHK from a tryptic digest of proteins extracted from 
human hepatocytes, showing varying degrees of phosphate retention. 
6.5 CONCLUSIONS 
Analyses of tens of thousands of HCD, UVPD, and NUVPD spectra revealed the 
complementary nature of traditional collisional activation (HCD) and novel photon-based 
activation (UVPD and NUVPD) methods. Combining these methods increased the total 
number of proteins identified by 12% and peptides identified by 29%. There are numerous 
instances for which a single method alone sequenced a limited portion of a protein, whereas 
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combining the results of multiple activation methods afforded nearly complete coverage. 
Furthermore, traditional collisional activation does not provide adequate fragmentation for 
confident peptide assignments in the negative polarity mode, resulting in limited 
identification of the most acidic portions of the proteome. A modified Byonic platform 
optimized for analysis of UVPD spectra returned a 64% improvement in the number of 
identified peptides relative to the more commonly employed database search algorithm 
(SEQUEST) and 18% more identified proteins compared to other available database search 
programs.  
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Extensive Characterization of Heavily Modified Histone tails by 193 nm 
Ultraviolet Photodissociation 
7.1 OVERVIEW 
The characterization of proteins bearing several post-translational modifications 
(PTMs) remains challenging for the traditional mass spectrometry (MS) based proteomics 
workflow, i.e. short peptide analysis (4-20 residues) via bottom-up MS. This is due to the 
lability of PTMs upon collisional activation dissociation and the difficulty of mapping 
combinatorial patterns of PTMs. There are also hurdles associated with top-down MS 
approaches related to limited data analysis options for heavily modified proteoforms and 
less efficient separation methods for intact modified proteins, together leading to poor 
quantification. These shortcomings have accelerated interest in middle-down MS methods 
that focus on analysis of large peptides generated by certain enzymes (e.g. GluC, LysC, 
AspN), limited digestion, or chemical cleavage (e.g., formic acid). Mapping multiple 
PTMs simultaneously requires the ability to obtain extensive sequence coverage to allow 
confident localization of the modifications. Ultraviolet photodissociation (UVPD) has been 
shown to generate high sequence coverage for peptides and proteins compared to 
traditional MS/MS methods. Histones are an ideal system to test the ability of UVPD to 
characterize multiple modifications as the combinations of PTMs are the underpinning of 
the biological significance of histones and at the same time create an imposing challenge 
for characterization. The present study focuses on determining the feasibility of UVPD for 
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identification and localization of PTMs on histones by UVPD and comparison to a popular 
alternative, electron-transfer dissociation (ETD), via a high throughput middle-down LC-
MS/MS strategy. In total, over 300 modified forms were identified, and the distributions 
of PTMs were quantified between these two methods. Results showed that both UVPD and 
ETD results efficiently quantified significant differences of PTM abundance when 
comparing control HeLa cell culture and treatment with deacetylase inhibitors. Additional 
ion types generated by UVPD proved essential for extensive characterization of the most 
heavily modified forms (> 5 PTMs). 
 
7.2 INTRODUCTION 
Post-translational modifications (PTMs) of proteins are implicated in an ever-
expanding number of crucial biological processes, ranging from gene expression to 
tumorigenesis to cell death.1–4 Not only the type of modification but also the number, sites, and 
pattern, collectively known as combinatorial modifications, create an elaborate diversity of 
protein structure and function. Even minor variations in the distribution of PTMs can 
significantly influence the outcomes of myriad of cellular processes. Key examples of 
landmark proteins in which combinatorial modifications have been found to be essential for 
triggering and regulating downstream effects include p53,5–7 histones (chromatin structural 
units),8,9 and the C-terminal domain of RNA polymerase.10,11 Hundreds of types of PTMs are 
now recognized to contribute to the coding of protein function,12,13 and the interplay between 
different PTMs has created an enormous need for methodologies that can characterize PTMs 
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and allow the cross-talk arising from combinatorial modifications to be deciphered. Significant 
effort has focused on improving analytical tools, particularly advanced mass spectrometry 
(MS), to characterize PTMs.14,15 Routine characterization of proteins which are modified at 
multiple residues remains a challenge,16–18 owing to the dynamic nature of PTMs, their low 
abundances and the large variation in stoichiometries.19 Other techniques are available to 
identify PTMs, such as modification-specific antibodies,20 and gel electrophoresis (limited 
applicability).21 However, these methods cannot identify unknown modifications nor co-
existing combinatorial PTMs. 
MS offers special attributes in the realm of high-throughput PTM analysis.22–24 In 
recent years, advances in MS analysis of PTMs have facilitated identification of even greater 
numbers and types of PTMs in a single experiment.25–27 Chief among the innovations enabling 
PTM analysis by MS are the development of selective enrichment methods25,28,29 and the 
introduction of new ion activation methods which reduce the loss of labile PTMs16,30–33 or 
enhance localization of modifications via greater sequence coverage.34 For example, 
collisional activation methods (CID, HCD) result in preferential cleavage of labile 
modifications such as phosphorylation and sulfation, thus impeding the ability to localize the 
sites of these modifications.30,35 Implementation of electron-based activation methods, such as 
electron captured dissociation (ECD)37 and electron transfer dissociation (ETD)38, and 193 nm 
ultraviolet photodissociation (UVPD) alleviates the loss of these labile modifications, enabling 
their identification and localization for high throughput applications.36–38 Another new option 
for MS/MS analysis is EThcD which is a hybrid method combining higher energy collisional 
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dissociation (HCD) and ETD, to more efficiently generate two series of diagnostic fragment 
ions (b/y, c/z type ions).39 Moreover, activated ion electron dissociation (AI-ETD) is a hybrid 
method which uses concurrent infrared laser irradiation during ETD to counteract the charge 
state dependency inherent to electron activation and overcome “ET-no-D” events which limit 
sequence coverage.40 UVPD is an alternative to electron- or collisional-based or hybrid 
methods. UVPD stands out among these methods in that it uses photons for ion excitation and 
affords retention of labile modifications.30,36,41 UVPD typically generates a larger array of ion 
types than other activation methods, including a, a+1, b, c, x, x+1, y, y-1, and z type ions.  
The development of alternative ion activation methods that allow retention and thus 
localization of PTMs has been particularly important for the characterization of some of the 
most heavily modified classes of protein, such as histones.19,42 Histones act as a structural 
scaffold for packaging of DNA as it wraps into chromatin. Importantly, the N-terminal and C-
terminal regions of histones extend beyond the coils of DNA and act as key coding substrates 
for modification in a way that modulates DNA-protein interactions. Acetylated N-terminal tails 
promote loose histone-DNA association that guide interactions with translation factors, 
whereas N-terminal methylation hinders DNA translation.43 The extent of modifications along 
the N-terminal histone tails (e.g. first 50 residues) can be quite complex with many possible 
co-existing modification patterns with different biological ramifications. This complex 




When mapping histone PTMs by tandem mass spectrometry (MS/MS), there are two 
notable hurdles that limit the success of traditional bottom-up MS/MS methods. Deciphering 
the contextual network of modifications among heterogeneous mixtures of histones is virtually 
insurmountable based on analysis of small proteolytic peptides. In addition, the prevalence of 
lysine and arginine residues of the N-terminal tails result in small tryptic peptides, often ones 
that are poorly separated by reversed phase chromatographic methods and for which 
combinatorial patterns are lost owing to the short lengths of the peptides.42  In an effort to 
directly characterize combinatorial PTMs, several groups have developed methods to 
characterize large peptides (middle-down) or intact proteins (top-down), enabling observation 
of all PTMs in a key region of a protein or in the entire protein sequence.42,44–46 Top-down 
workflows analyze even heavily modified proteins as intact species, thus offering an 
unsurpassed opportunity for mapping all PTMs. However, top-down analysis has greater 
technical challenges with respect to effective separation of intact proteins, ion activation 
methods that perform adequately for large ions, and bioinformatics needed to interpret very 
complicated spectra of proteins.44 The bioinformatics issue becomes particularly challenging 
when analyzing heavily modified proteins, such as histones, owing to the exponential increase 
in number of potential modification sites of intact proteins.47 Top-down analysis of histones 
has been extensively developed and successfully evaluated by several groups, including in a 
high throughput format for complex mixtures of histones.48,49 The most expansive top-down 
characterization of histones has been achieved by isolating and analyzing individual families 
of histones.49 Despite the advantages of direct analysis of intact proteins, the need for excellent 
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ion activation methods and the limited software for assignment and confident scoring of 
proteoforms with multiple PTMs have impeded widespread successful implementation of large 
scale LC-MS analyses of intact proteins. 
Middle-down strategies offer an intermediate compromise between top-down and 
bottom-up methodologies, typically achieved via enzymatic or chemical procedures which 
limit the extent of protein digestion, thus producing peptides that are typically much larger 
than those generated in conventional bottom-up workflows.19,45 MS/MS analysis of middle-
down sized peptides has the added advantage of having fewer fragmentation channels in which 
to distribute ion current compared to analysis of intact proteins, thus affording better S/N in 
the resulting spectra.40 Furthermore, database searches of middle-down sized peptides is 
accommodated by the multitude of robust informatics platforms currently available for 
analysis of bottom-up sized peptides.18,42,46 A majority of PTMs found on histones exist on the 
first 50-60 amino acids, and this N-terminal stretch may be covered by a single long peptide 
generated by using GluC or AspN to cleave the histones. The canonical analysis of histone 
PTMs by tandem mass spectrometry (MS/MS) adopts chemical derivatization of lysine 
residues to limit trypsin proteolytic cleavage, necessary owing to the large content of lysine 
and arginine residues on histone sequences. One of the most used approaches was developed 
by Hunt et al., who introduced the derivatization of lysine and N-terminal amines with 
propionic anhydride.50 Derivatization blocked the ɛ-amino groups of unmodified and 
monomethyl lysine residues, meaning that conventional trypsin proteolysis occurred only C-
terminal to arginine residues instead of at both arginine and lysine residues, ultimately resulting 
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in longer peptides. Moreover, N-terminal derivatization increased peptide hydrophobicity and 
thus retention on reversed phase media, affording better chromatographic separation.51 
Recently a selective protease, neprosin, has also been successfully utilized for middle-down 
analysis of histones.52 Neprosin cleaves C-terminal to proline providing 3-4 kDa size peptides, 
thus offering a promising option for histone characterization.52  
Despite the isolation of the most heavily modified region of the histone, the issue of 
separating hundreds of modified species has remained challenging. The Garcia lab pioneered 
the use of a mixed bed weak cation exchange hydrophilic interaction liquid chromatography 
(WCX-HILIC) resin to enable separation of N-terminal histone peptides based on number of 
modifications.17 Significant strides have been made to further develop this method for robust 
usage, including the introduction of software for filtering results obtained from canonical 
database searches and quantification.53 For example, false positive modification localization is 
a common problem encountered when analyzing MS/MS spectra of heavily modified peptides. 
The problem arises when one of two modifiable sites is modified, and upon MS/MS no 
backbone cleavage occurs between them to unambiguously assign the location of the 
modification. Often both possible sites will be reported despite one being a false positive.18 
Recently developed software (e.g., Histone Coder and isoScale) has addressed this issue by 
ensuring that each reported modified site was confirmed by the presence of fragment ions that 
unambiguously localize modifications, thus allowing curation of false positives and 
quantification of more than 700 combinatorial histone marks.18 
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Here, we report the use of UVPD for characterization of middle-down sized histone 
peptides. We used the canonical middle-down MS workflow, including GluC proteolysis 
followed by histone tail separation with WCX-HILIC coupled online to MS.17,42 We have 
previously shown that UVPD results in extensive fragmentation of proteins and peptides and 
does not cause loss of labile PTMs.36,44,54 In addition, the performance of UVPD is not strongly 
dependent on the size of the peptide nor charge state, thus making UVPD well-positioned for 
the analysis of histones.55 In this study, UVPD performance is benchmarked with attention to 
number of backbone cleavages, PTM site localization, and characterization of combinatorial 
PTMs. Having previously evaluated 193 nm UVPD for characterization of modifications on 
intact histone proteins,56 the advantages discussed above regarding the middle-down approach 
merited further investigation in order to evaluate the applicability of UVPD for 
characterization of PTMs.  
7.3 MATERIALS AND METHODS 
7.3.1 Materials 
GluC was purchased from Promega (Madison, WI.) All other reagents and solvents 
were purchased from Millipore Sigma (St. Louis MI) unless otherwise noted. 
7.3.2 HeLa cell preparation 
HeLa S3 cells were treated for 24 hrs with 10 mM sodium butyrate and harvested. 
Histones were extracted as previously described.82 Briefly, nuclei were isolated after 
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suspending the cell pellets in nuclei isolation buffer (250 mM sucrose, 0.2%NP-40, 1 mM 
CaCL2, 15 mM Tris-HCl pH 7.5, 15 mM NaCl, 60 mM KCL, and 5 mM MgCl2). Nuclei 
were then pelleted and resuspended in 0.4 N H2SO4 at a 5:1 ratio (v/v) and incubated for 2 
hrs at 4 oC with shaking. After acid extraction, histones were precipitated with 25% TCA 
(w/v). Purified histones (~300 µg) were separated by RP-HPLC as previously described.82 
Briefly, histones were fractionated on a Vydac C18 column (10 mm inner diameter, 250 
mm length, 5 um particle size). Histones were eluted over a 100 minute gradient from 30% 
to 60% solvent B at a flow rate of 1 mL/min. Solvent A consisted of 2% trifluoroacetic 
acid and 5% acetonitrile in water. Solvent B contained 0.19% triflouroacetic acid and 95% 
acetonitrile in water. The UV detector was adjusted to 214 nm, and fractions for H4, H2A, 
H2B, H3, H3.3, H3.2 and H3.1 were collected based on their characteristic retention times 
82. Fractions were dried using a SpeedVac concentrator and stored at -20 oC . Finally, the 
isolated histones H3 and H4 were submitted to GluC digestion (20:1, w/w – Histone to 
GluC) for 8 hrs in 50 mM ammonium acetate buffer (pH 4) prior to LC-MS analysis. 
7.3.3 Liquid chromatography mass spectrometry (LC-MS) 
The GluC peptides were resuspended in 2% ACN and separated using a Dionex 
RSLC 3000 nano-LC system (Thermo Fisher Scientific, San Jose, CA, USA). 
Approximately 1 μg of digest was loaded onto a 3 cm trapping column (100 μm i.d.) packed 
in-house with REPROSIL Gold (C18,3 µm particles, 300 Å pore size, Dr. Maisch, 
Germany). Peptides were then transferred onto a 20 cm fritted (75 µm i.d.) pulled tip 
analytical column (New Objective, Woburn, MA) packed in-house with (PolyCAT A, 3 
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µm 1500 Å pore size) a weak cation exchange hydrophilic interaction chromatography 
(WCX-HILIC) media (Poly LC, Columbia, MD). Peptides were eluted at a flow rate of 
300 nL/min using the following gradient: starting at 2% B for 20 minutes, going to 55% B 
at 23 minutes, then to 90% B at 160 min, and finally to 99% B at 170 min. Mobile phase 
A was 75% acetonitrile with 20 mM propionic acid (pH 6). Mobile phase B was 75% water 
with formic acid (pH 2.5). 
 
The nanoLC system was coupled to a Fusion Lumos Orbitrap mass spectrometer 
(Thermo Fisher Scientific, San Jose, CA) modified for 193 nm UVPD, as previously 
described.83 UVPD was performed in the high-pressure linear ion trap using two pulses 
(2.5 mJ) from a 193 nm Excistar XS excimer laser (Coherent, Santa Clara, CA). ETD was 
performed in the high cell of the linear ion trap with 30 ms reaction time for ETD (2 x 105 
reagent AGC,) based on optimized conditions reported by Sidoli et al.24 The mass 
spectrometer was run using the following parameters regardless of fragmentation type: 
MS1 at 60000 resolving power, 2 µscans averaged per spectrum, 1 × 106 AGC target and 
MS2 at 30000 resolving power running a top 8 data dependent method. 10 μscans were 
averaged per MS2 spectrum (1 × 106 AGC target). Only precursor ions in the 8+ charge-
state were selected for activation. An example chromatogram and precursor MS scan is 




Figure 7.1  Example chromatogram and precursor ion scan (inset) depicting typical nano 
WCX-HILIC separation of Histone tails. The inset shows the 8+ charge state 
of several H4 modification sates. The shorter,less modified, peptides tend to 
elute in the first 60 minutes. The full length modified H4 n-terminal tails 
eluted from 60-180 minutes. 
7.3.4 Data Analysis 
LC-MS data was searched using MASCOT (v 12) database searching software. 
Peptide specificity was set to c-terminal to E. For ETD c and z ions were selected and for 
UVPD a, b, c, x, y, and z ions were selected. The MASCOT output was further processes 
using the isoScale slim software package to remove any ambiquously localized 
modifications. 
Prior to analysis in ProSight Lite (Build 1.4.6) 5 scans were averaged to improve 
the S/N of fragment ions. The resulting spectra was deconvoluted using the Xtract 
algorithm available in the Xcalibur Qualbrowser (Thermo Fisher Scientific, San Jose CA) 
230 
 
software.  Monoisotopic output was selected and the S/N level was set to 3, all other 
parameters were left to default. The resulting deconvoluted peak list was input into the 
ProSight Lite software. The canonical H3 or H4 sequences (N-terminal GluC peptide) was 
imported into ProSight Lite. Monoisotopic input and UVPD or ETD were selected as the 
fragment type and a 10-ppm tolerance was applied.  Choice of PTM location was guided 
by intact mass, previously reported sites, and primarily the following metrics: P-score, 
number of matched fragments, and sequence coverage. 
7.4 RESULTS AND DISCUSSION 
The performance of each of the MS/MS methods was evaluated based on peptide level 
metrics including the number of unique peptide forms (including modifications) identified, 
sequence coverage, and number and position of diagnostic fragment ions; especially 
modification-localizing ions.  
7.4.1 UVPD Optimization 
The energy of a single 193 nm photon (6.4 eV) is sufficient to dissociate most 
peptides; however, other considerations such as photon flux and number of pulses affects 
the total energy deposition and potential for secondary dissociation.59 The photoabsorption 
cross-section scales with the size of the peptide or protein as the amides serve as the 
chromophores for 193 nm photoabsorption. A related consideration is the possibility of 
excessive energy deposition from absorption of multiple photons which can cause 
secondary fragmentation of ions in a manner that leads to production of un-assignable 
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internal ions or overly small, uninformative sequence ions. Thus, UVPD parameters were 
optimized for an ideal 5.6 kDa middle-down sized histone peptide originated from 
acH4K20me2 (52 residues of the N-terminal tail, net 5661.35 Da, 8+ charge state) 
possessing two modifications. This particular proteoform (acH4K20me2) is one of the 
most commonly detected and represents an ideal benchmark histone.44,48 Figure 7.2 shows 
the dependence of sequence coverage on the N-terminal peptide on laser pulse number and 
power. Sequence coverage and P-score values were generated using Xtract to deconvolute 
the raw data and ProSight Lite to match the deconvoluted fragment ions to the theoretical 
modified sequence of histone H4 (residues 2-53). Using a single laser pulse, the sequence 
coverage increased with increasing laser power; however, with multiple pulses the increase 
in sequence coverage peaked or plateaued at 2.5 mJ. Optimal sequence coverage (69%) 
was obtained using two pulses at 2.5 mJ. Other combinations of laser conditions yielded 
similar performance, such as 3 pulses at 2 mJ (67%). The P-scores were used to 
discriminate between the best performing UVPD conditions (Figure 7.3). The P-score, 
based on the probability of observed spectra matching theoretical spectra by random 
chance, is a useful metric as it is often utilized by database searching algorithms such as 
MASCOT (used in this study) during LC-MS data analysis. Applying 2 pulses at 2.5 mJ 
gave the lowest P-score (2.6E-66), indicating the highest confidence in the fragment-to-
theoretical spectral match. Secondary dissociation and generation of internal fragments 
occurs if the photon flux is too high or the ions are exposed to multiple pulses. These 
additional non-diagnostic ions can negatively influence spectral matching confidence, 
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which may be the case for the 3-pulse data, a factor that would explain the high sequence 
coverage (Figure 7.2) but non-optimal P-score (Figure 7.3).  
 
 
Figure 7.2  UVPD laser optimization: sequence coverage dependence on pulse number 






Figure 7.3  Effect of UVPD laser pulse number and power on P-scores of the UVPD mass 
spectra matched to (8+) acH4K20me2  
 
7.4.2 Benchmarking UVPD against ETD 
WCX-HILIC separations followed by high resolution ETD-MS has become the gold 
standard method for middle-down histone analysis, as originally implemented by Young et 
al.17 Given the large sizes of the N-terminal peptides and their basic nature, under the acidified 
conditions utilized in the WCX-HILIC separation they are often multiply protonated and found 
in charge states ranging from 5+ to 12+. ETD proved to be an efficient means to characterize 
these multiply charged basic peptides while retaining their abundant modifications.17 While 
UVPD is similar to ETD with respect to retention of PTMs and the ability to generate excellent 
sequence coverage, UVPD generates several additional ion types (UVPD: a,a+1,b,c,x,x+1,y,y-
1,z compared to c/z for ETD).60 These additional ion types have the potential to add confidence 
in localization of modification sites and improve sequence coverage, at the expense of 
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potentially reducing the S/N levels of the resulting MS/MS spectra owing to greater dispersion 
of the ion current.  
In order to evaluate the viability of UVPD for LC-MS analysis of the many modified 
forms of histone H3, a mixture of H3 tails were subjected to WCX-HILIC separation and 
analyzed by ETD and UVPD. To maximize the sensitivity of the analysis, a narrow mass 
window bracketing the +8 charge state of the H3 tail and its modified forms was used, followed 
by data dependent selection of precursors for MS2 analysis.17 The global performance of ETD 
and UVPD was evaluated based on the number of unique species identified, and detailed 
evaluation of the fragment ion spectra generated by both methods is discussed later. The 
number of unique species detected, after filtering out ambiguous matches and non-quantifiable 
species, was similar for histone H3 (175 proteoforms for ETD and 180 proteoforms for UVPD 
thus showing that UVPD is comparable to ETD with respect to number of identifications and 
is a competitive strategy for identification of heavily modified middle-down sized peptides.  
The histone peptides identified by ETD and UVPD were heavily modified. In order to 
characterize the multitude of modifications, each modifiable site was considered, and the 
relative contribution of acetylation (ac:yellow), methylation (me1:green), dimethylation 
(me2:blue), and trimethylation (me3:red) are displayed in Figure 7.4. Overall, the relative 
distributions of modifications characterized by UVPD and ETD were similar; however, UVPD 
of the untreated set resulted in identification of a greater proportion of methylation sites on 
residues closer to the C-terminus. Several abundant proteoforms identified by UVPD contained 
K27me1 and K36me1 and contributed to this finding.  Speculation why UVPD better for 
methylation close to C-term? I cant think of any mechanistic reason, my thought is that both 
of these sites are right next to another K or R and required a fragment at the K/R or K/K site 
in order to pass the isoScale filter. I presume that UVPD generated these specific (important) 







Figure 7.4 Distribution of specific modifications detected by ETD (A and C) and UVPD 
(B and D) based on analysis of the N-terminal peptides of histone H3 
(residues 1-50) for untreated (A and B) and butyrate-treated (NaBut) (C and 
D) cells. The distributions represent the summation of modifications found on 
all forms of H3. 
 
Among the proteoforms identified, K4, K9, K14, K18, K23 and K27 were found to be 
acetylated. After treatment with NaBut, acetylation of K14, K18 and K23 was detected at 
significantly increased levels by both UVPD and ETD, whereas acetylation of K9 and K27 
increased slightly. NaBut has been shown to block histone deacetylase enzymes (HDACs) 
resulting in hyperacetylation,17 so our results are consistent with this finding. Both UVPD and 
ETD yielded PTM distributions which were nearly identical and reflected a large increase in 
acetylation after NaBut treatment, confirming that UVPD should be applicable for relative 
quantitation of PTMs and is sufficiently sensitive to discriminate different modification 
distributions based on biological conditions (e.g. NaBut treatment vs. untreated).  
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Figure 7.5 shows the log fold change between NaBut-treated and control samples for 
the individual PTMs of histone H3 resulting from either the ETD or UVPD analysis. The 
abundance of the single PTMs was assessed by summing the relative abundance of all the 
quantified polypeptides carrying each individual PTM to obtain their total relative abundance. 
Change in acetylation is indicated by green data points in Figure 7.5 . Significant increases in 
acetylation were found by both UVPD and ETD, an outcome consistent with inhibition of 
HDACs by sodium butyrate. 
 
Figure 7.5 Fold change in modification relative abundance for Histone H3 identified by 
ETD (A) and UVPD (B). Green points indicate upregulated acetylation 
 
7.4.3 Comparison of modified forms 
The overlap of modified forms identified by both ETD and UVPD accounts for only 
15% of the total H3 histoforms, as summarized in the Venn diagrams shown in Figure 7.6. 
In fact, the forms identified uniquely by either ETD or UVPD account for over 80% of the 
total forms identified, strongly suggesting the complementarity of these two methods. In many 
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cases, a histoform identified uniquely by UVPD diverges from a similar one found by ETD 
based on a difference in a single modification. For instance, histone 
H3R8me1K14acR17me1K18acR26me1K36me2 (containing six modifications) identified by 
UVPD differs in only one position, K23, from 
H3R8me1K14acR17me1K18acK23acR26me1K36me2 (containing 7 modifications) 
identified by ETD. For this histone, 6 out of 7 modifications were identified in common by 
both methods and confirmed by manual interpretation. However, the one identified by UVPD 
displayed acetylation of Lys18, whereas the one characterized by ETD exhibited acetylation 
of Lys 18 and Lys23. Despite the large difference in the specific proteoforms identified by 
each method, the relative distributions of modifications were similar (Figure 7.4). Inspection 
of the abundances of the modified forms from Figure 7.6 indicates that the ~17% of modified 
histones found in common for UVPD and ETD account for approximately 30% of the total 
abundance of histoforms identified by UVPD and 40% of the total abundance found by ETD. 
Because we identify and quantify intact histone tails, it is possible to assess 
similarities and differences with the estimated co-frequencies of PTMs (i.e. instances 
where two PTMs occur on the same peptide). Figure 7.7 shows a web diagram illustrating 
the co-occurrence of modifications on untreated H4 as indicated by a weighted line 
connection. The abundance of these co-occurrences is denoted by the thickness of the line. 
Similar co-occurrences are observed by both ETD and UVPD, again confirming the 





Figure 7.6  Venn diagram showing the number of modified forms of n-terminal histone 









Figure 7.7 PTM co-existence web for histone H4 (1-50). The line connection indicates 
co-existence and the line thickness indicates frequency of co-existence. 
Thicker connection indicates those two modifications are more often found 
on the same peptides 
 
7.4.4 ETD and UVPD fragmentation 
One likely factor contributing to the differences in the distribution of PTMs, and both 
the number and overlap of identified species mentioned above is the significant number of ions 
generated by UVPD which are not utilized by MASCOT for scoring spectral matches. UVPD 
consistently generates many diverse ion types, including a, a+ 1, b , c , x , x +1, y , y –1, 
and z type ions.61 MASCOT has been designed to utilize a, b ,c, x, y, z, and z+1 ions for scoring. 
Figure 7.8 shows the distribution of ions generated by UVPD of one typical middle-down 
sized doubly-modified peptide, representing acH4K20me2, the same species used for the 
UVPD optimization. The fragment ions were matched at 10 ppm error using ProSight Lite. 
The results in Figure 7.8 imply that MASCOT utilizes only 53% of the total number of UVPD 
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fragment ions possible (corresponding to only 35% of the total abundances of identified 
fragment ions). Moreover, the presence of the diagnostic a+1, x+1, and y-1 ions are not utilized 
and may be counted as noise, actually depressing the MASCOT scoring metrics for UVPD 
peptide spectral matches.  
 
Figure 7.8 Ion type distribution (by number of matched ions) for UVPD spectra of 
acH4K20me2. Highlighted bars indicate ion types which are not used for 
scoring spectral matches. 
 
Better utilization of the ion types characteristic of UVPD of middle-down size peptides 
could increase the confidence of UVPD PSMs, increase the number of overall matched 
forms, and reconcile some of the differences seen between ETD and UVPD results. 
Although training MASCOT (or another platform) for UVPD spectra would result in a 
more ideal performance, the use of isoScale (a program currently only compatible with 
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MASCOT output) justifies the workflow used in this study. IsoScale further processes the 
MASCOT output, specifically focusing on culling false positive modification assignments 
by virtue of localizing fragment ions. After isoScale processing, the final results are 
unambiguous (i.e. each localized modification is supported by bracketing fragment ions.) 
This feature is crucial for analyzing datasets containing heavily modified peptides with a 
high level of confidence. 
7.4.5 Characterization of the most heavily modified species (> 5 PTMs)  
In light of the shortcomings of the current automated workflow, manual annotation 
can be used to achieve the greatest sequence coverage and PTM site localization from 
UVPD spectra. Both ETD and UVPD are effective for characterization of lightly and 
moderately modified species. UVPD is especially useful for heavily modified forms (i.e. 
ones containing more than five modifications). In order to highlight the proficiency of 
UVPD for characterization of highly modified histones, ProSight Lite was used to 
manually annotate UVPD spectra acquired for the most heavily modified species.62 Figure 
7.9 shows deconvoluted ETD and UVPD mass spectra of the hepta-modified peptide 
H3K4me1K9me2K14acK18acK23acK27acK36me3 (8+ charge state, a N-terminal tail 
containing 50 residues with mono-methylation of residues K4, dimethylation of residues 
K9, trimethylation of residues K36, and acetylation of residues K14,K18,K23 and K27). 
Both MS/MS methods adequately localized several of the modifications; however, UVPD 
was able to achieve higher confidence by virtue of production of multiple PTM-localizing 
fragment ions. For example, UVPD successfully characterized K14ac and K27ac, 
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generating the greatest number (three or more) of flanking fragment ions containing the 
modification, including both complementary C-terminal and N-terminal ions. K14ac was 
localized by a14 + 1, z37, y37 – 1, x37 + 1, and K27ac was localized by a27 + 1, y24 -1, and x24 
+ 1. By comparison, ETD best characterized K4me, K9me2 and K18, generating only one 
fragment ion containing the modification and one or more flanking ions facilitating 
localization 
 
Figure 7.9 Comparison of deconvoluted (A) ETD and (B) UVPD spectra of 
H3K4me1K9me2K14acK18acK23acK27acK36me3 (8+) showing fragment 
ion maps, P-score, sequence coverage and labeled solidification site 
localizing ions.   
 
7.4.6 Presence and use of neutral loss ions 
Modified peptides can undergo informative neutral losses after activation, often 
exploited for characterization of phosphorylated and glycosylated peptides.36,62 Traditional 
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bottom-up analysis of histone peptides has utilized neutral losses generated by HCD and ETD 
of methylated peptides, particularly 59.07 Da from trimethylated lysine and 45.06 Da from 
Arg residues of histones.63 The presence and diagnostic nature of neutral losses upon UVPD 
of methylated species has not been reported previously. These neutral losses can be very useful 
for determining the specific nature of modified lysines. For instance, the mass difference 
between a trimethylated lysine and an acetylated lysine is 0.036 Da which for a 5-6 kDa peptide 
represents a 6-7 ppm mass difference, well within the accepted mass tolerance of 10 ppm. The 
heavily modified H3 peptide shown in Figure 7.8 has several acetylated lysines and a 
trimethylated lysine residue. The presence of a 59.07 Da neutral loss upon UVPD can be used 
to discriminate between the K36ac and K36me3 forms. Figure 7.10 shows the occurrence of 
the 59.07 Da loss, thus confirming the presence of a trimethylation of K36. Conversely, when 
the trimethylated K36 residue is replaced with acetylated K36 in the search, several scoring 
metrics degrade, including P-score, number of matched fragments and the ppm mass error. 
Although other metrics can be used to discriminate between acetylation and trimethylation, the 
presence of the 59.07 Da mass loss provides further evidence supporting the assignment of 
trimethylation of K36 for this peptide.  
  Figure 7.11 shows the sequences and deconvoluted UVPD mass spectra of two nearly 
isobaric N-terminal peptides of H3K4acR8me2K23acK27me2 (5478.15 Da) and 
H3K9me3K14acKme2K36me2 (5478.19 Da), differing only by the acetyl-trimethyl mass 
difference. For each of these proteoforms, the 8+ charge state was subjected to UVPD. The 
trimethylated species displays the expected 59.07 Da neutral loss which is absent from the 
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UVPD mass spectrum of the acetylated species, confirming the assignment of trimethylation. 
The presence of this diagnostic neutral loss ion upon UVPD offer notable utility for correctly 
interpreting ambiguous spectra. 
 
 
Figure 7.10 Deconvoluted fragment ion spectra showing a -59.07 Da neutral loss ion 







Figure 7.11 Deconvoluted UVPD spectra showing the utility of the 59.07 Da neutral loss 
in confirming the presence of a trimethylation on two nearly isobaric species: 
H3K4acR8me2K23acK27me2(5478.15Da)and 
H3K9me3K14acKme2K36me2 (5478.19 Da) both 8+. 
 
7.5 CONCLUSION 
Results from LC-MS analyses of GluC-generated middle-down sized N-terminal tails 
of histone H3 and H4 demonstrate that UVPD is broadly applicable for characterization of 
heavily modified histones. The two methods identified largely unique (only 15% overlap) 
combinatorial species. However, UVPD and ETD led to highly comparable results when 
assessing the abundance of single and co-existing modifications, implying that the high 
orthogonality in terms of which combinatorial codes are identified in every MS run does not 
affect significantly the ultimate conclusions.  
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UVPD was useful for deciphering changes in modifications related to specific cellular 
treatments, as shown by the 2-fold to 4-fold up-regulation of acetylation in the NaBut-treated 
Hela cells. Evaluation of the differences between ETD and UVPD revealed that the automated 
data processing workflow, which relies on MASCOT, utilizes only approximately 50% of the 
ions generated by UVPD. Approximately 35% of the total matched fragment ion population 
from UVPD originates from the a+1 ion series which is not considered by MASCOT. Moving 
forward, a fully trained search algorithm would extend the capabilities of UVPD for high 
throughput analysis of modified middle-down sized peptides. In order to evaluate the ability 
of UVPD to characterize the most heavily modified peptides, manual spectral interpretation 
facilitated by ProSight Lite was a key to success. The N-terminal peptide of hepta-modified 
histone H3K4me1K9me2K14acK18acK23acK27acK36me3 was well-characterized and 
yielded 90% sequence coverage, motivating future investigation of UVPD for interrogating 
other heavily modified middle-down sized peptides. UVPD also resulted in characteristic 
neutral loss pathways. For example, loss of 59.07 Da upon UVPD differentiated trimethylation 
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Top-Down Characterization of Heavily Modified Histones using 193 nm 
Ultraviolet Photodissociation (UVPD) Mass Spectrometry 
 
8.1 OVERVIEW 
The characterization of protein post-translational modifications (PTMs) remains a 
significant challenge for traditional bottom-up proteomics methods owing to the lability of 
PTMs and the difficulty of mapping combinatorial patterns of PTMs based on analysis of 
small peptides. These shortcomings have accelerated interest in top-down MS/MS methods 
which focus on analysis of intact proteins. Mapping all protein PTMs simultaneously 
requires the ability to obtain extensive sequence coverage to allow confident localization 
of the modifications.  193 nm Ultraviolet photodissociation (UVPD) has been shown to 
generate unparalleled sequence coverage for intact proteins compared to traditional 
MS/MS methods. This study focuses on identification and localization of PTMs of histones 
by UVPD, higher-energy collisional dissociation (HCD) and the hybrid method electron-
transfer/higher-energy collision dissociation (EThcD) via a high throughput LC-MS 
strategy.  In total over 500 proteoforms were characterized among these three activation 
methods with 46% of the identifications found in common by two or more activation 
methods. EThcD and UVPD afforded more extensive characterize of proteoforms than 
254 
 
HCD with average gains in sequence coverage of 15% and C-scores that doubled on 
average. 
8.2 INTRODUCTION 
Mass spectrometry-based strategies for proteomics have advanced to the point that 
hundreds to thousands of proteins can be identified in a single run.1,2 Improvements in 
sample preparation methods and development of state-of-the-art LC-MS/MS technologies 
enable deep profiling of post-translational modifications (PTMs), including 
phosphorylation, glycosylation, acetylation, methylation among others.3–8 Despite these 
significant advances, routine identification and characterization of co-existing 
modifications remains an outstanding challenge.9,10  Characterization of multiply modified 
proteins is critical to facilitate the study of PTM crosstalk, the phenomena where multiple 
modifications act in concert to modulate a biological outcome. 11,12  Given that the typical 
size range of peptides generated from conventional bottom-up proteolytic methods is  1-2 
kDa, multiple peptides must be tracked and re-assembled to indirectly piece together the 
PTM landscapes of the parent proteins.13,14  
In order to directly observe and map combinatorial PTMs, a number of groups have 
developed mass spectrometry approaches to characterize larger peptides (middle-down) or 
intact proteins (top-down), thus facilitating simultaneous characterization of all PTMs in a 
key region of a protein or in the entire protein sequence.15–18 Middle-down strategies use 
enzymatic or chemical procedures which limit the extent of protein digestion, thus 
producing peptides that are typically much larger than those generated in conventional 
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bottom-up workflows.19 Top-down and middle-down mass spectrometry methods require 
the use of mass spectrometers that offer both high resolving power and high mass accuracy 
to allow the confident identification of fragment ions, typically that are large and multi-
charged.18,20,21 As the size of the peptides or proteins increases, assignment of the fragment 
ions becomes more challenging, especially as the signal-to-noise (S/N) of the spectra 
diminishes as the ion current is dispersed among more fragmentation channels. Another 
challenge is the significant demand of data processing and analysis, though recently new 
software packages have become widely available to handle this burden.22–24   For cases in 
which the targeted proteins of greatest interest are relatively small or when the use of 
proteases might obscure the presence of endogenously truncated proteins that are indicative 
of certain biological scenarios or activities, then the top-down method offers substantial 
advantages 18,21,24. Analysis of intact proteins offers the potential for characterization of the 
complete PTM landscape not confounded by possible truncations. The ability to create 
confident maps of the sites of PTMs arises from extensive sequence coverage and 
minimization of the loss of labile modifications, two critical factors of any ion activation 
method utilized for MS/MS characterization of proteins. Neutral losses can be 
advantageous for determining the presence or absence of certain PTMs and differentiating  
similar mass PTM’s such as acetylation and trimethylation on peptides.25 However, neutral 
losses from intact proteins is less feasible for identifying and localizing PTMs owing to the 
possibility of multiple modifications and multiple locations, thus obscuring the ability to 
pinpoint specific sites. 
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Histones are particularly well-suited for analysis as intact proteins as they are 
generally less than 25 kDa, an ideal size for top-down methods. Histones have been 
implicated in the regulation of transcription, cell cycle progression, and DNA damage 
repair through dynamic variations in their PTM repertoire, making characterization of the 
various combinations of great interest.26–30  This dynamic modification landscape has been 
termed the “histone code” and is often very complex, involving multiple PTMs across 
multiple histone subunits. These codes enable unique recognition sites for complexes of 
chromatin readers, benchmarking DNA readout and other functions. In particular, histones 
are heavily modified on the first 50 amino acid residues of the N-terminus, and these 
information-rich tails are key features that are known to mediate the structure and functions 
of nucleosomes. The N-terminal stretches have unusually high frequencies of lysine and 
arginine residues, making them prone to excessive degradation by trypsin in conventional 
bottom-up mass spectrometric approaches. Although traditional antibody-based ELISA 
analyses are purportedly specific, targeting just one or a limited number of PTMs, often 
they result in false negatives and false positives and can be biased towards heavily modified 
proteoforms.20,20,30,31  These factors have motivated the development of other mass 
spectrometry-based methods for histones, including middle-down and top-down 
approaches.9,15,20,26,32–38 
Mass spectrometry of intact proteins has been pursued more widely in recent year 
owing to the increasing accessibility of high resolving power mass spectrometers.21 
Activation of multi-charged proteins can generate hundreds of fragment ions (i.e a,b,c,x,y, 
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and z type ions) in multiple charge states, thus reinforcing the need for high performance 
capabilities of the mass spectrometer.21,35 In the context of top-down MS/MS analysis 
histones, both collisional and electron-based activation methods have been evaluated.33,34 
Traditional collisional activation methods have not proven to be ideal because the large 
number of positives charges on multi-protonated histones results in sparse fragmentation, 
and labile PTMs are commonly lost during collisional activation.38 Electron-based 
dissociation methods such as electron transfer dissociation (ETD)  and electron capture 
dissociation (ECD) are more well suited for histones owing to the ability to retain 
modifications and fragment even very basic proteins.36,39 Electron-based activation 
methods are dependent on the charge state of the protein, a factor that is not readily 
controlled for histones.40,41 The ideal activation technique would cleave at every inter-
residue position, allow localization of PTMs, and yield high performance metrics 
regardless of charge state.  Three new methods have been introduced to meet these 
demands: electron transfer higher-energy collisional dissociation (EThcD),42,43 activated 
ion electron transfer dissociation (AI-ETD),44,45 and 193 nm ultraviolet photodissociation 
(UVPD).46,47 EThcD is a hybrid method that combines two activation techniques, HCD 
and ETD, to generate a greater array of fragment ion types (b,y and c,z type ions).43 AI-
ETD uses infrared laser irradiation during ETD as a form of supplemental activation to 
overcome charge state dependency and “ET-no-D” events which limit the extent of 
fragmentation and curtail sequence coverage.45 UVPD utilizes absorption of energetic 
photons, typically 193 nm, to energize and dissociate proteins.46–49  UVPD results in 
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production of an array of ion types, including a,b,c,x,y, and z types, and does not cause 
dislodgement of labile PTMs.46–48  The performance of UVPD for high throughput analysis 
of intact proteins has been reported in two recent studies.47,50 The present study focuses on 
the use of three activation techniques, EThcD, UVPD, and traditional HCD, to characterize 
a series of histones and evaluate the performance metrics of these activation methods. 
8.3 EXPERIMENTAL 
8.3.1 Materials and Methods 
Lyophilized calf thymus histone extract was purchased from Sigma Aldrich (St. 
Louis, MO). LC-MS solvents were purchased from EMD-Millipore (Bilerica, MA). 
8.3.2 LC-MS 
The histone extract proteins were resuspended in 2% ACN and separated using a 
Dionex RSLC 3000 nano-LC system (Thermo Fisher, San Jose, CA, USA). Approximately 
1 μg of extract was injected onto a 3 cm PLRP-S (5 μm particles, 1000 Å pore size, Agilent, 
Santa Clara CA) reverse phase trapping column (100 μm i.d.) packed with 5 μm particles 
(1000 Å pore size). Proteins were then transferred onto a 30 cm fritted (75 μm i.d.) pulled 
tip analytical column (New Objective, Woburn, MA) packed in-house with PLRP-S. 
Proteins were eluted at a flow rate of 300 nL/min using the following gradient: starting at 
2% B, going to 10% B at 8 min, then to 23% B at 10 min, and finally to 40% B at 130 min. 
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Mobile phase A was water with 0.1% formic acid and mobile phase B was acetonitrile with 
0.1% formic acid. Examples of chromatographic traces are shown in Figure 8.1.  
 
 
Figure 8.1  Examples of nano LC traces for HCD, EThcD and UVPD experiments 
illustrating the level of reproducibility. 
 
The nanoLC system was coupled to a Fusion Lumos Orbitrap mass spectrometer 
(Thermo Scientific Instruments) modified for 193 nm UVPD, as previously described.51 
UVPD was performed in the high-pressure trap using a single pulse (1.7 mJ) from a 193 
nm excimer laser (Coherent Excistar XS). HCD was performed in the ion routing multipole 
at 20% NCE. EThcD was performed in the ion trap (ECD) and ion routing multiple (HCD) 
with a 6 ms reaction time for ETD and 12% NCE for HCD, based on optimized conditions 
reported by Brunner et al.42 The Orbitrap mass spectrometer was run using the following 
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parameters regardless of fragmentation type: MS1 at 120000 resolving power, 3 μscans 
averaged per spectrum, 1 × 106 AGC target, 20 V source fragmentation, intact protein 
monoisotopic precursor selection; and MS2 at 120000 resolving power with top speed 
mode enabled for 7 s, 6 μscans averaged per spectrum, and 1 × 106 AGC target. Precursor 
ions in charge-states 8+ to 24+ were selected for activation; additional precursors with 
undetermined charge state were also selected for activation. Top-speed mode allows the 
user to select the length of time between sequential MS1 scans. During this period the 
instrument isolates and activates as many precursors as possible for acquisition of MS/MS 
spectra. Therefore, the number of MS2 spectra per MS1 spectrum is variable unlike a 
traditional Top X method where X isolation/activation events (MS/MS spectra) are 
performed per MS1 spectrum. 
8.3.3 Data Analysis 
Raw data were uploaded to the National Resource for Translational and 
Developmental Proteomics (NRTDP, Northwestern University, Evanston, IL TDPortal13 
high-performance computing environment for analysis of high-throughput top-down 
proteomics data (available for academic collaborators at: 
http://nrtdp.northwestern.edu/tdportal-request/). Details of the search strategy have been 
previously reported by Cleland et al.50 Briefly, MS1 spectra were first averaged using the 
cRAWler algorithm, followed by deconvolution to monoisotopic masses by using Xtract 
(Thermo Fisher Scientific). Processed data were then searched against the Bos Taurus 
database. All searches entailed a three-pronged strategy, each mode of which was first 
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defined for ProSight PTM 2.0.42. For convenience each unique PTM-protein combination 
discussed in this study is referred to as a proteoform.52 
8.4 RESULTS AND DISCUSSION 
Despite the growing body of work showing the utility of 193 nm UVPD for the 
identification and characterization of intact proteins, there has been relatively little focus 
on characterization of PTMs.47,50,53   In order to establish the feasibility of PTM 
identification and localization using UVPD and benchmark UVPD against other methods, 
a mixtures of histones was analyzed by high resolution LC-MS/MS using three different 
activation methods: UVPD, HCD, and EThcD. The performance of each of the MS/MS 
methods was evaluated based on proteoform level metrics including the number of 
proteoforms identified, sequence coverage, and C-score, the latter representing 
characterization of the protein backbone and modifications as defined by the number of 
matched fragment ions that localize PTMs. Examples of the MS/MS spectra obtained by 
HCD, EThcD, and UVPD for one representative histone, H3K9me2K27me, and the 




Figure 8.2 Examples of MS2 spectra for histone H3K9me2K27me (23+), sequence maps 
and score metrics for: A) HCD, B) EThcD and C) UVPD.   
 
This proteoform was selected owing to its multiple modifications and its 
identification in the UVPD, EThcD and HCD datasets. A significant feature of the 
sequence maps, which are discussed in more detail later, is the striking difference in the 
types of fragment ions generated by UVPD (great diversity among a/x, b/y, and c/z) relative 
to HCD (all b/y) and EThcD (mostly c/z). While this study focuses exclusively on 
fragmentation metrics, the challenge posed by co-eluting isobaric proteoforms remains 
unsolved. In this report when multiple species are co-isolated and co-fragmented, the best 
PSM is reported. In the event of two equal scoring PSMs, both are reported. 
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8.4.1 UVPD optimization 
Absorption of even a single UV photon (193 nm in the present study) can activate 
ions into excited electronic states, resulting in access to many fragmentation channels. Both 
the laser flux (e.g., the power) and the number of consecutive pulses can be adjusted 
depending on the desired analytical outcome.  For intact proteins generally a single lower 
energy laser pulse has been found to promote extensive backbone fragmentation and to 
yield the most informative spectra.46,50,54  At the same time, using only a single pulse or a 
lower power pulse mitigates the prevalence of secondary fragmentation, a process which 
depletes the population of the larger fragments that are often most diagnostic and increases 
the production of smaller fragment ions and internal ions. Internal ions, which contain 
neither the C-terminus nor the N-terminus, are not assigned in conventional database 
searches owing to the exponentially larger search space. Because histones often have 
multiple modifications near the N-terminus, the impact of both the number of laser pulses 
and laser power on the total sequence coverage and localization of modifications near the 
N-terminus was evaluated in detail. 
Figure 8.3A shows the number of proteoforms identified by UVPD using three 
laser powers ranging from 1.0 to 2.0 mJ and a single laser pulse. The optimal laser power 
was determined to be 1.7 mJ as it resulted in identification of 288 + 33 (n=3) proteoforms, 
48 more than obtained using 1.5 mJ. Figure 8.3B also displays examples of sequence maps 
and scoring metrics for one representative proteoform: N-terminal acetylated H2A 
obtained using a single UV laser pulse of 1.5 mJ, 1.7 mJ or 2.0 mJ. The P-score, C-score, 
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and sequence coverage were most favorable for the spectrum acquired using a single 1.7 
mJ pulse, thus reflecting the importance of adjusting the laser power for optimal UVPD 
performance. The size range of the histones based on canonical sequence alone is relatively 
narrow (11.4 kDa to 20.8 kDa [based on the Uniprot entries for bovine histones]) which 
means that acquiring MS/MS spectra using a wide range of UVPD parameters is unlikely 
to return large gains in the number of identifications and level of coverage. Figure 8.4A 
illustrates the impact of using one or two pulses (1.7 mJ per pulse) on the number of 
proteoforms identified and average C-score obtained for the mixture of histones. For this 
comparison, using a single pulse resulted in identification of 306 proteoforms, 
approximately 50% more than obtained using two pulses. A similar level of enhancement 
was observed for the average C-scores obtained using a single pulse relative to two pulses. 
An example of the higher sequence coverage, P-score, and C-score obtained using a single 
pulse is shown for one mono-acetylated proteoform of H2A in Figure 8.4B, with a notable 
gain in sequence coverage near the N-terminal stretch that improved localization of the N-





Figure 8.3   A) Number of proteoforms identified using one laser pulse at different 
energies. B) Examples of sequence coverage and proteoform metrics at 





Figure 8.4  A) Results obtained for different numbers of laser pulses showing the number 
of identified proteoforms and average C-scores using one or two laser pulses 
at 1.7 mJ. B) Examples of sequence coverage and proteoform metrics obtained 
using one or two laser pulses (1.7 mJ). 
 
8.4.2 Comparison of fragmentation of modified histone H3 by HCD, EThcD and 
UVPD 
After optimization of the laser power and pulse number, UVPD was benchmarked 
against two other methods: the gold-standard collisional activation method HCD and 
another newly emerging hybrid activation technique EThcD. As mentioned earlier, Figure 
8.2 shows comparative MS2 spectra of histone H3K9me2K27me (23+) collected using the 
three activation methods. HCD yielded the lowest sequence coverage (23%) and generated 
few fragment ions around the two methylated lysines of the N-terminal region, leaving 
them ambiguously localized (Figure 8.2A). EThCD significantly extended the sequence 
coverage to 51%, however characterization of the two methylated lysines was only 
moderately improved relative to HCD. EThcD generated extensive fragmentation N-
terminal to dimethylated K9 and C-terminal to methylated K27, but there was little 
fragmentation in the sequence stretch between these modified residues which impeded their 
localization (Figure 8.2B). UVPD of this H3 proteoform (Figure 8.2C) resulted in a net 
sequence coverage of 53%, similar to EThcD, yet with backbone cleavages occurring 




8.4.3 Global comparison of activation methods 
A mixture of histones was separated and analyzed by LC-MS/MS (Figure 8.5) with 
each activation mode, HCD, EThcD or UVPD, run in triplicate to allow a more systematic 
comparison of the number of identified proteoforms, sequence coverage of proteoforms, 
and characterization of modified proteoforms for each activation method. Figure 8.6a 
shows the numbers and overlap of unique proteoforms identified by each method, and the 
numbers and overlap of unique proteoforms containing one or more modifications are 
compared in Figure 8.6b. HCD identified 321 proteoforms, slightly more than UVPD, an 
outcome attributed to its higher acquisition speed and efficiency at generating short 
“sequence-tag” stretches of proteoforms (see Figure 8.7). EThcD identified 278 unique 
proteoforms, whereas UVPD resulted in 313 identifications. Of the 530 total proteoforms 
identified, only 137 were found in common by all three methods, meaning that many 
unique proteoforms were identified by each method and recapitulating the complementary 
nature of the three MS/MS techniques. Considering only proteoforms containing 
modifications, Figure 8.6b shows that each MS/MS method yielded similar performance 
based solely on the number identified (ranging from 232 for EThcD to 262 for UVPD). For 
the 102 proteoforms identified uniquely by HCD, the average sequence coverage is 12%, 
average P-score is 3E-7, and average C-score is 10. For the 79 proteoforms uniquely 
identified by UVPD, the average sequence coverage is 23%, average P-score is 8E-10, and 
average C-score is 19. For the 65 proteoforms identified uniquely by EThcD, the average 




Figure 8.5 Typical liquid chromatogram of a mixture of intact calf histones separated on 




Figure 8.6  Venn diagrams showing a) overlap of all proteoforms identified by UVPD (1 
pulse 1.7 mJ), EThcD (6 ms reaction time for ETD and 12 NCE supplemental 
activation) and HCD (20 NCE), and b) overlap of modified proteoforms 























Figure 8.7 Fragmentation maps, sequence coverage and scoring metrics of histone 
acH4K16acK20me2 (10+) obtained by HCD (20 NCE), EThcD (6 ms ETD 
reaction time and 12 NCE supplemental activation), and UVPD (1.7 mJ, 1 
pulse). 
 
Despite the similar total number of identifications returned by each MS/MS 
method, the sequence maps and scoring metrics for one proteoform (acH4K16acK20me2, 
selected owing to its multiple modifications and positive identification by all three MS/MS 
methods) shown in Figure 8.7 sheds light on the impact of the activation method in the 
context of PTM localization. The HCD sequence map displayed several short but well-
sequenced stretches of the protein backbone which allowed unambiguous protein 
identification and resulted in a P-score of 2E-80 and sequence coverage of 37%. The 
















stretches of the adequately sequenced backbone occurred mainly along the C-terminal half 
of the protein, leaving the modifications of the N-terminus, K11 and K16 ambiguously 
localized (e.g., no fragment ions flanking the modified residues). This patchy coverage 
resulted in a low C-score of 15. EThcD showed improvement for several metrics, 
delivering 67% sequence coverage, and a significantly better P-score of 7E-117 and C-
score of 372. Importantly, the localization of the modified residues was more confident 
upon EThcD owing to the fragment ions flanking acetylated K16, flanking ions within one 
residue of dimethylated K20, and the z101 and c3 ions which effectively bracketed the 
acetylated N-terminus. UVPD exhibited a marked improvement for all metrics: 90% 
sequence coverage, with an impressive P-score of 4E-130 and C-score of 566.  Although 
EThcD afforded good localization of modifications, UVPD generated key fragment ions 
that flanked all modified residues. In fact, owing to the unique ability to generate a/x, b/y, 
and c/z ions (Figure 8.7), UVPD produced five types of flanking ions that bracketed 
dimethylated K20 and afforded unparalleled confidence.  As shown in Figure 8.8 for 
histone acH2A (19+), one of the hallmarks of UVPD is the production of a greater array of 
fragment ion types compared to the more limited set for HCD (b/y) or EThcD (b/y, c/z).  
This greater array of fragment ions explains the higher sequence coverage and better 
characterization of PTMs (C-scores) often observed for UVPD, at the expense of S/N that 
may reduce the total number of PSMs. In this same vein, Figure 8.9 shows the distributions 
of protein spectral matches (PSMs) relative to the number of identified fragment ions for 
the histone datasets generated for HCD, EThcD and UVPD. The majority of PSMs 
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obtained by HCD contained 70 or fewer fragment ions, whereas EThcD and UVPD 
generated PSMs based on more than 100 fragments per PSM which provided greater 
sequence coverage and enhanced localization of modifications. 
 
Figure 8.8  Typical distribution of fragment ion types generated by UVPD, EThcD and 





Figure 8.9  Histogram showing the percentage of all PSMs identified by HCD, EThcD or 
UVPD as a function of the number of matched diagnostic ions for all 






Figure 8.10  Differences in sequence coverage of 134 modified proteoforms identified in 
common by HCD and UVPD from Figure 8.6b.  Blue points indicate 
proteoforms for which UVPD generated greater sequence coverage than 
HCD (by more than 2%), green points indicate proteoforms for which HCD 
yielded greater sequence than UVPD (by more than 2%), and red points 
indicate proteoforms for which the sequence coverage differed by less than 
2%. Proteoforms were ordered based on the difference in coverage. The 
activation conditions used were: HCD (20 NCE) and UVPD (1.7 mJ, 1 
pulse). 
 
8.4.4 Sequence Coverage of Modified Proteoforms 
Figure 8.10 compares sequence coverages generated by UVPD and HCD for the 
134 modified proteoforms found in common by the two MS/MS methods. (Figure 8.11 
compares coverages for all 177 identified proteoforms). Each point represents the 
difference in sequence coverage between UVPD and HCD for a proteoform found in 
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common by each method (when a proteoform was identified multiple times, the highest 
sequence coverage was used). The proteoforms are ranked based on the difference in 
sequence coverage for HCD and UVPD and categorized for clarity.  UVPD outperformed 
HCD for nearly 80% of the proteoforms found in common, in some cases afforded a gain 
of nearly 70% in coverage.  A similar outcome was obtained when all 177 proteoforms 
(modified and unmodified) were compared (Figure 8.11).  
C-scores of the same 134 proteoforms are displayed as a scatter plot in Figure 8.12 
in which the C-scores obtained by UVPD are plotted against the C-scores from HCD. A 
guiding line demarcates where the C-scores are equal for UVPD and HCD for the same 
proteoform. The majority of the points from the global histone dataset lie above the y = x 
guide-line, reflecting the enhanced ability of UVPD to characterize proteoforms relative to 
HCD, a result that echoes the single proteoform result shown in Figure 8.7. 
A comparison of sequence coverages obtained by UVPD and EThcD for 153 
modified proteoforms found in common is illustrated in Figure 8.13. The number of 
proteoforms is nearly equal above and below the 0% axis, indicating that both activation 
methods generate on average nearly identical sequence coverages for modified histone 
proteoforms. However, UVPD yields consistently higher sequence coverages by a wider 
margin for all of the cases in which UVPD outperforms EThcD. The average sequence 
coverage for all 153 proteoforms in Figure 8.13 was 28±17% for UVPD versus 32±18% 





Figure 8.11  Difference in sequence coverage for the 177 proteoforms identified in 
common by HCD and UVPD from the Venn diagram in Figure 8.6. Each 
point represents the difference in sequence coverage between UVPD and 
HCD. Results are ordered based on the caliber of results for UVPD relative 
to HCD.  All data points above the x-axis indicate better performance for 






Figure 8.12 Scatter plot showing C-scores for 134 modified proteoforms identified in 
common by HCD and UVPD.  A y = x line is plotted for reference. An 









Figure 8.13. Differences in sequence coverage of 153 modified proteoforms identified in 
common by EThcD and UVPD from Figure 8.6b.  Blue points indicate 
proteoforms for which UVPD generated greater sequence coverage than 
EThcD (by more than 2%), green points indicate proteoforms for which 
EThcD yielded greater sequence than UVPD (by more than 2%), and red 
points indicate proteoforms for which the sequence coverage differed by less 
than 2%. Proteoforms were ordered based on the difference in coverage. The 
activation conditions used were: EThcD (6 ms ETD reaction time and 12 NCE 
supplemental activation) and UVPD (1.7 mJ, 1 pulse). 
 
To better understand the features of the proteoforms that differentiate the 
performance of EThcD and UVPD, a number of characteristics were considered, such as 
the size of the protein. The proteoforms were grouped into three bins based on molecular 
weight: 11-12 kDa, 12-14 kDa and 14-16 kDa.  Core histones naturally fall into these rather 
narrow mass bins owing to their well-known molecular weights (H2A: 13.9 kDa, H2B: 
13.7 kDa, H3: 15.3 kDa, H4: 11.2 kDa).  Figure 8.14 shows the box and whisker plots for 
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For these plots, the height of the box conveys the range of values, the horizontal line within 
each box represents the median value, and the cross mark indicates the average value. For 
both activation methods, sequence coverage decreased as mass increased (Figure 8.14), an 
unsurprising trend considering the well-known mass dependence of top-down MS/MS 
proteomics methods.  The performance of EThcD and UVPD for characterizing 
modifications as a function of protein size is summarized in Figure 8.15, again for the 153 
modified proteoforms identified in common.  For this plot positive values represent 
instances where UVPD generated a larger C-score (i.e. based on the difference in C-scores 
for UVPD and EThcD). Figure 8.15 shows that as the proteoform mass and complexity 
increases (i.e. more modified forms), UVPD generally returns a higher C-score than 
EThcD, whereas the opposite outcome is true for proteoforms of lower mass. Proteoform 
mass is based on both the total number of residues in the protein plus additional 
modifications, thus the largest and most heavily modified proteoforms (generally histone 
H3 in the present study) fall into the largest mass bin, whereas the smaller and typically 
less heavily modified proteoforms (H4 and H2A) fall into the lower mass bins. In total, 77 
proteoforms were identified by both EThcD and UVPD for H3, whereas only 38 were 
identified by both EThcD and UVPD for H2A and H4.  This simple comparison of the 
number of identified proteoforms suggests that H3 has more combinatorial PTM variation 
which is consistent with prior reports 9,33,39.  The combined outcomes illustrated in Figure 
8.15 and Figure 8.14 are interesting because it demonstrates that although sequence 
coverages are generally similar for UVPD and EThcD, the greater number of fragment ion 
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types generated by UVPD particularly increases confidence in localization of 




Figure 8.14  Box and whisker plot showing the sequence coverage of proteoforms 
common to UVPD and EThcD from Figure 8.6b. Results were sorted by 




Figure 8.15  Box and whisker plot showing the difference in C-score of 153 proteoforms 
identified in common to UVPD and EThcD from Figure 8.6. Each bin 
contains the following number of proteoforms (11-12 kDa: 38, 12-14 kDa: 
38, 14-16 kDa: 77) 
 
The distribution of UVPD and EThcD C-scores for proteoforms modified 1 to 4 
four times was generated for total identified by either method Figure 8.16 and modified 
proteoforms found in common by both methods Figure 8.17. The C-scores were binned 
into three ranges (0-3, 3-40, >40) based on the principals laid out by Kelleher et al.55  
Briefly a proteoform with a C-score of 0-3 is poorly characterized, while a proteoform with 
a C-score of 3-40 is partially characterized, and a proteoform with C-score greater than 40 
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is considered well characterized. Both Figure 8.16 and Figure 8.17 show that as the 
number of modifications increase a greater percentage of proteoforms identified by UVPD 
garnered C-scores higher than 40 and UVPD identified more heavily modified proteoforms 




Figure 8.16  C-score distribution for all proteoforms identified by UVPD and EThcD 






Figure 8.17  C-score distribution for proteoforms identified in common by UVPD and 
EThcD with 1,2,3 or 4 modifications. 
 
Inspection of individual MS/MS spectra sheds light on the main reasons why HCD 
and EThcD outperform UVPD in some cases. In most instances in which HCD or EThcD 
significantly outperforms UVPD, the abundance of the precursor is low. The S/N of UVPD 
mass spectra is frequently lower than that of HCD or EThcD spectra for two reasons: (1) 
the production of a,b,c,x,y,z ions disperses the ion current among more channels, and (2) 
the laser power (photon flux) is kept relatively low to minimize secondary dissociation. 
Since the S/N of an MS/MS spectrum is related to the abundance of the precursor, it means 
that the overall performance of UVPD degrades for low abundance precursors owing to the 
inability to accurately deconvolve the resulting low abundance fragment ions. In cases in 
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which UVPD slightly underperforms HCD or UVPD, often HCD or EThcD generated a 
large series of fragment ions which entirely bracketed a particular modification, whereas 
UVPD only covered the modification with N-terminal or C-terminal ions but not both. In 
essence HCD or EThcD promoted more bidirectional fragmentation; some of the 
complementary fragment ions from UVPD might have been unassigned owing to low S/N 
and inadequate deconvolution of overly fragment-rich regions of the spectra. 
8.5 CONCLUSIONS 
Analysis of hundreds of histone proteoforms by HCD, EThcD and UVPD revealed 
the overall complementary nature of the three MS/MS methods based upon the large degree 
of shared identifications; however, the methods differ in their ability to characterize 
proteoforms. While HCD identified a greater number of proteoforms, EThcD and UVPD 
offered distinct advantages for histone analysis including greater sequence coverage (HCD: 
15±7%, UVPD: 28±17%, EThcD: 32±18%) and proficiency for characterization, measured 
as average C-score (HCD: 34±78, UVPD: 76±149, EThcD 78±139) for modified histone 
proteoforms. EThcD and UVPD displayed a great degree of complementarity regarding 
the number of identified proteoforms and sequence coverage. The ability of these 
techniques to characterize proteoforms varied based on the mass of the proteoform: EThcD 
displayed enhanced characterization of smaller proteoforms, while UVPD resulted in better 
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The growth of mass spectrometry based proteomics in the past decade is largely 
due to significant improvements in mass spectrometric instrumentation, tandem mass 
spectrometry methods, and database searching software. Along with these advancements, 
newer complex challenges such as intact protein analysis and analysis of PTMs have arisen, 
leaving much room for future improvements.1,2 The ability of tandem MS to generate rich 
and informative fragmentation of difficult samples will continue to play a critical role in 
overcoming these challenges.3 Therefore, continued development of novel fragmentation 
techniques such as UVPD which delivers an extensive and meaningful array of diagnostic 
product ions is crucial for the continued success of mass spectrometry based proteomics.4 
In chapter 3, a simple, cheap, and highly efficient derivatization scheme 
(carbamylation) was utilized to block the basic charges found on lysine residues and the 
N-termini of peptides and enhance deprotonation. In turn these passivated peptides were 
analyzed in the negative polarity mode (deprotonating conditions) and showed enhanced 
charging and sensitivity. This method was used to enhance the traditionally 
underrepresented acidic proteome. After derivatization and negative mode UVPD analysis 
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a nearly 30% increase in peptide identifications was reported compared to an underivatized 
sample. 
In chapter 4 peptide characteristics that directly influence the performance of two 
activation methods (HCD, UVPD) were compared on the basis of number of identified 
peptides, and sequence coverage. Overall HCD of basic tryptic peptides led to the greatest 
number of peptide identifications and greatest sequence coverage. However, when the 
peptides were longer (cleaved after only lysine residues) or had more acidic C-termini 
(cleaved after glutamic and aspartic acid) UVPD generated slightly better performance 
suggesting that UVPD is less dependent on mobile proton mediated dissociation. 
Additionally a very modest enhancement was noted for chromophore-bearing peptides 
(peptides having tryptophan, tyrosine and phenylalanine), reinforcing the role of photon 
absorption in the success of UVPD.5 
Carbamylation was revisited in chapter 5 to investigate the role of protonation in 
HCD and UVPD dissociation of intact proteins and the effect on their chromatographic 
characteristics. Results from dissociation of six model proteins showed that UVPD was 
able to achieve excellent backbone sequencing of fully carbamylated proteins, comparable 
to the unmodified versions. HCD was unable to generate satisfactory dissociation and 
yielded poor sequence coverage for all modified proteins except for ubiquitin which was 
the smallest protein studied (8.5 kDa.) These results support the hypothesis that UVPD 
dissociation of intact proteins is not primarily driven by mobile protons and so is minimally 
influenced by precursor charge state and protein modifications. Additionally, upon LC 
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separation of unmodified and carbamylated E. coli ribosomal proteins two trends were 
noticed: longer retention due to greater hydrophobicity after modification and improved 
peak shape due to reduced electrostatic interaction with the stationary phase (via capping 
charged sites through carbamylation at lysine and the N-terminus).  
Building on the established utility in chapter 1 of negative mode UVPD, in chapter 
6 HCD, positive mode UVPD, and negative mode UVPD were collectively used to improve 
the depth and breadth of coverage for a cell lysate of hepatocyte cells. The combination of 
positive and negative mode UVPD increased the number of peptides and proteins identified 
by 25%. Additionally, for the first time a widely available database searching algorithm, 
Byonic, was trained to analyze both positive and negative mode UVPD data. Byonic 
expanded the number of identified peptides and proteins over currently available software 
by more than 15%   
UVPD of large middle-down sized heavily modified histone peptides was 
investigated in chapter 7.  Histone modifications are biologically important for gene 
regulation, generating a very complex epigenetic code. UVPD performed comparably to 
the currently adopted method of ETD for determination of the distribution of modifications 
along the backbone of histone H3. Importantly it was discovered that the current state of 
the art workflow, which was developed for ETD, only utilized approximately half of the 
information rich UVPD fragment ions (by abundance). Upon manual interpretation of the 
most heavily modified forms UVPD showed distinct advantages which were reflected by 
several performance metrics. Additionally, it was found that like other methods UVPD 
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generates informative neutral loss ions which can be used to discriminate between two 
nearly isobaric modifications (acetylation and trimethylation). 
In chapter 8 shotgun UVPD analysis of intact histones was evaluated. When tested 
against HCD and EThcD, HCD identified the largest number of proteoforms. However, 
UVPD and EThcD were able to better sequence and characterize the identified proteoforms 
as measured by sequence coverage and C-score. Furthermore, UVPD better characterized 
the most heavily modified H3 proteoforms. 
9.2 FUTURE WORK 
 Future work should focus on developing new UVPD methods for facilitating the 
analysis of middle-down sized and intact proteins which contain biologically relevant 
modifications. In particular effort should  focus on training or developing software which 
takes full advantage of the rich array of ion types generated upon UVPD.6 
 One such class of proteins which would make an excellent candidate for UVPD 
analysis is glycoproteins. Glycoproteins serve many key biological functions such as 
protein-protein binding, receptor signaling and immune protection.7,8 The glycosylation 
patterns associated with these functions often involve extensive modification of the host 
protein.9 193 nm UVPD could be used to enhance analysis of glycosylated proteins. The 
extensive fragmentation afforded by UVPD allows precise localization of glycosylation on 
the protein backbone as shown in Figure 9.1 for avidin. Despite the impressive ability of 
UVPD to sequence the protein backbone and pinpoint glycosylations, enrichment 
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procedures and chromatographic methods also need to be developed to aid in the high-
throughput analysis of glycopeptides and intact glycoproteins.9,10 
 
 
Figure 9.1  UVPD fragment ion map of avidin from egg white. UVPD was able to 
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